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Surgical treatment for severe functional MR often involves mitral annuloplasty to improve leaflet
apposition and ultimately downsize the dilated mitral valve. However, the high rate of operative
mortalities of up to 6 ~12% have limited the more expanded use of this procedure. Recently, minimally
invasive percutaneous transvenous mitral annuloplasty (PTMA) approaches using entirely catheter-based
methods have been developed to reduce procedural morbidity and mortality. One of the approaches is to
utilize the proximal location of the coronary sinus (CS) to the mitral annulus (MA) to percutaneously
deploy a PTMA device within CS vessel. When the device contracts, it indirectly reshapes the MA and
decreases MR. Although the approach has been shown to be promising in several animal studies, device
dysfunction and fatigue fracture have been reported in human clinical trials. In this research, integrated
experimental and computational studies were performed to apply quantitative analysis to study the
biomechanical tissue-stent interaction (TSI) between PTMA device and CS vessel. Both human and
animal CS tissue properties were characterized experimentally and implemented into finite element (FE)
simulation. Realistic patient-specific geometries of the CS vessel were obtained from clinical imaging
data and reconstructed into three-dimensional (3D) FE model. By incorporating proper tissue material
properties and realistic 3D patient-specific geometries, FE simulation of the device deployment into the
vessel could be achieved to investigate TSI and the associated biomechanics involved in the system.
Quantitative understanding of the biomechanics in PTMA intervention is clearly an enabling step for
science-based design of the devices.
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1 Introduction*
Cardiovascular disease remains to be the number one killer in the United States. Among various
types of cardiovascular disease, valvular heart disease is a significant cause of morbidity and mortality. In
the United States, it is estimated that approximately 85,000 heart valve related procedures are performed
annually. Valvular heart disease is responsible for about 22,144 deaths per year [1]. The two most
common valvular heart diseases are aortic stenosis and mitral valve regurgitation. Structurally, mitral
valve is more complex than aortic valve, which result in under-treatment and consequently high rate of
mortality. In this dissertation, my research effort primarily focuses on the study of mitral valve function
and the modeling of the associated mitral valve intervention techniques. Thus, I will begin this chapter
with a brief introduction of the heart and its four valves, then the normal mitral valve structure and
function, followed by main clinical issues and current clinical treatment techniques for mitral valve
disease. Then, I will give a brief overview of current mitral valve biomechanical studies, which will lead
to the motivation of my research on the modeling of minimally invasive mitral valve repair.

*

Some of the contents of this chapter are taken from:

W. Sun, C, Martin and T Pham, "Computational Modeling of Heart Valve Function and Intervention ", Annual Review of

Biomedical Engineering, accepted.
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1.1 The heart and heart valves
The heart has four major valves: the aortic, mitral, tricuspid and pulmonary valves. As illustrated
in in Figure 1-1, the tricuspid valve is located between the right atrium and right ventricle. The pulmonary
or pulmonic valve is between the right ventricle and the pulmonary artery. The mitral valve is between
the left atrium and left ventricle. The aortic valve is between the left ventricle and the aorta. These valves
share a common function which is to ensure unidirectional flow of blood in and out of the heart.
Biomechanically, these four valves are primarily passive structures i.e., they open and close due to the
differential blood pressure on each side of the valve leaflets. Closure of the valve is achieved by
coaptation of the leaflets (or cusps). Proper coaptation of the leaflets prevents backflow of blood.
Diseases of the valve often involve improper closure of the leaflets; and the two most common heart
valve diseases are stenosis and regurgitation. Stenosis is narrowing of the valve orifice which results in
constriction of the blood flow. Regurgitation, on the other hand, is dilation of the valve orifice which
results in blood leaks back through the valve in the opposite direction. Other valvular diseases are
rheumatic diseases which results in valve leaflet prolapse, or billowing of the leaflets, and sometimes
cause regurgitation. The mitral and aortic valves are frequently affected by diseases because they are
located on the left side of the heart, where hemodynamic conditions are highly dynamics and deemed to
frequent alternations. The study in this dissertation will mainly focus on the mitral valve function and the
modeling of the associated mitral valve intervention techniques.
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Figure 1-1: Anatomical structure of the heart and the heart valves (adopted from www.webmed.com)

1.2 Mitral valve structure and function
The mitral valve (MV) is a complex yet elegantly structured cardiac valve that consists of four
anatomic components working congruently during a cardiac cycle: an annulus, two leaflets,
approximately 25 chordae tendineae, two papillary muscles, and the underlying left ventricular
myocardium (Figure 1-2). The mitral annulus (MA) of MV serves as a fulcrum for the leaflets. It is
subdivided into lateral (anterior) and septal (posterior) portions that separated by the two trigones [2]. A
lateral portion is mainly composed of cardiac muscles, while a stiff and dense fibrous section runs along
the septal section. This fibrous tissue is shared by the non-coronary aortic valve leaflet, often called
aortic-mitral curtain, where its left and right are formed by denser fibrous interleaflet triangles or trigones.
This region is less prone to dilation compared to the muscular septal portion, which often undergo mitral
repair by resecting extra tissues.
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Figure 1-2: The anatomy of human mitral valve within a) the left heart and b) dissected from
explanted heart showing mitral annulus, mitral leaflets, chords and papillary muscles. (Fig. a)
is adapted from http://www.heart-valve-surgery.com.

The MV has two leaflets, the larger anterior (AML) and the smaller posterior mitral leaflet (PML)
that are connected by the anterior and posterior commissural leaflet portions (Fig. 1-2b). The two leaflets
detach during diastole and coapt or meet during systole to prevent regurgitation. Both AML and PML
have two zones, the smooth that runs radial from the annulus to mid belly section and the rough zones
that ends at the leaflet free-edge, where rough zone corresponds to the insertion (bumpy) locations of
chordae tendineae. Histology of the microstructure of the MV leaflet revealed that it is composed of the
atrialias, spongiosa, fibrosa and ventricularis layers. Similar to aortic and other valve leaflet constituents,
the main components of MV layers include the extracellular cells, interstitial fibroblasts and connective
fibers. The atrialis comprises of a thin layer of endothelium and elastin/collagen fibers. The spongiosa
layer is mainly consists of extracellular matrix inconsisting of proteoglycans (PGs) and glyosaminglycans
(GAGs). The GAGs and PGs provide cushion to withstand compressive tension [3] and promote sliding
of collagen bundles [4], particularly proteoglycans which bind to the surface of collagen fibrils to transfer
load from fibril to the matrix to relieve the fibril stress [5]. The fibrosa is the thickest layer of the MV
leaflet and is the main load-bearing layer, consisting of GAGs/PGs and abundant circumferential aligned
collagen fibers from where the leaflets exhibiting its strength and stiffness under high systolic pressure
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loading. The stiffness of collagen fibrils of porcine AML was estimated to be 95.5 ± 25.5 MPa from
biaxial loading tension of > 20 N/m [6], compared to ~ 1 GPa stiffness of collagen strength found in
normal tendon. The ventricularis layer has elastin and collagen fibers with endothelial cell lining, where
the chordae tendineae (chords) are attached to. The structure and material properties at these attachment
regions were found to vary greatly due to the regional variations of collagen fiber angle and degree of
alignment that affect the stress distribution of the entire mitral valve leaflets [7]. The fibrous chords are
mainly composed of collagen bundles, which grant chord its stiffness and minimal extension that
restraining the leaflets from pillowing into the left atrium (LA) during systole. There are three types of
chords which are named in many ways, they are preferred as basal, marginal and strut chords herein. The
basal chords originate from the base of the leaflets and marginal chords from free-edge zone. While both
basal and marginal chords are multiple and vary in size, there are only two strut chords that attach at midlength of the ventricular surface of the AML. The chords can originate either from the two major papillary
muscles (on the anterolateral and posterolateral walls) or multiple small musclebundles attaching to the
ventricular wall. Normal MV function involves a proper force balance between each of its components
working congruently during a cardiac cycle.
Hemodynamics of the MV is highly complex that involves changes in pressure, and spatial and
temporal orientation of all components. Mitral valve opens during the diastolic filling cycle where the
annulus and leaflets are in resting and passive state. At late diastole, after left atrial systole, the pressure in
the LV begins to rise above the pressure of the left atrium, causing the mitral valve to begin closing. As
the pressure in the left ventricle rises rapidly during systole, the two leaflets begin to coapt. The mitral
valve leaflets experience large deformation during valve closure [8] that could bulge toward the left
atrium. However, bulging of the mitral valve leaflet is prevented by the tension of the chordae tendineae.
It has been shown that rupture of the chordae tendineae leads to malcoaptation of leaflets and
consequently valve regurgitation [9]. Contraction and motion of active muscles in the left atrial [10],
mitral annulus [11] and papillary muscles [12, 13] are also important for valve closure during systole.
Therefore, a balance of the mitral valve apparatus during systole enables proper leaflet closing.
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1.3 Main clinical issues and current clinical treatment techniques for mitral
valve disease
Heart valve disease is a significant cause of morbidity and mortality. In the United States, it is
estimated that approximately 85,000 valve related procedures are performed annually. Heart valve disease
is responsible for about 22,144 deaths per year [1]. In the past two decades, major advances have been
made towards our understanding of the natural history of valvular heart disease. These advances have
resulted in enhanced diagnostics, as well as interventional cardiology and surgical procedures, and have
increased patient survival. However, valve procedures still have an overall in-hospital mortality rate of
4.22%, a figure that is much higher than that for many other cardiac procedures, including: coronary
bypass graft surgery, percutaneous coronary intervention, and defibrillator implantation.
The two most common presentations of valve disease are aortic stenosis and mitral valve
regurgitation. Mitral regurgitation (MR) is an abnormal leakage of blood from the left ventricle (LV) back
into the left atrium during systole (Figure 1-3). Pathological alterations affecting any mitral valve
component, such as mitral annulus (MA) dilatation, papillary muscle displacement, leaflet calcification
and myxomatous disease can lead to altered mitral valve function and cause MR [14].

Figure 1-3: (a) a normal mitral valve function during systole and b) mitral valve with MR - an abnormal
leakage of blood from the leftventricle back into the left atrium during systole. (adopted from
http://uvahealth.com)
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MR is one of the most common valvular lesions with a prevalence of 1 to 2% among adults [15],
and this prevalence rises up to 13.2% beyond the age of 75 [16]. Moderate to severe MR occurs in up to
19% of patients after myocardial infarction and in 15% of patients with dilated cardiomyopathy [17, 18].
In these patients with functional MR, a combination of changes in left ventricular and mitral annulus (MA)
geometry/function induces leaflet malcoaptation and regurgitation. Functional MR represents a major
clinical challenge, often poorly recognized and undertreated, and is associated with high mortality [19].
Standard treatment techniques for MR are MV repair or replacement. The MV repair, benefited
from improved understanding of MV mechanics and function, is now a preferable surgical approach to
valve replacement. Common MV repair techniques include triangular or quadrangular resection, slide
annuloplasty, ring annuloplasty, chordal cutting and transposition [20], artificial chord use [21, 22] and,
recently, percutaneous technologies[23]. Surgical annuloplasty has been a commonly used treatment
technique for severe functional MR intending to improve leaflet apposition by posterior annular
correction. However, the reported operative mortalities of up to 6 ~12% have limited the more expanded
use of this procedure [24-27].

1.4 Current biomechanical analysis of mitral valve function and intervention
The MV’s primary function is essentially mechanical - preventing backflow of blood back to the
left atrium during systole. Thus, biomechanics plays a central role in its function. Biomechanical analysis,
encompassing experimental characterization of tissue properties, constitutive modeling of experimental
data and computational simulations of tissue behavior, is playing an increasingly important role in
enhancing our understanding of the normal MV physiological function, etiology of MV diseased states,
surgical and interventional planning, and in the design and evaluation of artificial MV implants. In this
section, I will give a brief review of methods of testing methods, modeling and computational simulation
techniques.
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1.4.1

Review of the state of the art of the biaxial testing method
Testing methods to characterize MV tissue properties usually include uniaxial and biaxial studies

of material properties of MV, and pressure-inflation tests of structural properties of MV. As shown the
following chapters, I have been using the biaxial testing method extensively to obtain MV tissues
mechanical properties, thus its testing setup and theories behind the data analysis are briefly summarized
here.
Illustrated on Figure 1-4 is a typical setup of a biaxial testing device. Biaxial experiments are
generally performed a square piece of planar soft tissue, with the sample of about 10-25 mm of lateral
length. The specimen is mounted to the biaxial device in trampoline-like fashion using thin threads, which
allows the edges to expand freely in the lateral direction. Testing is generally performed with the
specimen completely immersed in phosphate buffered normal saline (pH 7.4) at room or body (37 C)
temperature. The central target region must be sufficiently small and located away from the outer edges to
avoid the tethering effects. Thus, in the central target region the stress and strain field is generally
considered homogeneous.

Figure 1-4: a) The biaxial testing system with an actual testing setup, showing the camera, the
two load cells, the two signal conditioners and the four motors; b) A representative specimen is
submerged in an appropriate physiologic solution, marked with four black graphite particles
(optical markers for strain measurement) and attached to the device via four hooks at each side.
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The following is a brief summary of the most important aspects of the kinematics of a biaxial
mechanical test [28]. Consider deformation of membrane tissues under a biaxial stress state, including
non-zero in-plane shear stresses. For this case, let 0 and  be the (fixed) reference and deformed
configurations of the continuous body, respectively. Consider the general mapping  : 0  R 3 , which
transforms a material point X  0 to a position x  ( X )   in the deformed configuration. For
planar homogeneous deformations that occur during a biaxial test, this mapping reduces to

x1  1X1  1X 2, x 2   2 X 2   2 X1, x 3  3 X3

(1.1)

where i are the axial stretch ratios and i measures of in-plane shear. i and i are also components of the
deformation gradient tensor F, which for deformation described in eqn. 1.1 is F  Grad( x ) or

 x1
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 x
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 x3
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X 2
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X 2
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X 2
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   2 2 0 
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 0 0 3 
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(1.2)

where the out-of-plane stretch 3  h/ H is the ratio of deformed (h) to the undeformed thickness (H) of
specimen. F is a critical mathematical quantity since it completely describes the deformation state. Since
soft tissues are composed primarily of water and have negligible permeability [29], they can be
considered incompressible so that J=detF=1. From F the right Cauchy-Green deformation tensor is
defined as C=FTF, from which the components of the in-plane Green-Lagrange strain tensor E = ½ (C –
I), where I is the identity tensor. E is the most common finite strain measure in the soft tissue literature
due to the simplicity of the constitutive formulations. In practice the components of E are computed more
directly using:
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The components of F are determined optically to avoid any mechanical interference with the specimen.
As mentioned above, biaxial testing of biological tissues is performed using thin specimens (no
more than ~3 mm, usually <1 mm) and acted on by only in-plane loads. A state of plane stress is thus
assumed so that the components ti3 (i=1,2,3) of the Cauchy stress t (force/deformed area) are 0. During
actual experiments one can directly measure only the initial specimen dimensions, so that the Lagrangian
stresses T (force/unit original cross-sectional area) are used for convenience. The components of T are
computed from the measured axial forces P using

T11 

P1
,
hL 2

T22 

P2
hL1

(1.4)

where h is the specimen thickness and Li are the specimen lengths. Since experimentally applied loads are
normal to the edges, T12=T21=0. The 2nd Piola-Kirchhoff stress tensor S is the most commonly utilized
stress tensor for soft tissue constitutive theories, and is determined using S=TF-1. The Cauchy stress
tensor t is determined using t=FT/J, which in component form is given by (with T12=T21=0):

t11 1 T11 , t22 2 T22 , t12 1 T22 , t21 2 T11

(1.5)

In the case where there is negligible shear strain (i.e. E12~0), the normal components of the two stress
tensors are related by:
S11 = T11/1, S22 = T22/2
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(1.6)

1.4.2

Review of constitutive models of heart valve mechanical properties
Linear elastic models. Early attempts to describe valve tissue properties relied on the linear

elastic material model, following the generalized Hooke’s law [30, 31]
,
where

is the stress tensor,

is the strain tensor and

(1.7)
is the fourth order elasticity tensor. Linear

elastic models are appropriate when the stress-strain relationship is indeed linear, and are typically
restricted to relatively small deformations. Linear elastic material properties were chosen for various
reasons [32-34], but mainly to simplify the simulation process in order to achieve numerical convergence
in FE simulation solutions. Over the physiological range of pressures, valve tissues have been shown to
exhibit a relatively linear stress-strain relationship [35]. However, for a FE simulation of valve
deformation from the undeformed state to a deformed state, the valve material response is clearly
nonlinear and the use of nonlinear material models is essential for any realistic valve simulations.
Fung-elastic model The Green-strain based exponential model proposed by Fung [29] is
probably the most commonly used hyperelastic model for characterizing the mechanical response of soft
tissues [29, 36]. A two-dimensional Fung-type strain energy function W can be expressed as:
1,
2

(1.8)
2

2

where c and Ai are material constants, E is the Green strain tensor. Note that Eqn. (1.8) has other variants
that could be easily treated as a subset or expansion of this model [37]. Eqn. (1.8) is often used to model
planar biaxial mechanical responses of valve tissues [38] and should be implemented with plane stress
elements, such as shell or membrane elements. One problem with Eqn. (1.8) is that the transverse shear
stiffness in the 13 and 23 directions are undetermined due to the lack transmural response definitions in
this model. As shown by Sun et al. [37], valve peak stress is insensitive to change of TSS values for the
valve closure simulation. However, to simulate valve opening, the tissue bending response is critical, and
without accurate transverse shear stiffness values, the use of Eqn. (1.8) may give inaccurate results. The
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details on the FE implementation of Eqn. (1.8) can be found in Sun and Sacks [37]. The 3D Fung model
has not been widely used to model valve functions. Labrosse et al. [39, 40] has successfully utilized a 3D
Fung model in simulation of native AV deformation.
Strain invariant-based fiber-reinforced hyperelastic model. Weiss et al. [41] and Holzapfel
[42] presented a computational framework to implement strain invariant-based models that can
accommodate the effects of one or two families of elastic fibers. To use this class of models, typically,
the valve tissues are assumed to be composed of a matrix material with two families of imbedded fibers,
each of which with a preferred direction. The deviatoric strain invariant I is used to describe the matrix
material; and I4i is used to describe the properties of the fiber families. One example of such models
proposed by Holzapfel et al. [42] can be expressed as
W=C10 I1 -3 +

k1
2k2

∑2i=1 exp k2 κI1 + 1-3κ I4i -1

2

-1 +

1
D

J-1

2

, i=1,2

(1.9)

where, C10, k1, k2 and D are material constants. Particularly, C10 describes the matrix material and D
enforces near incompressibility. In addition, a dispersion parameter, κ, is used to describe the distribution
of the fiber orientation. Local coordinate systems should be defined for each leaflet to include fiber
orientations. There are several variations of the model that have been applied to heart valve simulations.
Prot et al. [43] implemented the Holzapfel material model into the analysis of healthy and pathological
human mitral valves. Wang et al. [44, 45] simulated AV and MV functions with a variation of the
material model. Similarly, in the study by Stevanella et al. [46], the MV dynamics were simulated where
leaflet properties were characterized through a transversely isotropic model proposed by May-Newman
and Yin [47], while the same material model was used by Conti et al. [48] and Auricchio et al. [49] to
simulate AV biomechanics.

1.4.3

Review of computational studies of MV function and intervention
Kunzelman and co-workers were among the pioneers in developing 3D FE models of the normal

[31] and pathologically altered [50, 51] MV. Their MV model, albeit limited by symmetric geometry
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based on the excised porcine MV, included all the essential components of a MV. The model has been
used extensively to analyze various MV repair procedures [50, 52, 53]. Although various designs of
annuloplasty rings including: undersized, rigid, semi-rigid, flexible, D-shape and dog bone shaped, are
commercially produced, the optimal shape is uncertain. Kunzelman et al. developed static FE models of
the normal and dilated MV to simulate the effects of flexible and rigid annuloplasty rings [50].
Subsequently, Maisano et al. [54] and Votta et al. [34] showed that dog bone-shaped annuloplasty with
selective reduction in the septolateral dimension is more effective than a conventional prosthesis for
treating leaflet tethering in functional MR. These studies however excluded or simplified the LV
geometry. Wong et al. [55] reconstructed a 3D FE model incorporating the LV, annulus and chordae
tendineae from 3D cardiac MRI images of sheep. They successfully simulated the MR scenario and
observed that the stress reduction with the saddle-shape MA was slightly greater than that of the
asymmetric rings. More recently, research groups have begun to construct in vivo patient-specific MV
models using clinical Echo [56, 57] and MRI [46, 58]. For instance, 3D Echo images were used by Xu et
al. [56] to reconstruct MV models to predict leaflet and chordal stresses. MV geometries were perturbed
to examine how MV leaflet coaptation area, non-coapted leaflet area and inter-leaflet coefficient of
friction, affect leaflet and chordal stress distribution. Their results indicated that mitral valve repair
techniques that increase or preserve noncoapted leaflet area might decrease stresses and thereby enhance
repair durability. Similarly, Stevanella et al. [46] utilized cardiac MRI to develop patient-specific MV
models of one healthy subject and one patient with ischemic MR. Their diseased model captured actual
regurgitant characteristics and revealed abnormal tensions in the annular region and subvalvular
apparatus.
One of the inaccuracies in MV modeling is the bulging of anterior leaflet into the atrium, which
could be due to incorrect assumptions about chordal length, chordal origins and insertion points at the
mitral leaflets. Such structure details are not distinguishable in the current clinical MRI or TEE images
due to their poor spatial resolution. Multi-slice CT images offer much better spatial resolution, e.g., 64-
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slice CT of 0.625mm. CT images were used to reconstruct patient-specific MV models in the study by
Wang and Sun [45]. In the study, the MV models incorporated not only the mitral leaflet thickness, but
the papillary muscle locations, chordal origins, and chordal insertion points, as shown in Figure 1-5.
Dynamic motions of the mitral annulus and papillary muscles were obtained from middle systole and
middle diastole; and were prescribed as boundary conditions for the FE simulation. Simulation results
were validated by comparing FE deformed MV geometries with the CT images at systole and a close
match was obtained (Figure 1-5c) [45]. Significant bulging of the mitral leaflets was not observed at peak
transmitral pressure [45]. As there is evidence of muscle fibers and innervation in mitral leaflets [59],
Skallerud et al. [60] applied a simple active stress component into modeling the porcine mitral valve,
which resulted in a significant reduction in the leaflet bulging.
Percutaneous catheter-based Edge-To-Edge (ETE) repair using MitralClip has grown rapidly in
Europe during the past years. Over 10,000 MitraClips have been implanted worldwide to date [61]. MV
mechanics under ETE repair conditions are thus of great interest. Using idealized geometries of the MV
and LV, Radealli et al. [62] and Fiore et al. [63] were able to provide a good estimation of the pressure
drop across the ETE repaired valve and assess the leaflet stress pattern from the 8-mm ETE suture [64].
Consistent with clinical observations, FE simulations confirmed that using an annuloplasty ring in
conjunction with ETE is favorable if mitral annular dilation is present, because it could reduce leaflet
stresses [65, 66]. Dal Pan et al. [67] employed a parametric study of the ETE technique to investigate
stress and strain distributions on leaflets at various suture positions and extension lengths as well as
dilated annulus dimensions. The study provides useful analyses for technique improvement and
optimization.
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Figure 1-5: (A) The CT long-axis two chamber view of a close mitral valve (MV) showing a good
visualization of chords and papillary muscles (PMs); (B) the short-axis and long-axis views of the
reconstructed finite element (FE) MV model overlapped with the CT images; (C) the overlapping of
geometries of the close MV valve from the CT scans (green) and the simulated result (red) after applied a
pressure demonstrates a good match; open MV valve geometry and the anatomical locations of chordae
tendineae with chordal origins and papillary muscles are shown in the (D) long-axis & (E) short-axis
views.
There are relatively few FSI studies on MV structural and hemodynamic function. Kunzelman et
al. [68] developed a fully-coupled FSI model using the LS-DYNA (Livermore Software Technology
Corporation, Livermore, CA). The model was substantially enhanced from their previous models [31] by
incorporating a fiber-reinforced hyperelastic material model for the leaflets, non-uniform leaflet
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thickness, branched chords and fluid flow. The simulation results agreed well with physiological data
reported in the literature. By varying the parameters of the fiber model, the authors also investigated
effects of pathological changes. More recently, Ma et al. [69] developed a FSI MV model using the
immerse boundary method. The model was generated from MRI data of a healthy patient. Linear elastic
material models were used for both leaflets and chords. From the simulation results, the authors
concluded that the differences in the thicknesses of the leaflets play an important role in maintaining the
physiological curvature of the MV leaflet during its dynamic motion. Neither Kunzelman et al. [68] nor
Ma et al. [69] incorporated the left atrium and LV into their models. Dahl et al. [70], however, reported a
FSI study on the MV behavior during LV filing with the realistic left atrium and left ventricle obtained
from echocardiography. Although limited by performing a 2D simulation with prescribed rigid wall
motions (thus, not a coupled FSI), their results underscored the importance of incorporating the
asymmetric leaflet geometry and left atrium to obtain accurate MV flow fields.

1.5 Emerging percutaneous mitral valve repair methods
A number of new approaches to percutaneous treatment are now developing rapidly.
Percutaneous edge-to-edge mitral valve repair using the MitraClip ® system is the only endovascular
approach that demonstrates as a viable treatment option for severe MR patients when compared with
standard surgical repair in a randomized trial. Over 10,000 MitraClips have been implanted worldwide to
date [61]. However, a considerable number of patients with functional MR will present with extensive
annulus dilatation and minimal vertical leaflet coaptation that potentially preclude them from this
beneficial technology for anatomical reasons [71].
Recently, since 2006, there have been several new minimally invasive transcatheter devices to
treat MR utilizing the coronary sinus (CS), because of the advantage of proximity of the CS location to
the MA, as a conduit to deliver a device that partially encircles the mitral annulus. Illustrated in Figure
1-6 is one of PTMA devices. This PTMA device is consisted of a 12F-outer-diameter guide catheter and
dilator, a 9F delivery catheter, and a nickel-titanium alloy (Nitinol) implant. The implant itself is
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composed of three sections: a distal self-expanding anchor, a springlike “bridge,” and a proximal selfexpanding anchor. The proximal and distal self-expanding anchors, once embedded within the coronary
sinus (CS), will expand and position at the CS ostium and the great cardiac vein (GCV) ends,
respectively. The bridge element can be shortened. Hence, it will pull the proximal and distal anchors
together, displacing the posterior annulus anteriorly and reducing the mitral annulus diameter in the
septal-lateral distance.

Figure 1-6: Illustration of a PTMA device deployed into the CS vessel, which is adjacent to the mitral
valve posterior annulus. “Ant.” for the anterior mitral leaflet and “Post.” for the posterior mitral leaflet.
Several animal and human clinical trials using various PTMA devices have recently been
conducted [27, 72, 73]. Although early clinical efficacy was demonstrated, device dysfunction and fatigue
fracture were reported in these studies. The first-in-human clinical trial of the PTMA Monarc device, by
Edwards Lifesciences as showed in Figure 1-6, in five patients was conducted by Webb et al. [72] in
2006. In this study, device fracture at the bridge section was reported in three patients and severe MR
grade recurrence was observed after bridge separation. In addition, although no severe injury of CS was
detected, compression of surrounding artery (i.e., left circumflex artery) was reported [72-76]. Because
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the PTMA device is directly in contact with the CS, the biomechanical interaction between the device and
the tissue could be a critical factor for device ending results.
For three percutaneous devices reported in 2006 and 2007, the results were all suboptimal. The
CARILLON device (Cardiac Dimensions, Kirkland, Washington), which consists of distal and proximal
anchors (Nitinol and titanium) and joined by a Nitinol ribbon connector, could reduce the dilated annulus
by manually pulling the proximal anchor toward the CS ostium. Duffy et al. [73] observed that the distal
anchor of a Carillon PTMA device did not hold tension during device traction in two of five temporarily
implanted patients. Due to the difficulty in anchoring to the CS wall, a second generation device was
developed with a twist at the distal anchor. The device was implanted in humans for up 6 months of
follow-up [77]. A total of 30 out of 40 patients successfully received the device with an average of 23%
MR reduction. However, three patients suffered from CS perforation and dissection.
Another device, Viacor (Viacor, Wilmington, Massachusetts), consists of up to three rigid Nitinol
rods. Various rod sizes and stiffness are used to achieve the desired MR reduction. The issues with this
device were associated with fracture, migration and delivery failures due to the vast difference in CS
structures and geometries [27, 78]. Dubreuil et al. [79] reported temporary placements of a Viacor PTMA
device in patients with an ischemic MR and MA dilation. They found that the MA diameter after the
device implantation remained large compared to the surgical annuloplasty results.
Following the study by Webb et al. [72], A more recent study in 2010 on the second generation
Monarc PTMA device reported a reduction in MR by ≥ 1 grade at 12 months in 50% of 22 implanted
patients [80]. Unsuccessful implantations were associated with the lack of appropriately-sized devices (n
= 13), inaccurate device positioning resulting in no MR reduction (n = 4), device migration (n = 1) and
fracture of the proximal anchor (n = 4).
Currently only one device (Carillon, Cardiac Dimensions, LLC) remained in clinical trials.
Despite the early failure and challenges encountered in these indirect approach techniques, the CS route
remains highly attractive due to its simplicity. Thus, evaluation and knowledge of the CS structure and
anatomy both before and during the implant procedure is critical.
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Another minimally invasive mitral valve technique, called direct annuloplasty approach, involves
direct implantation of a minimally invasive device into the mitral annulus, which is more similar to the
surgical annuloplasty ring. So far two companies Mitralign and Guided Delivery Systems have developed
devices using a direct approach. Although the direct approach has an advantage of avoiding coronary
compression, it is more challenging than the indirect approach where the mitral annulus is assessing
directly. Percutaneous mitral repair and replacement techniques are still in early development phase, and
much more experimental and clinical trials are anticipated.
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1.6 Motivation of the dissertation
Percutaneous transvenous mitral annuloplasty technique is still at its infant stage. The underlying
biomechanical interaction between venous and mitral tissue and PTMA device is largely unknown.
Device fatigue failure, as reported by Webb et al. [72], reflects the pressing need for a clear understanding
of the biomechanical environments that the devices experienced. Unfortunately, up to today, there is no
comprehensive study on the biomechanics of PTMA procedure in the literature.
Quantification of the mechanical properties of the CS vessel is critical for estimating the tissueimplant biomechanical interaction and for understanding device failure mechanisms. Although the
anatomical studies of the CS have been well reported [81-83], there is a dearth of study on the mechanical
properties of the tissue. One of objectives of this dissertation research is to quantify the CS structural
(Chapter 2) and material (Chapter 3) properties and compare them among different species, i.e., porcine,
ovine and human, to elucidate the biomechanical difference between these species, which may explain the
discrepancy between animal and human clinical trials. To evaluate the cinching effect, via the contractive
force of a PTMA device applied to the CS, on the change of mitral annulus area and the amount of MR,
an ex vivo whole heart experiment study (Chapter 4) is needed. Building upon the experimental data, a
computational analysis can be performed to quantify the stresses and strains that are on the CS tissue and
PTMA stents. PTMA device deployment process requires two essential steps, 1) development of the
anchoring stent, and 2) device contraction to reduce MR. Thus, the PTMA stent fatigue study should be
conducted at the anchoring stents (Chapter 5) and the whole device with the bridge (Chapter 6).
The overall goal of this dissertation is to investigate the biomechanics involved in the
transcatheter repair of functional MR using the coronary sinus annuloplasty approach. Using a combined
innovative experimental and computational approach, the biomechanics of PTMA can be effectively
investigated. The objectives of this dissertation are:
 Establish quantitative dataset for tissue structural and material properties and geometries
related to the PTMA intervention.
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 Provide engineering analysis of stress and deformation of mitral tissues undergoing PTMA
intervention using computational methods.
 Predict PTMA device failure modes and provide insights for implant design improvement
Successful completion of the proposed work will establish a computational simulation procedure,
not only applicable to Monarc PTMA, also to other future devices using the indirect coronary sinus
approach. The procedure includes collection of experimental data and constitutive modeling techniques to
characterize the mechanical properties of mitral tissue, and finite element modeling of mitral valve
geometry (based on clinical cardiac images), which will enable the simulation of PTMA device
deployment and device-tissue interactions, and prediction of PTMA failure modes. Such biomechanical
simulations will allow one to virtually assess and predict results of PTMA intervention, which is
unprecedented in academia and the heart valve industry.
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2 Characterization of Structural Properties of Porcine
Coronary Sinus Vessel*
In the next two chapters, the three experimental studies used to characterize the biomechanical
properties of the coronary sinus vessel will be introduced. The experimental characterization of tissue
biomechanical properties is challenging and important that provides information necessary to formulate
constitutive relations as well as solving many boundary condition and initial value problems in
biomechancs. The most common experimental methods for quantifying mechanical properties of soft
tissues include tensile uniaxial test, planar biaxial test and inflation tests. Because the coronary sinus
vessel serves as a conduit for the deployment of the PTMA device for the treatment of functional mitral
regurgitation, characterization of CS structural response is an important step toward an understanding of
tissue-device interaction in the PTMA intervention. In this chapter, structural characterization of the
porcine CS vessel using pressure-inflation test and constitutive modeling using a four-fiber family model
will be introduced.

The contents of this chapter are published partially in:
T. Pham and W. Sun, Characterization of mechanical properties of coronary sinus
for percutaneous transvenousmitral annuloplasty, Acta Biomaterialia 6(11): 4336‐4344 (2010).
*
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2.1 Introduction
2.1.1

Anatomy and structure of coronary sinus vessel
Coronary sinus is a large venous vessel that returns deoxygenated blood from the left heart and

drains into the right atrium. It begins at the termination of the great cardiac vein (GCV), marked by the
valve of Vieussens internally and the small oblique vein or vein of Marshall (OV) externally. Located in
the sulcus of the atrioventricular groove, CS runs along the posterior side of the annulus of the left atrium
and ends at the Thebesian valve, where it marks the CS ostium [81-83].

A study by Valle-Fernadez et al. [84] showed that there are dynamic changes in the relationship
between CS/GCV and the MA. From 56 patient computed tomography angiographies, the distance
between CS/GCV and MA progressively increased over the first 4 to 5 cm of the CS/GCV trajectory and
decreased afterward (p < 0.001). The CS/GCV was larger in phase 40% (end-of-systole) than in phase
75% (mid-diastole) and was smallest in phase 0% (end-of-diastole). El-Maasarany et al. [85] showed that
there are three patterns for the CS/GCV and MA relation (described as six regions, each 36 degree wide):
1) pattern A: CS was widely separated from the MA at 9.4, 10.6, 9.9, 9.1, 6.6 and 5.8 regions, 2) pattern
B: CS was widely separated from the annulus at its ostium and became closer distally towards the GCV at
11.6, 11.1, 10.6, 9.8, 8.3 and 7.0 mm, and 3) pattern C: a non-consistent pattern.
These findings indicate that there is a highly variation in the CS/GCV/MA geometries and
dynamic changes. Several studies also noted the coronary artery traverses between the CS/GCV and the
MA [84]. Therefore, patient selection for the PTMA technique to reshape the MA using CS approach
needs a detailed prospective imaging evaluation.
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Figure 2-1: The major tributaries of the CS, with a) of the great cardiac vein (GCV) and the oblique vein
of Marshall (OVM), b) the inferior left ventricular vein (VA).

2.1.2

Porcine versus human models
Porcine hearts were studied in various medical applications due to their similarity in structures

with human hearts. Similar to human CS vessel, porcine CS vessel has the same major tributaries, which
are the great cardiac vein (GCV), the oblique vein of Marshall (OV) that descends along the lateral and
inferior wall of the left atrium and joins the GCV to form the CS, and the inferior left ventricular vein
(VA) that drains from the diaphragmatic surface of the left ventricle (see Figure 2-1). However, we
noticed that there is a distinct difference between porcine and human coronary sinus. Unlike human OV
which is small [81, 83], porcine OV’s diameter is as large as the CS’s diameter (see Figure 2-1a) and
there is no obvious landmark that separates this vessel from the CS. Illustrated in Figure 2-2b is the CS
cut along its long axis. The internal surface of the CS resembles the right atrial endocardium, other than
the endothelium of a vein. The free wall of the CS is surrounded by a striated myocardial fiber (SMF) cuff
that runs obliquely starting from the OV. Superior to this SMF sheet is a thin layer of connective tissues,
which also surrounds the OV (Figure 2-2a). The anterior part of the CS is attached to the left atrial
appendage (LAA), and the barrier between the LAA and CS can also be identified, see long-dashed line
in Figure 2-2c.
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Figure 2-2: –

a) Coronary sinus (CS) vessel fixed in 10% formalin in 2 days, with its

connective tissue (CT) being peeled off exposing the striated myocardial fiber (SMF) layer, b)
axial view and c) its closer view of the CS’s inner wall with distinctive layers of SMF, CT, and
left atrial appendage (LAA). The long-dashed line indicates the barrier between CS wall and
LAA.
In this chapter, we reported, to our knowledge, the first biomechanical characterization
of the CS vessel using a porcine model. A pressure-diameter inflation test was performed on
the CS vessel at its intact, in-service configuration, e.g. CS was not dissected from its
surrounding myocardium, to quantify its in vitro mechanical responses. A structure-based
strain energy function (SEF) was utilized to characterize the nonlinear hyperelastic properties
of the vessel wall. In addition, the microstructure of the CS through histology was studied to
elicit its structure and relate it to its mechanical properties.
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2.2 Materials and Methods
2.2.1

Pressure-inflation experiment
Coronary sinus is a large venous vessel that returns deoxygenated blood from the left heart and

drains into the right atrium. It begins at the termination of the great cardiac vein (GCV), marked by the
valve of Vieussens internally and the small oblique vein or vein of Marshall (OV) externally. Located in
the sulcus of the atrioventricular groove, CS runs along the posterior side of the annulus of the left atrium
and ends at the Thebesian valve, where it marks the CS ostium [81-83]. In this study, we focused on the
material characterization of the CS ostium region about 10 mm from the Thebesian valve since it is the
region that is directly in contact with the proximal anchor stent of the PTMA device. Porcine hearts were
used in this study because of similarity between porcine and human hearts for mitral valve related
applications [86].
A total of seven fresh porcine hearts, typical of 6 - 9 months old with a weight range of 400 - 500
g, were obtained from a local abattoir. Upon delivery with ice, they were subjected to vessel pressureinflation testing within 48 hours. Prior to testing, the hearts were separated from excess tissues (e.g. aorta
arch, fat) and blood clumps. The right atrium was incised to expose the CS ostium and a small section
about 5 mm from the CS ostium was detached from the left atrial appendage (LAA) for the purpose of
connecting the plastic cannula to the CS for the inflow pressure. The plastic cannulas were varied in sizes
to fit with various CS diameters (e.g. 4, 6, & 8 mm). The other end of the CS (at the junction of the CSGCV) was secured with a surgical forceps. To ensure pressure stabilization, all other branches of CS
vessel were occluded with ligatures. Then the whole heart was submerged in a small plexi-glass tank (21L
x 18W x 18H mm, 2.8 mm thick), and the front side of the tank was replaced with a thin (0.35 mm thick)
clear plastic sheet for the purpose of imaging. The tank was filled with Ca2+-free saline solution at room
temperature. The heart was stabilized by resting on a sponge placed at the bottom of the tank. The cannula
at the CS ostium end was connected to the pressure gauge, which was linked by a flexible plastic tube to
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the water tank where a hand-operated pump was used to apply pressure to the CS. The ultrasound probe
(7.5 MHz transducer of RT320, General Electronic Inc.) was projecting perpendicular to the CS at the
clear plastic sheet side of the tank to collect 2D cross-sectional images of the CS, see Fig. 2-3a. Since the
water tank is clear, ultrasound wave traveled through the tank, the water and to tissue and traveled back to
the probe. All data were recorded at the cross section about 10 mm from the CS ostium.
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Figure 2-3: A) An ultrasound image of cross section of the inflated CS vessel, with two line segments D1
and D2 for measuring diameters and three line segments T1, T2, and T3 for thickness measurements; B)
thickness measurements using the FWHM method (to obtain Tpixel, or thickness in pixel—width of the
half amplitude of the peak), and C) diameter measurements (distance between the two crosses—in pixel),
both processed by the Matlab improfile function.
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Each specimen was subjected to preconditioning by inflating up to 80 mmHg and then
venting the pressure back to 0 mmHg.
hysteresis.

This process was repeated 20 times to minimize

Testing was then conducted by increasing pressure from 0 to 80 mmHg in

increments of 5 mmHg per second. At each pressure, a 2D ultrasonic image of the CS crosssection was taken immediately using a custom-made image capturing software. A total of 17
images were taken for each heart, and inner diameter and CS wall thickness data were
measured using an image post-processing code written in Matlab (Mathworks, Natick, MA).
Utilizing ultrasound images to capture the cross-sections of CS geometry during the inflation
test allows a direct measurement of tissue thickness. This method may provide a more accurate
estimation of circumferential stretch and stress using Eqns 2.1-2.3 below, compared to other
methods that used the derived thickness based on markers on the surface of vessel, particularly
when the vessel is curved and partially imbedded in surrounding tissues.

2.2.2

Ultrasound Image Analysis
All images were imported into the Matlab program and analyzed using a Matlab function called

improfile. Briefly, the image processing technique involved identifying boundaries of tissues from the
change of impedance of the medium when the ultrasound wave travels from water to tissue and from
tissue to water. The change of impedance resulted in the change of the image intensity, where high
(white) and low (black) intensity determine the tissues and water, respectively. The improfile function
will identify the intensity values along a line or a multiline path specified by the user, performing
interpolation to find the intensity value for each pixel, and graphing these intensity values. Both diameter
and thickness values were determined by detecting the pixel-value along line segments (Fig. 2-3b & c).
For diameter measurements, two line segments were drawn across the anterior-posterior and
superior-inferior view on the vessel. As CS is partially imbedded in the myocardium, the inflated vessel
circumference at low pressure may not be circular. Therefore, two measurements of diameters were

29

recorded and averaged. A center point was determined from an intersection of these two lines. Thickness
was measured by drawing three lines, which originate from the center point and each goes separately
through three different sections across the thickness, see Fig. 2-3a. Thickness measurement was estimated
using a basic image analysis technique called Full-Width Half-Maximum (FWHM) [87]. Real
measurements of tissues using a non-rotating thickness gauge (Mitutoyo, Model 7301) determined that
FWHM provided a good approximation of thickness. Basically, FWHM is the full width of the section
(across CS wall) at the half maximum value (intensity value). Three measurements of thickness were
averaged to obtain the mean. Units in pixel were converted to lengths according to ultrasound image
calibration.

2.2.3

Histology
Each CS vessel was removed from the heart and fixed in formalin for 24 hours prior to the

histology process. Cross-sections through the thickness of both anterior and posterior CS sections were
examined. Each sample was sliced into 6 μm piece in both circumferential and longitudinal directions
using a cryostat microtome and then stained with the Verhoeff Van-Gieson (VVG) stain. Thus, the black
strands are elastic fibers and the bright red materials are the collagen fibers. Muscle fibers can also be
distinguished with a duller red or light brown color. Histological images were obtained through an
Olympus220 digital camera that coupled to an OlympusCX41 light microscope and analyzed using
LabView software (National Instruments, Austin, TX).

2.2.4

Constitutive modeling
The pressure-radius data were utilized to characterize CS mechanical properties using a four-fiber

family SEF [88]. For a segment of CS with initial and deformed axial lengths of L and l, respectively,
with the assumption of tissue incompressibility, the vessel wall volume, V, is a constant during the
inflation. Thus, we have
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,

(2.1)

where A and B denote initial, unloaded inner and outer radii, respectively, a and b denote deformed,
loaded inner and outer radii, respectively. Following the method presented in Wicker et al. [88], the
associated mean stretch ratios in the CS circumferential and axial directions were computed as
/
/

,

.

(2.2)

Note that both of the initial and deformed lengths were not experimentally measured in this study.
Instead, using the Eqn. 2.1 and the assumption of tissue incompressibility, the axial stretch was calculated
using the Eqn. 2.2 above. The mean circumferential (

) and axial (

) Cauchy stresses [89] can be

calculated using the pressure-radius experimental data in the deformed configurations,
,

,

(2.3)

where, P is the luminal pressure (outer pressure was assumed to be approximately zero),
thickness, and

is the

accounts for the luminal pressure acting over the projected inner cross-sectional area

of the CS.
We assumed that the CS behaves as a hyperelastic material following the concept of
pseudoelasticity [29], the four-fiber family model W is expressed as
3
where c,

, and

∑

exp

1

1 ,

(2.4)

are the material parameters, the superscript k represents the kth fiber families. For the

fiber families k = 1 and 2 represent axially (0˚) and circumferentially (90˚) oriented fibers, respectively,
and fiber families k = 3 and 4 represent diagonally oriented fibers, see Fig. 2-4. Note that these fiber
families do not reflect the physical fibers, instead they are the virtual fibers representing all fibers oriented
in four directions throughout the vessel wall. The parameter
Green tensor,

is the first invariant of the right Cauchy–

is the stretch of kth fiber family,

between the fiber family and the CS axial direction, with
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= 0,

= 90, and

represents the angle
. For Eqn. 2.4,

,

,

, and

are typically assumed [88, 90, 91], therefore, a total of six

parameters is needed to be determined.
Finally, the associated mean circumferential and axial Cauchy stresses are [91],
,

.

(2)

(2.5)

90˚
(3)

Axial

α

Circumferential

Figure 2-4:

0˚
(1)

(4)

Schematic of the vessel fiber orientation, with k = 1 and 2 are 0˚ (axial) and 90˚

(circumferential) oriented fibers, respectively; and k = 3 and 4 are diagonally oriented fibers.
The constitutive model was fit to the individual experimental pressure-diameter data, yielding six
optimal parameters for each dataset. In addition, the mean response of seven pressure-diameter data was
obtained and fitted. The material parameters of the mean response (P_Mean_Exp_Data) and the mean
values of the optimal material parameters (P_Mean_Para) were compared. The goodness of the fit was
determined using the R-square value based on the Levenberg-Marquardt nonlinear regression algorithm
using SYSTAT 10 (Systat Software Inc., Chicago, IL). Variation of test data was presented in terms of
standard errors.
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2.3 Results
2.3.1

Mechanical responses of the coronary sinus
Initial and maximum dilated diameters and thicknesses of seven specimens were listed Table 2.1.

The mean pressure versus the inner diameter response of seven CS’s was illustrated in Fig. 2-5. The CS
exhibited a S-shape curve, typical for blood vessels [89]. Below a pressure of 10 mmHg, the CS did not
exhibit obvious dilatation. However, between a pressure range of 10 to 30 mmHg, there was a rapid
extension of the CS diameter. As the pressure increased above 30 mmHg, the wall became progressively
less distensible and nearly stayed flat at the high pressures. At 30 mmHg pressure, the CS could be
dilated approximately up to 60%, and at 80mmHg, up to about 88%. The CS vessel wall thickness
decreased with the applied pressure (see Fig. 2-5b), as one would expect.
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Table 2-1. Initial and maximum dilated diameters and thickness of seven specimens .

Specimen

D0

D

T0

T

D/D 0

T/T0

1

4.90

12.50

1.37

0.71

2.55

0.52

2

3.11

6.55

0.56

0.55

2.11

0.98

3

5.04

10.09

1.12

0.63

2.00

0.56

4

8.54

11.72

1.06

0.62

1.37

0.58

5

7.06

10.86

1.54

1.02

1.54

0.66

6

4.22

7.59

1.54

1.15

1.80

0.75

7

6.00

10.95

1.42

0.63

1.83

0.44

Mean

5.55

10.04

1.23

0.76

1.88

0.64

Do is the initial diameter, D is the maximum distended diameter; To is the initial thickness, and T is the
thickness at maximum pressure, 80 mmHg. All measurements are in mm.
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Normalized Inner Diameter
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Figure 2-5: a) The normalized pressure versus inner diameter experimental result from seven porcine
CS’s inflated to a maximum pressure of 80 mmHg, b) the thickness change of the anterior section of the
CS vessel. Data was expressed in terms of mean and standard error.
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The mean stress versus stretch curves of the CS obtained from the pressure-inflation experiments
can be seen in Fig. 2-6 for both axial and circumferential directions. The maximum stress values were
35.5 ± 4.64 kPa and 75.95 ± 9.34 kPa for the axial and circumferential, respectively, under the 80 mmHg
pressure. The response in the axial direction showed an initial contraction which ceased at about 10
mmHg and followed by an extension at higher pressures.
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-10
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Mean Stress
Figure 2-6: Stretch-stress curves of the CS obtained from the pressure-inflation tests. The upper curve
represents the response in the circumferential (Circ.) direction and the lower curve is for the axial
direction. Data was expressed in terms of mean and standard error.
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2.3.2

Microstructure of CS vessel wall
The circumferentially-cut sections of the posterior (or the free wall) and the anterior (or a section

attached to the LAA) CS vessel were illustrated in the Fig. 2-7. The posterior CS sections were covered
by a layer of SMFs oriented circumferentially (see Fig. 2-7a). Within the CS wall, unlike other vessel
wall, it was mainly composed of SMFs, with a small content of smooth muscle cell (SMC). The SMCs
were only observed in bundles in the outer layer of the anterior section of the CS vessel (see Fig. 2-7b,
arrow). The SMF orientations were similar in both anterior and posterior sections where they aligned in
the circumferential direction in the luminal layer and realigned into transverse direction in the media
layer. Collagen and elastin fibers were found throughout the vessel wall (see Fig. 2-7c & d), collagen
fibers were slightly scattered in the SMF layer. Elastin fibers were aligned in the axial direction in the
luminal layer and realigned into the circumferential direction in the media layer of the CS wall. Crimping
of the collagen fibers were also observed in the axial direction in the CS luminal layer (see Fig. 2-7c).
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Figure 2-7: Circumferential-cut sections of a) the posterior (free wall) and b) the anterior wall
of the CS. Close-up views of the CS at the luminal layer in the c) axial and d) circumferential
axes. The arrow indicates smooth muscle cells (SMCs).

2.3.3

Constitutive Modeling
Material parameters and R-square values of seven individual specimens obtained from the four-

fiber family model fit were summarized in Table 2. The model could capture the tissue response well with
the mean R-square value of 0.914 ± 0.036. The parameters of P_Mean_Para and P_Mean_Exp_Data were
also listed in Table 2.2.
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Table 2-2. Material parameters for the four-fiber family model.
Material parameters

R2

Specimen

c (kPa)

c11,2 (kPa)

c21,2

c1 3,4 (kPa)

c23,4

α0

1

0.00E+00

3.94E‐22

1.12E‐07

31.36

0.51

31.60

0.996

2

1.85E+00

3.25E‐21

1.36E‐08

2.21

0.23

60.34

0.800

3

1.57E+01

1.16E‐17

1.00E‐02

1.66

0.66

46.29

0.816

4

8.97E+00

3.50E‐21

2.31E+00

28.40

1.34

58.76

0.998

5

1.64E+01

2.76E‐20

2.43E+00

5.43

3.37

49.18

0.970

6

4.30E+00

1.00E‐05

1.00E‐02

1.17

1.40

70.81

0.823

7

3.01E+00

2.71E‐21

1.00E‐02

2.51

1.22

53.17

0.995

Mean_Para

7.18E+00

1.43E‐06

6.82E‐01

10.39

1.25

52.88

0.914

Standard Error

2.52E+00

1.43E‐06

4.36E‐01

5.07

0.39

4.68

0.036

Mean _Exp_Data

1.30E+00

2.23E‐17

1.87E‐08

28.88

0.91

42.03

0.998

Illustrated in Fig. 2-8 was a comparison between the fits of two parameter sets. The fit was
excellent for the P_Mean_Exp_Data parameters in both circumferential (solid line) and axial (long-dash
line) directions. In contrast, the P_Mean_Para did not produce a desirable fit. It underestimated the axial
direction and largely overestimated the fibers in the circumferential direction.
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Figure 2-8: Fits of the mean experimental data of all seven specimens (P_Mean_Exp_Data)
and mean parameters obtained from averaging individual parameters (P_Mean_Para). Solid
lines are the circumferential fits and long-dash lines represent the axial. Fitting results show
that parameters obtained from averaging experimental data (P_Mean_Exp_Data) provided a
better fit. Data was expressed in terms of mean and standard error.
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2.4 Discussion
Although mechanical properties of arteries have been studied extensively, there are relatively
fewer studies on the mechanical properties of venous tissues [29, 89], and to our knowledge, none on the
CS vessel. This is probably because the CS has seldom been treated as a load bearing tissue. Recent
applications of PTMA devices for the treatment of MR utilize the CS as a hosting conduit for deployment
and function of the devices. It is, thus, important to quantify the CS mechanical properties so that the CS
tissue-device interaction can be better understood and the device failure as observed in Webb et al. [72]
could be avoided in the future.
In this study, we observed that the CS pressure-diameter response is generally similar to many
artery and vein responses [92-95]. The CS was very distensible at low pressures and became much stiffer
when over physiologic pressure (see Fig. 2-5a). However, the difference between CS vessel and other
vessels observed from our histological study was the presence of the high content of SMF in the CS wall,
with a relatively lower content of collagen, elastin and smooth muscle cells. Apparently, the structural
constituents of the CS were very different to that of a typical vein or artery, in which the collagen, elastin
and smooth muscle cells are the premier constituents. Similar findings of SMF layers covering the CS
were reported in the anatomical studies of human CS [81, 82]. It was argued that the CS vessel might be a
small cardiac chamber that joins the other four chambers at the level of the crux cordis [81]. The
histological structure obtained from this study appeared to concur that the CS may not be a cardiac vein,
but rather a structural extension of the right atrial chamber because of the high content of SMF in the
vessel wall.
The four-fiber family model is an extension of Holzapfel’s two-fiber family model [90], which
has been successfully utilized to model various blood vessel tissues [96-99]. In general, this model can
capture the CS mechanical responses well. The model and the associated parameters obtained in this
study can be implemented in numerical simulations to further investigate the tissue-implant mechanical
interactions. The material constants of the model obtained from fitting of the experimental data might not
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be unique. Multiple other sets of material constants may result in the same goodness of the fit. The issue
of determinability of constitutive models has recently been discussed in Criscione 2004 and 2008 [100,
101]. A new set of kinematic tensor basis proposed by Criscione [100] might have the potential to
overcome the covariance or coalignment issues inherent in the kinematical variables of strain invariant or
Green strain based formulations.
Typically, the modeling approach with tissue micro-structure considerations, based on the
pioneering work by Lanir 1979 [102], has employed either discrete [90, 103] or statistical distribution
functions [104, 105] to describe orientations of tissue fibers. The four-fiber family model utilized the
isotropic term for the tissue matrix substance and the anisotropic terms for the fibers at four assumed fiber
directions. For the isotropic term, the parameter c represents the relative contribution of extracellular
matrix (ECM). The mean value of 1.3kPa obtained in this study suggested the isotropic ECM played a
significant role in CS wall responses. For anisotropic fiber responses, we observed that c1,2 was close to
zero. It indicated that axial and circumferential fibers have negligible contributions. However, fibers in
the diagonal direction, represented by c3,4, appeared to be responsible for most of overall tissue
mechanical responses. Since we did not perform quantitative histology on the CS wall, a definitive
correlation between the model predicted and actual fiber architectures cannot be established.
The response in the axial direction varied from contraction to extension at low to high stress,
respectively. As showed in Fig. 2-6, the initial decrease in axial stretch at low stress occurred
simultaneously with the dramatic increase in the circumferential stretch. This behavior might be due to
the tissue incompressibility, or volume preservation. However, as the CS wall consists of complex multilayer nonlinear, anisotropic tissue structures, the coupling between axial and circumferential directions
could be more complex than that due to the tissue volume preservation.
In our estimation of the CS wall stress, we utilized the ideal cylindrical model. However, the CS
wall has an oval shape due to the partial attachment to surrounding myocardium (see Fig. 2-3a). During
the inflation tests, the averaged minor to major axis ratio of the CS vessel was 0.48 at 5 mmHg, 0.7 at
20mmHg, 0.85 at 50 mmHg and 0.93 at 80 mmHg. Using the cylindrical model in data analysis is a way
42

to represent the averaged stress in an oval shape. A precise estimation of stress in an oval shape should be
as follows: Let m and n equal the semi-axes of an oval shape, with n > m. The minimal and the maximum
stresses in the oval shape are σ
point (x, y) can be obtained by σ x, y
the cylindrical model, we used σ

and σ
y

, respectively, and the stress in between at the
x

, where s is the arc length on the oval shape. By

, which is the mean value between the maximum and minimal

stresses. Thus, the maximum error we could have with the cylindrical model is σ

, which is

located at the minor and major axes of the oval shape. Based on the minor to major axis ratios during the
inflation test, the maximum errors in the stress estimation were 26% at 5 mmHg, 15% at 20 mmHg, 7.5%
at 50 mmHg and 3.5% at 80 mmHg. To convert them into actual stress values, they were 0.63, 1.78, 3.39
and 2.63 kPa at 5, 20, 50 and 80 mmHg, respectively.
There are some limitations in this study. First, the sample size is small. We only
performed experiments on seven porcine hearts. A larger number of specimens may provide a
more statistical power in analyzing the data. Also, the extrapolation of the porcine CS
mechanical properties to the human CS is currently unknown. A study of human CS tissue
properties is currently ongoing in our lab. We hope that in the near future we could compare
human and porcine data, and use them to explain why PTMA devices respond differently in
animal and human clinical trials [27, 72, 73, 106-108]. Lastly, we only studied passive
behaviors of the CS vessel. The in vivo observation by Barcelo et al. [81] using cine digital CS
angiography showed the reduction of the CS’s diameter during the cardiac cycle, where the
maximal diameter was observed at the ventricular systole, intermediate diameter during
diastole and the minimal diameter at the atrial systole. This diameter change may be caused by
active contraction of myocardial fibers or simply by the pressure change during the cardiac
cycle. The further investigation on this phenomenon is also necessary.

2.5 Summary
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In this Chapter, we presented a study of biomechanical characterization of porcine coronary sinus.
Under a 80 mmHg pressure-only loading condition, the CS vessel exhibited a S-shape pressure-radius
response and could be dilated up to 88%. The model fitting results indicated that the four-fiber family
model could capture the experimental data well. From the histology study, we observed abundant SMFs
covering the CS and also within the CS vessel wall, while smooth muscle cells are very low in content.
The elastin and collagen fibers are highly concentrated in the luminal and outer layers of the CS wall, but
sparsely distributed in the medial layer. In future studies, we will conduct finite element analysis of the
interaction between the CS vessel and the proximal stent, utilizing the mechanical properties of the CS
vessel obtained in this study. We may also conduct the mechanical characterization of human CS using
cadaver tissues. Nonetheless, this study represents one of early steps towards a complete understanding of
the PTMA intervention and analysis of device failures observed in current clinical trials.
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3 Comparison of Biaxial Mechanical Properties of
Coronary Sinus Tissue from Porcine, Ovine and Aged
Human*
In this chapter, the material property characterization of the CS vessel using planar biaxial testing
method will be introduced. Pre-clinical studies of PTMA devices often use animal models (i.e. porcine,
ovine and canine) to obtain either acute or short-term animal trial outcomes. However, compare to preclinical animal studies, human clinical outcomes were sub-optimal. To investigate underlying causes of
the discrepancy between the animal and human results, in this chapter, the CS tissue properties of human
were compared to ones of porcine and ovine and human models. The CS tissues were subjected to multiprotocol biaxial tests and characterized by the Fung-type elastic model. Histological analysis was also
performed to compare the difference in tissue microstructure among porcine, ovine and aged human CS
tissues.

The contents of this chapter were partially published in
T. Pham and W. Sun, Comparison of biaxial mechanical properties of coronary sinus tissues from
porcine, ovine and aged human species, Journal of the Mechanical Behavior of Biomedical Materials 6:
21‐29 (2012).
*
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3.1 Introduction
Quantification of the mechanical properties of the CS vessel is critical for estimating the tissueimplant biomechanical interaction and for understanding device failure mechanisms. Although the
anatomical studies of the CS have been well reported [81-83], there is a dearth of study on the mechanical
properties of the tissue. Recently, Pham and Sun [109] reported the diameter-pressure relation of porcine
CS from a vessel inflation experiment. There are two limitations in the paper: 1) the experiment was
conducted under relatively simple pressure inflation loading conditions, and 2) only the porcine CS was
examined. Due to complex tissue-device interactions, quantification of tissue behaviors under multi-axial
loading conditions may be needed. Moreover, a study of CS tissue properties from different species (i.e.,
porcine, ovine and human) may be helpful in understanding the outcomes among animal trials and human
studies, and establishing a proper animal model to evaluate the device efficacy.

3.2 Materials and Methods
3.2.1

Materials
The human cadaver CS tissues were selected from an age group of 86.5 ± 9.7 years old. Human

cadaver hearts were obtained from Cardinal Biologicals, Inc. (Tyler, TX; n = 2) and National Disease
Research Interchange (NDRI, Philadelphia, PA; n = 8). The use of human tissues was approved by the
Institutional Review Board at the University of Connecticut. The hearts were fresh frozen within a postmortem recovery interval (15.32 ± 6.51 hours) and remained frozen until delivery on the next day. All
hearts were stored in a -80˚C freezer and were taken out individually for testing within 3 months. Porcine
hearts (n = 10, 6 - 9 months old with a weight range of 418.60 ± 71.81 g) from the Animal Technologies,
Inc. (Tyler, TX) and sheep hearts (n = 10, 1 year old, 280.08 ± 28.17 g) from the Brother Quality, Inc.
(Stafford Springs, CT) were obtained fresh and stored in a -80˚C freezer until testing within 2 weeks.
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Following the two-stage slow thawing method proposed by Bia et al. to void tissue damages
[110], each heart was held at room temperature (20˚C) for 30 minutes and then submerged in a 37˚C
water bath until totally defrosted. The entire CS vessel could be removed from the heart because only the
anterior section of the vessel is partially embedded in the myocardium, as shown in Fig. 3-1. After
carefully procuring the vessel and removing the excess tissues (e.g. fat and loose connective tissues), a
square specimen, about 15 mm in length, and at a region near the CS ostium end (or the proximal
section), was excised for testing, see Fig. 3-1. The tissue thickness was measured at six regions with a
thickness gauge (Mitutoyo, Model 7301) and the average value was recorded. Four small graphite
markers were placed at the center on the inner surface of the posterior (i.e., myocardium-free) section of
the CS vessel to demarcate a small quadrilateral for strain calculation.

Figure 3-1: The anatomy of the intact coronary sinus (CS) vessel showing the excised location for biaxial
testing. The image on the right shows the CS specimen mounted in the biaxial machine bath. C circumferential, L - longitudinal, LA - left atrium, LV - left ventricle.

3.2.2

Planar Biaxial Mechanical Testing of CS tissues
Details on planar biaxial mechanical testing techniques and methods of analysis adopted in this

study can be found in Sacks and Sun 2003 [38]. Briefly, all specimens were mounted in a trampoline
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fashion, and the vessel circumferential and longitudinal directions were aligned with the primary axes of
the biaxial test fixtures. Human tissue samples were tested in a Ca2+-free phosphate buffered saline (PBS)
solution at 37°C. Due to their young age and relatively high muscle content, animal tissue samples were
tested in a Ca2+-free and glucose-free Tyrode solution (mM: NaCl 136.9, KCl 2.7, MgCl2 1.05, NaHCO3
11.9, NaHPO4 0.47, EGTA 2.0, and 0.1M papaverine) at 37°C. Using Ca2+-free solution is to minimize
the active contraction of muscle fibers in order to obtain the passive mechanical properties of the CS
vessel. Adding EGTA, a chelating agent with a high affinity for Ca2+, would actively remove the
intracellular Ca2+ concentration. The similar protocols have been used in studies of passive blood vessel
mechanical properties [111-115]. As reported by Tritthart et al. [116], exposing Ca2+-free solution several
times in succession could have a comparable result as to the EDTA-containing solution. A stresscontrolled test protocol was utilized [117], wherein the ratio of the normal Lagrangian stress components
T11 : T22 was kept constant with T12 = T21 = 0. Maximum load was applied without causing tears at the
edges of the specimens. Preconditioning was performed to minimize tissue hysteresis. Each tissue
specimen was preconditioned for at least 40 continuous cycles with T11 : T22 = 1 : 1. Seven successive
protocols were performed using ratios T11 : T22 = 1 : 0.3, 1 : 0.5, 1 : 0.75, 1 : 1, 0.75 : 1, 0.5 : 1, and 0.3 :
1. This range was chosen for extensive coverage of the in-plane strain state [38]. All specimens were
cryopreserved [110] after biaxial testing and stored at -80°C.

3.2.3

Histology
The structural constituents of the CS vessel, primarily elastin, collagen, and muscle fibers, were

analyzed across the thickness. After thawing and removing the cryoprotectant agent following a protocol
proposed by Bia et al. [110], tissue specimens were fixed in 10% formalin for 24 hours. Each sample was
dehydrated through a process of varied alcohol concentrations, embedded in paraffin, and sectioned at 5
μm in thickness. Samples were then mounted on microscope slides and dried. After deparaffinization,
slides were then stained with Verhoeff Van-Gieson (VVG). Elastic fibers could be visualized as black
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strands, collagen fibers as red, muscle fibers as a duller red or light brown color. Histological images were
obtained from an Olympus U-TVO.5xC digital camera coupled to an Olympus BX40 light microscope.

3.2.4

Constitutive Modeling
The coronary sinus tissue was assumed to be homogeneous, non-linear hyperelastic and

anisotropic. Therefore, the Fung-type elastic model [29] was used to characterize the biaxial
experimental data. The in-plane second Piola-Kirchhoff stresses, S, were derived from a strain
energy function W,
(3.1)
where Eij is the Green-Lagrange strain tensor and W is expressed as:
1

(3.2)

and Q as:
Q

2

2

2

(3.3)

with c and A1-6 are material parameters.
The constitutive model was fit to the seven stress-controlled protocols for each individual
specimen to obtain the material parameters. The goodness of the fit was determined by the R-square value
based on the nonlinear regression Levenberg-Marquardt algorithm in SYSTAT 10 (Systat Software Inc.,
Chicago, IL). Each parameter set was tested for convexity using the method in Sun and Sacks 2005 [118].
Variation of the parameters is presented in terms of the standard deviation.

3.2.5

Data Analysis
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The mechanical properties of the human CS were quantified and compared to those of
ovine and porcine CS tissues. The tissue stiffness was investigated by means of the secant
modulus at a low stress value of 15 kPa and a high stress value of 50 kPa. One of the human CS
specimens (Specimen 2) has a maximum testable stress below 35 kPa in both the circumferential
and longitudinal directions, therefore, was omitted in the stiffness analysis at 50 kPa.
To quantify the degree of anisotropy (DA) among the specimens, the ratio of
circumferential to longitudinal strains at 15 and 50 kPa stresses from the equibiaxial protocol
(T11 : T22 = 1 : 1) was used. Thus, DA = E22 : E11. A DA value of 1 indicates an isotropic tissue
response, whereas other values represent various degrees of anisotropy. In addition, the
relationship between age and 1) thickness, 2) stiffness, and 3) maximum equibiaxial strain in
human specimens were also investigated.

3.2.6

Statistical Analysis
Differences between means were determined using the analysis of variance (ANOVA) test

followed by the Holm-Sidak test and the Dunn’s Method test for pair-wise multiple comparisons. The
Independent two-sample t-test was used to determine significant differences in anisotropy. Nonparametric tests, including the Wilcoxon signed-rank test and Mann-Whitney rank sum test, were used for
non-normal distributed sample groups. Correlation was determined using the Pearson’s correlation
coefficient (r), and p-values were calculated based on the aforementioned statistical tests. All values of
measurement are presented as a mean ± standard deviation. A probability value less than 0.05 was
considered statistical significant, with high significance indicated by p < 0.001. Statistical analyses were
performed using SigmaPlot (V11.0, Systat Software Inc., San Jose, CA).

3.3 Results
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3.3.1

Patient characteristics and specimen thickness
Table 3.1 lists characteristics of human hearts investigated in this study, including

patient age, gender, cause of death, primary disease, and risk factors. The thickness of all CS
specimens was determined.

Human (0.74 ± 0.16 mm) and ovine (0.78 ± 0.12) were not

significantly different (p = 0.537). However, porcine CS (1.24 ± 0.18) was significantly thicker
than human (p < 0.001) and ovine (p < 0.001).
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Table 3-1. Anamnesis of patients.

Specimens
1

2

3

4

5

6

7

8

9

10

Age (yrs)

69

88

78

96

95

79

98

87

80

95

Sex

M

F

M

F

F

F

F

F

F

M

PMR (hr)

22

11

10

21

7

11

18

8

21.5

23.7

Cause of death

HB

Alz

CPA

CPA

RA

CPA

RA

Alz

ukn

NC

Mean ±
SD
86.5 ±
9.70
15.32 ±
6.51
-

CAD

CA

ukn

ukn

Hyp

ukn

ukn

PKD

n

-

Primary disease HB
Risk factors
Hypertension

y

n

y

n

n

y

n

n

n

n

-

Cholesterol

n

n

n

n

n

n

n

n

n

n

-

Diabetes

y

ukn

n

n

n

ukn

y

n

n

n

-

GERD

n

y

n

n

n

n

n

n

n

n

-

Pneumonia

n

n

n

n

y

n

n

n

n

n

-

Dementia

n

n

n

n

n

n

n

y

n

n

-

Atherosclerosis
Coronary
n
y
n
n
n
n
n
n
n
n
PMR = post-mortem recovery time, Alzheimer’s = Alz, CA = cardiac arrest, CAD = Coronary artery
disease, CHF = Chronic heart failure, CPA = Chronic pulmonary aspergillosis, COPD = Chronic
obstructive pulmonary disease, GERD = Gastroesophageal reflux disease, HB = Heart blockage, Hyp =
Hypertension, NC = Natural causes (old age), RA = Respiratory arrest, PKD = Polycystic Kidney
Disease, ukn = unknown.

3.3.2

Biaxial mechanical behavior
Individual equi-biaxial responses for ten human CS vessels are plotted in Fig. 3-2-A&B. There

was a large variation in mechanical responses in both circumferential and longitudinal directions within
the human samples, particularly the circumferential response which varied the most from a minimum
strain of 0.18 in Spec 6 to a maximum of 0.45 in Spec 7. At low stress, the circumferential direction was
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very extensible, while the longitudinal direction stiffened more rapidly at low strain. At high stress above
20 kPa, the tissue response in both directions exceeded the typical “toe” region and exhibited rapid
stiffening.

Figure 3-2: Equibiaxial results of ten human coronary sinus specimens in a) the circumferential (Circ.)
and b) longitudinal (Long.) directions.
To compare the stress-strain responses of human, ovine and porcine specimens, mean response
curves for each species are plotted in Fig. 3-3. All tissues exhibited the nonlinear stress-strain behavior of
a typical blood vessel. However, a more gradual transition from low to high stiffness regions was
observed in ovine and porcine, while human CS had a more pronounced rapid stiffening effect at the
transitional region in both directions.
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Figure 3-3: Mean equibiaxial responses of human (H), porcine (P) and ovine (O) CS tissues in the
circumferential (C) and longitudinal (L) directions.
Differences in tissue properties among the species were examined by means of the secant moduli
at stress levels of 15 and 50 kPa. In Fig. 3-4, a statistically significant difference was found between
human and ovine (p < 0.001 at 15 kPa and p = 0.001 at 50 kPa) and between human and porcine (p =
0.002 at 15 kPa and p = 0.003 at 50 kPa) in the longitudinal direction. Ovine and porcine tissues did not
differ at either stress level (p = 0.449 at 15 kPa and p = 0.437 at 50 kPa). For the circumferential response,
only human and porcine tissues were significantly different at 50kPa, with p = 0.024.
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Figure 3-4: Tissue stiffness computed at membrane tensions of 15 and 50 kPa, comparing between
human, ovine, and porcine tissues. (*) indicates the statistical significant difference between the two pairs.
Data are presented as mean and standard deviation.
The DA value by means of the strain ratio at a stress of 50 kPa was determined. The anisotropy of
human tissues (0.59 ± 0.26) was greater than those of porcine (0.78 ± 0.15) and ovine (1.02 ± 0.37).
Ovine tissue exhibited a nearly isotropic response, which can be seen in Fig. 3-3. To further analyze the
tissue anisotropy, a paired-t test was used to quantify the association between the two directions of each
species. Human and porcine exhibited a statistically significant anisotropy with p = 0.004 and p = 0.002,
respectively, while ovine tissues did not show anisotropy, p = 0.618.
Statistical analysis did not reveal any correlation between age and thickness, stiffness,
and maximum strain in human specimens. Though there was not enough data to group the
results based on medical conditions, equibiaxial data did show that stress-strain curves of three
hypertensive patients were shifted to the left of the data range (Fig. 3-2).

3.3.3

Constitutive Modeling
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The constitutive parameters for each species are summarized in Table 3-2. The Fung-type elastic
model was able to capture the CS planar biaxial mechanical behavior well with the high R-square (R2)
value of 0.95 ± 0.03 for human, 0.93 ± 0.09 for porcine and 0.93 ± 0.05 for ovine. Representative curve
fitting plots of human, ovine and porcine CS are shown in Fig.3-5.

Table 3-2. Fung model parameters for human, ovine and porcine CS specimen. Data are presented as
mean ± standard deviation.
Specimen
Human
Ovine

A6

R2

0.47 ± 0.28 28.62 ± 12.94 76.10 ± 30.76 1.99 ± 7.69 48.80 ± 16.52 -0.10 ± 4.08

-2.79 ± 8.66

0.95 ± 0.03

6.22 ± 3.07

-0.24 ± 1.78

0.93 ± 0.05

0.20 ± 0.44

0.93 ± 0.09

C

A1

A2

A3

A4

A5

9.22 ± 8.77 12.28 ± 14.31 0.45 ± 3.86 10.82 ± 12.43 -0.25 ± 1.12

Porcine 7.99 ± 10.17 4.17 ± 2.29

9.85 ± 6.45

1.59 ± 2.43
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6.84 ± 2.97

-0.14 ± 0.56

Figure 3-5: Representative stress-strain response data for human (top row), ovine (middle row) and
porcine (bottom row) CS tissues (dot lines) fitted with Fung elastic model (red lines). CIRC circumferential direction, LONG – Longitudinal direction.
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3.3.4

Histology
Differences in the microstructure between human, ovine and porcine specimens can be seen in

Fig. 3-6. In Fig. 3-6, the circumferential histology images of CS posterior section of each species showed
differences in the content of striated muscle fibers (SMFs) and elastic constituents. The intima layer of
aged human CS tissues was composed of a highly dense network of collagen fibers which intertwined
with longitudinal elastin fibers. It was prominently thicker than those of younger ovine and porcine
tissues. The decrease in wall media in human tissues was accompanied by a significant decrease in the
SMFs and a noticeable increase in collagen fibers. Elastin were found to be abundant in both the internal
elastic lamina and the media but organized in multiple fragmented layers. In contrast, elastin fibers as
well as collagen were less developed in younger ovine and porcine tissues.

Figure 3-6 – The cross-section histological results of human, ovine, and porcine posterior CS sections in
the circumferential direction. Human CS is thinner with less striated myocardial fibers (SMF) and
exhibits a higher elastin/collagen contents than ovine and porcine CS in the intima layer. Black fibers elastin, pink fibers - collagen, brown fibers - striated myocardial fibers. (x100 Magnification, bar length is
200 µm).
Studies on the CS anatomy reported a continuous cuff of striated muscle surrounding the external
wall of the CS vessel [81, 82]. Similar structure was observed in all specimens. However, in human CS
tissues, the striated muscle cuff is scarcely distributed around the posterior wall, that is the free-wall
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region of the CS. In contrast, the muscle cuff covered the posterior sections and accounted for the
majority of the wall thickness in both ovine and porcine tissues. The anterior section of the CS wall for
human, ovine, and porcine tissues was composed mainly of the striated muscle fibers with dispersed
elastin and collagen fibers.

3.4 Discussion
3.4.1

Anatomical differences
Several anatomical differences of the coronary venous vasculature between human, porcine and

ovine species were observed. First, the oblique vein of Marshal (OVM) of the left atrium is found in
human while the left precaval vein (LPV) is seen in both porcine and ovine, see Fig. 3-7. Both the OVM
and LPV are remnants of the left superior vena cava. The LPV is completely patent and its diameter is
larger than that of the OVM, but they both have the same function, which is to drain blood into the
coronary sinus. The porcine LPV is found to be the largest and appears to be a continuation of the CS.
The larger LPV, in some cases, resulted in a reduction of CS length and a wider junction of the LPV,
GCV and CS. This could possibly prompt stent slippage due to lack of anchoring if positioned near the
junction. Second, the GCV was observed to be narrowest in porcine, and the ovine GCV was smaller but
similar in size to the human GCV. For the distal anchor of the PTMA device to be deployed, the GCV
diameter needs to be equal or larger than 3 mm [80]. The porcine GCV appeared to be smaller than 3 mm
in diameter and might not be suitable for the distal anchor deployment. Lastly, a high variation in the
location of the left circumflex artery (LCX) was observed in all species, suggesting a careful imaging
assessment prior to the procedure is necessary to reduce LCX perforation and impingement in the
coronary flow in all species.
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Figure 3-7 A sketch of the tributaries of the coronary sinus vessel, showing the tapered oblique
vein of Marshall (OVM) in human and the patent left precaval vein (LPV) in ovine and
porcine tissues. The great cardiac vein (GCV) of porcine is narrowest among the three species.
(*) indicates the ostium of the CS vessel.

3.4.2

Mechanical properties and implications of PTMA intervention.
Our results showed that the excised human CS stress-strain relationship is non-linear and

anisotropic with the circumferential direction being more compliant. When comparing with ovine and
porcine CS tissues, human tissues were found to be stiffer and highly anisotropic. High stiffness of human
CS tissues might be accounted for by the advanced age of the patients selected in this study (86.5 ± 9.7
years). Tissue stiffness has been shown to increase with age due to the degeneration and fragmentation of
elastin fibers [119] and an increase of collagen content [120, 121] which were observed in our human CS
tissues. Therefore, it is possible that the mechanical properties of older porcine and ovine CS tissues
more closely resemble those of an aged human, although this has not been assessed.
Animal models were first tested to evaluate the feasibility of the PTMA devices for the treatment
of MR. Previous studies using ovine models demonstrated the feasibility of PTMA devices in reducing
MR. However, for the human trials of three PTMA devices reported in 2006 and 2007, the results were
suboptimal. Specifically, Webb et al. [72] reported fracture of the device bridge element in three of four
patients implanted with a permanent Monarc PTMA device. Duffy et al. [73] observed that the distal
anchor of a Carillon PTMA device did not hold tension during device traction in two of five temporarily
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implanted patients. Dubreuil et al. [79] reported temporary placements of a Viacor PTMA device in
patients with an ischemic MR and MA dilation. They found that the MA diameter after the device
implantation remained large compared to the surgical annuloplasty results. A more recent study in 2010
on the second generation Monarc PTMA device reported a reduction in MR by ≥ 1 grade at 12 months in
50% of 22 implanted patients [80]. Unsuccessful implantations were associated with the lack of
appropriately-sized devices (n = 13), inaccurate device positioning resulting in no MR reduction (n = 4),
device migration (n = 1) and fracture of the proximal anchor (n = 4). Thus, the success of PTMA animal
trials was not reflected in human trials. Even though doubts always exist regarding the validity of animal
models and their applicability to humans, there is clearly a lack of scientific evidence and engineering
quantification of the discrepancy between animal and human trials.
In this chapter, we observed substantial differences in material properties between the animal and
human CS, where the animal CS tissues were more compliant and deformable than the human ones. This
indicated that the biomechanical environment in which the PTMA device is embedded was different in
animals and humans. Therefore, the PTMA device might function well in animal models due to a
relatively low tissue-stent interaction force. In contrast, under the stiffer mechanical environment in
humans, the PTMA device may experience a higher interaction force which could possibly affect its
durability. This observation underscores the importance of having an appropriate animal model for
evaluating device function for its ultimate use in human.

3.4.3

Limitations and future study
The age range for the majority of MR patients is 60-70 years. In this study, our patient group is

87 ± 10 years old. The material properties of soft tissues were known to be stiffer with age and diseased
cardiac tissues are age-related. However, in this study, we did not study the influence of age on the human
CS tissues and only compared the available aged human group to animal types. In addition, due to
limited access to fresh human tissues, in this study, we used fresh frozen human tissues. To facilitate the
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comparison of human, porcine and ovine tissues, we also froze fresh porcine and ovine tissues at -80°C
prior to biaxial mechanical testing. Thus, by utilizing a similar freezing protocol for all of our samples, we
could avoid inconsistency in tissue storage. Nonetheless, the fact that we do not have fresh human tissue
is a limitation of this study.

Our histological analysis showed that CS is non-homogenous and composed of layers of
constituents (elastin, collagen, and striated myocardial fibers). In this study, the CS was modeled as a
single-layer homogenous structure. A multiple layered material model incorporating structure-motivated
phenomenon might provide a more accurate estimate of layer-specific material properties [122]. Other
imaging methodologies such as scanning electron and two-photon laser scanning confocal microscopy
might be helpful for collagen and fiber structural analysis (e.g., the fiber diameter and undulation period),
to further correlate the structural findings with the mechanical properties of the vessel. Moreover, PTMA
devices interact with the CS wall as well as the surrounding tissues, i.e., the mitral annulus, leaflets,
chordae tendineae and the adjacent myocardium. To fully evaluate the PTMA device function, the
mechanical properties of these interposed tissues, besides the CS wall, need to be quantified as well.
Lastly, the sample size for each species in this study was relatively small; a larger sample size would
provide more conclusive results.

3.5 Summary
We observed a discrepancy in mechanical and microstructural properties of CS vessels in aged
human, ovine and porcine species. Overall, the human CS vessels were stiffer in both the circumferential
and longitudinal directions than the ovine and porcine CS vessels. Higher collagen, lesser SMF, and
fragmented elastin fibers found in human CS tissues demonstrated the effects of aging. This study also
showed that the mechanical properties of CS tissues varied largely among patients. PTMA device studies
involving animal models should be evaluated carefully given the distinguishable mechanical and
structural differences between aged human, ovine, and porcine CS vessels obtained in this study.
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4 Quantification of Tension to Cinch the Mitral Annulus
Through the Coronary Sinus*
As mentioned in Chapter 1, PTMA device’s main function is to shrink or cinching the mitral
annulus to reduce the dilated mitral annulus, thus improve MR. Currently, there is a lack of information
on the magnitude of the cinching force required to shrink the mitral annulus. In addition to the structural
and material property characterizations of the CS vessel conducted in Chapter 2 and Chapter 3, in this
chapter, an ex vivo whole heart study was performed. An novel experimental setup was developed to
obtain the relation between cinching force, via the CS vessel imbedded in the heart, and mitral annular
area reduction, using a ovine model.

4.1 Introduction
Previous investigation on MA mechanics demonstrated the tension was lower in the commissural
section (17.8 N/m) compared to anterior (40.0 N/m) or posterior (30.6 N/m) sections of the annulus [123126]. These studies offered insights into the underlying mechanism of annular dilatation. Annuloplasty
complicates the annular mechanics by undersizing the dilated MA geometry [127].

Some studies

measured the forces generated by the myocardium on a prosthetic device and correlated them with
changes in MA geometry. The maximum in-plane MA force generated by the myocardium on a rigid
annulplasty ring in a porcine mitral valve was 6 – 8 N at mid-systole[128]. The influence of a flexible ring
was studied in swine models and the maximum force was in a range of 4.4 – 13.9 N [129]. Later, the
development of saddle-shape bioprosthetic valve represented a novel advance in design to reduce the
leaflet stress [130-133]. In a comparative study, the forces on the anterior and commissural annular

The contents of this chapter were partially published in:
S. Bhattacharya, T. Pham, Z He, W Sun, “Tension to passively cinch the mitral annulus through
coronary sinus access: an ex vivo study in ovine model”, Journal of Biomechanics, (submitted).

*

63

segments of the flat ring were 0.72 ± 0.14 N and 1.38 ± 0.27 N, respectively, while the saddle-shaped ring
exhibited nearly zero[134].
These studies, however, only provided knowledge of cyclic forces that a device could experience
during implantation, e.g. myocardial forces acting on the device, but not the force generated by devices
necessary to reduce the dilated MA. A fundamental question arises: what are the contributions from active
myocardial contraction, passive myocardial deformation, hydrostatic blood pressure and leaflet annulus
tension to the forces on the devices? The answer will not only facilitate the design and increase safety of
annuloplasty devices but help to understand myocardial function and MA dilatation mechanism. In this
chapter, an ex vivo technique was developed to quantify the CS cinching tension. The goal is to form a
baseline value of cinching tension needed to correct dilated MA. The ovine model has been used
extensively in experimental mitral valve mechanics studies [135, 136] and pre-clinical studies of TMVR
[137-139]. The impact of cinching tension on the MA area, septal-lateral (S-L) and commissurecommissure (C-C) diameters and leakage in dilated valves were investigated.

4.2 Materials and Methods
4.2.1

Specimen Preparation
Ten fresh adult ovine hearts (mean weight: 313.5 ± 51.90 gram) were obtained from a local

slaughter house. The hearts, which were not tested within 48 hours upon arrival, were cryopreserved at 80°C [110]. Studies have shown that a short period of cryopreservation do not induce significant changes
in vascular tissue mechanical properties [140-143]. For each heart, the left atrium was carefully removed
to expose the mitral valve (MV), the MA, the CS vessel and CS ostium. Small graphite markers were
affixed to the MA to demarcate the area to be measured (Fig. 4-1c). A suture was inserted within the CS
vessel with one end tied at the GCV end and the other end exited the CS ostium. The coronary arteries
and CS attributes were occluded by sutures.

64

Figure 4-1: a) An image of the mitral valve (MV) cinching system consists of a computer acquisition
system, a force transducer connects to a slider and a digital camera; b) a top view of a representative heart
showing the location of the MV, the tissue dye highlighting the measured MV area, the coronary sinus
(CS) vessel, the Great Cardiac Vein (GCV) vessel and the cinching force, F; c) the representative
captured digital images of the reference area, A0 and the area after pulled at a distance, Ai.

4.2.2

The MV cinching system setup
The experimental system consists of a water column, a pump, a clear Plexiglas solution chamber,

a custom-made rigid supporting structure, a slider system, one digital camera and a computerized data
acquisition system (Fig.4-1a). Each heart was stabilized by fixing the right ventricle to the custom-made
supporting structure placed inside the Plexiglas chamber. The left ventricle (LV) pressurization was
achieved by injecting saline solution into the LV through a cannula, which was inserted into the
ascending aorta vessel and passed the aortic leaflets. The water column, fabricated with a large-bore
tubing attached to the aortic cannula. Ethylene-Glycol-Tetraacetic acid (EGTA, 2.0 mM) and papaverine
(0.1M) were added to the saline solution (37ºC) to minimize the active contraction of muscle fibers in
order to obtain the passive mechanical properties of the heart. The LV pressure was controlled by the
height between the saline level in the water column and the mitral annular plane [144]. A quasi-static
system was chosen as the MV experiences highest force during peak systole or when the valve is fully
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closed. A peak hydrostatic systolic pressure of 90 mmHg is chosen for the physiological pressure of an
ovine heart [145, 146]. The leakage volume was measured by an amount of fluid regurgitated back into
the left atrium during pressurization. The testing chamber was threaded with an outlet tube that drained
the regurgitated fluid into a graduated cylinder for leakage measurements.

The slider system consists of a force lever, which was connected to a 10 N force transducer
mounted on a linear stage. The handle of the linear stage can be manually rotated to linearly displace the
force lever with an accuracy of ± 0.01 mm. The force transducer was connected to high-performance data
acquisition device (National Instrument,NI SCC-68/SCC-SG24, NI 6351). A custom-made LabVIEW
program was created to record the force transducer data at each displacement. The force transducer was
calibrated prior to each experiment. The MA measurements were obtained from a digital camera mounted
perpendicular to the MA plane.

4.2.3

Experimental protocol
Each heart was preconditioned by applying 10 consecutive pressure loading (90 mmHg) cycles.

The experimental measurements including the MV cinching tension, MV area, leakage and MA area
measurements were obtained during the three phases when the mitral valve was: 1) open (no pressure,
P0), 2) close (pressurize at 90 mmHg, P90), and 3) altered or dilated at 90 mmHg pressure (P90-D). The
P0 was performed to measure the cinching force generated by the suture inside the CS vessel during the
passive relax state. The P90 was chosen as a baseline value for normal valve function during left
ventricular filling. For P90-D, the MV dilation was achieved by injecting phenol (95%), into the muscular
MA using a needle. The toxic substance in phenol can damage the structure and function of the muscle
and has been utilized in an in vivo study to simulate the dilation of the mitral annulus [147]. To cinch the
MA, the suture end at the CS ostium was pulled in the direction perpendicular to the C-C direction of the
MA (Fig. 4-1b). For each pull, a linear displacement, d, of 2 mm for a total of 9 displacements in each
phase was achieved (di, i = 0, 2, 4…12, 16 and 20 mm).
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4.2.4

Data acquisition and analysis
The cinching tension (T) and the corresponding image of MA were measured simultaneously at

an instant of a displacement. All the MA dimensions were measured using ImageJ (National Institute of
Health). The MA area, A, was defined as the area encompassed by the markers. The S-L diameter was
calculated as the distance between the two markers placed on the mid-septal and mid-lateral mitral
annulus, and the C-C diameter was measured as the distance between the two markers placed on the
commissures (Fig. 4-1c). The leakage (L/min) was measured after visualization of full expansion of the
LV and closing of the MV for 20 seconds.

4.2.5

Statistics
All measurements are shown as mean ± standard deviation (SD). The analysis of variance

(ANOVA) test followed by the Holm-Sidak test and the Dunn’s Method test were used to compare
measurements between the three phases. Data were tested for normality using the Shapiro-Wilk test. The
Student’s t-test was used to determine significant differences. The paired Student’s t-test was employed to
determine the significant changes in parameters at a certain pull distance. Correlations between the
parameters were determined using the Pearson’s (for normal) and Spearman (for non-parametric data)
correlation coefficient (r). A probability value less than 0.05 was considered statistical significant, with
high significance indicated by p < 0.001. All statistical analyses were performed using SigmaPlot (Systat
Software Inc., San Jose, CA) and SYSTAT (Systat Software, Chicago, IL).

4.3 Results
The MA deformation after each incremental load increase of a representative ovine heart during
the three phases is shown in Fig. 4-2. The decrease in the mean MA area after each pull in each phase is
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shown in Fig. 4-3a. Prior to pulling, the MA area increased 23.34 ± 18.02% from P0 to P90 and dilated
further by 22.83 ± 0.06% in P90-D. Upon pulling about 16 mm (d16), the dilated MA area was reduced by
26.17% (from 8.35 ± 2.00 cm2 to 6.62 ± 1.85 cm2) and similar to the baseline value (6.80 ± 1.89 cm2).
From Fig. 4-3b, at d = 16 mm, T required to reduce the dilated MV area to the baseline was 2.10 ± 0.47
N. It can also be seen that T generated by the suture (P0) alone without pressurization was 0.38 ± 0.10 N.
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Figure 4-2: Images of a representative mitral valve deformation at d = 0, 4, 8, 12, 16 and 20 mm during
the three phases: (P0) when the mitral valve was open at zero pressure), (P90) close or pressurized at 90
mmHg, and (P90D) after the mitral annulus was dilated and pressurized. (Dimension is in millimeter)

The mean S-L diameter increased significantly by 26% from the baseline to dilation (from 2.23 ±
0.31 cm to 2.81 ± 0.25 cm, p < 0.001). At d16, the mean S-L diameter was significantly lower than d0
(2.14 ± 0.27 versus 2.81 ± 0.25, p < 0.001) and below the baseline value (2.14 ± 0.27 cm to 2.23 ± 0.31
cm, p = 0.485). The C-C diameter was increased by 11% after dilation. However, the C-C diameters
obtained during P90-D remained unaffected throughout the experiment (Fig. 4-3c). The mean C-C
diameter in P90 at d0 was 3.09 ± 0.39 cm and in P90-D at d16 was 3.36 ± 0.36 cm, p = 0.121. A summary
of comparisons of the MV area, the S-L and C-C diameters and the leakage rate between baseline at no
pull (d = 0) and dilated condition at 16 and 20 mm pulling distances (d = 16 and 20) are listed in Table 41.
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Table 4-1. Summary of ovine heart data showing the mean and standard deviation (SD) of the mitral
valve area (MV), septal-lateral (SL) and commissure-commissure (CC) diameters, leakage at 90 mmHg
pressure and the change in pressure during the experiment.

2

MV (cm )
S‐L dia (cm)
C‐C dia (cm)
Leakage (L/min)

During pressurization of 90 mmHg
Baseline
Dilated
at d=0
at d=0
at d=16
6.80 ± 1.89
8.35 ± 2.00
6.62 ± 1.85
2.23 ± 0.31
2.81 ± 0.25*
2.14 ± 0.27†
3.09 ± 0.39
3.42 ± 0.36
3.36 ± 0.36
0.09 ± 0.07

0.18 ± 0.09

0.09 ± 0.07

at d=20
6.27 ± 1.77
2.01 ± 0.26†
3.38 ± 0.35
0.08 ± 0.05‡

* compared to baseline d=0, P < 0.001, † compared to dilated d=0, P < 0.001, ‡ compared to
dilated d=16, P < 0.05
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Figure 4-3: The relations between distance pulled and a) area (cm2), b) force (N) and c) septal-lateral (SL) and commissure-to-commissure (C-C) diameter of the ovine hearts in three phases of valve open
(P=0), valve close at 90 mmHg pressure (P=90) and valve dilation at 90 mmHg (P=90 Dilation). Data are
shown as mean ± standard deviation.
The relation between MA area and T in each phase is shown in Fig. 4-4a. At a maximum pulling
distance (d20), a small tension of 0.6 N was required to shrink 58% of the MA area during P0. At the same
tension, as expected, only 9% and 11% MA reduction were achieved for P90 and P90-D, respectively. At
15% MA area reduction, the tension of both P90 and P90-D was 1 N. After this point, the P90-D response
curve shifted down slightly, indicating a larger tension would be required to shrink the MA area. The
decrease in the MA area was accompanied by the reduction in the S-L and C-C diameters, and no
difference was observed between P90 and P90-D, see Fig. 4-4b. At 2.10 ± 0.47 N, when the dilated MA
area returned back to the baseline value, a 21.30 ± 5.6% reduction in the MA area and a 24.18 ± 5.28%
reduction in the S-L diameter were achieved.
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Figure 4-4: The relation between (a) mitral annulus area and cinching tension, and between (b) S-L and
C-C diameters and cinching tension. Data are shown as mean ± standard deviation.

Figure 5-5 shows the changes in the MA area, the tensions and the leakage rates from the initial
(d0) to the final (d24) pulling distances. In the normal hearts, we observed a small leakage of 0.094 ± 0.070
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L/min. After phenol application, the leakage rate increased to 0.181 ± 0.008 L/min or by 93%. The
progression of annular cinching caused the MA area to decrease progressively with leakage rate (r =
0.992, p < 0.001 for P90 and r = 0.957, p < 0.001 for P90-D). The T was reversely correlated with leakage
rate (r = -0.983, p < 0.001 for P90 and r = -0.912, p < 0.001 for P90-D). Leakage was reduced to normal
leakage rate at 1.71 N, and the MV area approached to normal at 6.76 cm2.
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Figure 4-5: The correlations between the mean leakage rate and mean mitral area and mean cinching
tension in the a) normal and b) dilated conditions. Solid and dashed lines are the linear fits of the data.
The d0 indicates no pull, and d20 is 20-mm pulling distance.

4.4 Discussion
Despite the increase in the development of TMVR devices, limited information is available on
device forces required to restore normal valve function. An ex vivo technique developed in this study aims
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to quantify the cinching tension (T) needed to restore normal MA from dilation in the passive ovine heart
model. The MA dilation was achieved up to 22.83% and the S-L and C-C diameters were increased by
26% and 11% upon dilation, respectively. Various studies have demonstrated significant changes of MA
in either ischemic or acute cardiomyopathy that resulted in significant MR. An in vivo animal study
demonstrated that in chronic ischemic MR condition, the entire mitral annular regions, including the
fibrous (anterior) and muscular (posterior) sections, dilates proportionally [148]. Timek et al. [149]
showed that the progression of acute ischemic MR in ovine models was characterized as 20% - 28%
(mild/moderate – moderate/severe) increase in MA area and 14% - 19% increase in S-L diameter. For
human study, significant MR caused by ischemic cardiomyopathy was characterized as 31% increase in
MA area and 17% and 11% increase in S-L and C-C diameters [150]. Thus, the increase in both MA area
and S-L and C-C diameters in this study showed an indication of MA dilation.
The loading condition on the MA is primarily due to the LV pressurization achieved by the
hydrostatic pressure. The T from the suture is, therefore, an additional force on the LV wall and the
leaflets connecting to the MA to balance the hydrostatic pressure force. From Fig. 4-3, during the P0, T
generated by the suture was 0.06 ± 0.01 N (P0, d = 4 mm), resulting in MA area of 4.88 ± 1.63 cm2. The
T required to reduce to a similar MA area with a presence of the hydrostatic pressure was 2.80 ± 0.56 N
(P90, d = 20 mm). Thus, the increase in T as the result of hydrostatic pressure can be calculated as P90 –
P0, approximately 2.74 N or increased by 4557%. This drastic increase in T between P0 and P90
indicates that LV pressure is an important factor in determining the effective T of the device. To
determine the change in T with the presence of MA dilation, the difference between T at P90 and P90D
was obtained. At a MA area of 6.3 ± 1.8 cm2, T of P90 and P90D were 0.41 ± 0.09 N and 2.62 ± 0.43 N,
respectively, resulting in 2.21 N, or increased by 539%. Since the pressure was constant for both phases,
this increase in tension directly relates to the impaired muscular tissue around the MA due to phenol
injection. Thus, we can view this suture cinching tension as a compensation force in MA reduction. In
other words, T indicates the maximum force to be generated by the device necessary to restore normal
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MA geometry without active myocardial contraction, and usually depends on severity of annular
dilatation.
The cinching tension, however, can be less in magnitude during LV contraction. An in vivo ovine
study of Siefert et al. [151], they measured the MA forces using a custom-made device with strain gauges
placed directly on the MA in S-L and C-C directions [151]. The mean S-L and C-C forces of normal
ovine group at 90 mmHg were 3.9 ± 0.8 N and 2.6 ± 0.6 N, respectively. In another study [152], the same
group found a significant decrease in the S-L forces as the result of ischemic MR with inferior left
ventricular infarction. Their findings support the notion that the active contraction mechanism might have
been impaired in ischemic MR [153-155]. Daimon et al. [153] found that their IMR patient group had an
attenuated mitral annular motion and a reduction in MA contraction by 23.0 ± 6.5% compared to the
normal group of 42.6 ± 7%. In addition, their analysis showed that annular contraction was the strongest
determinant of the severity of MR among the annular measurement. The hydrostatic pressure in this study
is not considering in vivo annular contraction and expansion of myocardial fibers. Thus, the active
contraction properties of the MA might relieve this suture tension. However, active contraction in relation
to cinching tension is remained to be determined.
The experimental technique used in this study for MA restoration only allowed a significant
reduction in the S-L dimension while the C-C dimension remained unchanged, which can be seen in Figs.
5-3&5-4. The impact of C-C dimension in restoring MV competency, however, is still a debate. Several
clinical and experimental studies have shown that S-L dimension has a prominent role in functional MR
[156] and that reduction in S-L diameter alone is sufficient to restore leaflet coaptation [157, 158].
Restoration of normal MV by cinching the MA was adopted by several novel methods. A device
called the cerclage, was designed and tested in swine subjects to shrink the entire annular circumference
and S-L diameter [159]. The device is made of a braided non-absorbable suture that encircles the mitral
annulus via the CS vessel, septal myocardicum, right ventricle and atrium path, and tying the two ends.
Using 16 swine subjects, the S-L diameter reduction was measured at three tension forces (200g, 400g
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and 600g), and a maximum of 20% of the reduction in both systole and diastole at 600 g (~6 N) of tension
was observed. This high magnitude of tension could be the result of shrinking a massive muscular
structure that included both MA and right ventricle. Timek et al. demonstrated that S-L diameter
reduction was achieved by more than one trans-annular sutures connected from locations on the anterior
fibrous region to the posterior annulus[160, 161] but no force was measured. Recently, Jensen et al. [162]
found that at 32% of trans-annular trigone-posterior annulus distance reduction at three different location,
the peak forces were 1.2 ± 0.9 N, 1.5 ± 1.0 N, and 0.8 ± 0.2 N with no significant difference between
them. Interestingly, the sum of the forces ranged from 0.12 ± 0.03 N to 3.5 ± 1.3 N, which matches our
results even though force directions and suture techniques were different. Their cyclic traction suture
forces increased with increasing levels of downsizing as our cinching tensions increased with increasing
MA area reduction. It should be noted that the magnitude of forces measured is dependent on the type of
device [162] and how it shapes the MA. Difference in the locations of device implantation (e.g. within the
CS vessel or directly on the MA) and various hemodynamic and boundary condition could affect both
MA geometry and mechanics.
Currently, there is a lack of understanding of biomechanics involved in the device design and
optimization of TMVR devices, possibly due to the complex MV geometries. Fortunately, in the past
decade, the mechanical testing techniques and constitutive modeling in cardiovascular mechanics have
improved tremendously. Human tissue material properties can now be tested extensively [163], modeled
and implemented in computational studies [45]. Improved computational models of MV has evolved [31,
46, 164-167] and predicted several diseased states [43, 168-170]. Thus, the data in this study can be used
in validation of computational models to predict the functionality of TMVR devices.
There are several limitations in this study. The data are valid for isolated MA dilation model
which is distinctly different from ischemic MR model [171]. The mitral valve closure due to the
hydrostatic pressure could alter the native MA mechanics by the expansion of the global LV. Leaflet
coaptation height, depth and tethering length were not recorded as the result of 2D imaging, thus, MR
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grade was not classified. Future study using 3D echocardiography as an imaging acquisition technique
will provide a new insight into the 3D dynamic behavior of the MV during cinching. This study did not
account for global expansion and contraction of left ventricle, in vivo annular contraction and expansion
of myocardial fibers. Thus, the active contraction properties of the MA and left ventricle may relieve this
suture cinching tension.

4.5 Summary
This chapter investigated the cinching tension required to reduce MA dilation in passive ovine
heart model. The MA was dilated up to 22.83%. A mean force of 2.1 ± 0.47 N was required for 21.30 ±
5.6% in MA area reduction, reduced leakage by 51.72 ± 16.19% and restored the normal condition with a
significant reduction in the S-L dimension. The cinching tension generated by the suture acts as a
compensation force in MA reduction, implying the maximum tension to be generated by annuloplasty
device to restore normal MA geometry. Several approaches that utilize the CS to rectify MA dilation have
been developed, but long-term durability is yet to be achieved due to current fatigue and fracture events.
Therefore, knowledge of the cinching force with the corresponding MA geometry will greatly contribute
to the development and design of future TMVR devices and understanding of myocardial contraction
function.
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5 Simulated Biomechanical Interaction between
Coronary Sinus and PTMA proximal anchoring stent*

In previous chapters, we have collected experimental data and obtained material parameters from
various constitutive models to characterize the mechanical properties of mitral tissues. From this chapter
and onwards, we will implement the tissue properties and material models into Finite Element (FE)
simulation and analysis. In this chapter, we will first introduce a method to analyze the biomechanical
interaction between stent and tissue model using only a proximal section of the PTMA and a simplified
CS geometry. As we performed and compared tissue properties between human and animal models in
previous chapters, we will also applied different tissue properties and elucidate any difference between
the human and animal models in the assessment and prediction of PTMA intervention. The FE software,
ABAQUS (Pawtucket, RI), will be used throughout the dissertation as the finite element implementation
platform due to its wide commercial availability.

The contents of this chapter were partially published in:
T Pham, M Deherrera and W Sun, “Biomechanical interaction between coronary sinus and proximal
anchoring stent in percutaneous treatment of mitral regurgitation”, Computer Methods in Biomechanics
and Biomedical Engineering 6(11): 4336–4344, 2012.
*
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5.1 Introduction
5.1.1

Nitinol stent and application
Nickel Titanium or Nitinol (NiTi) material is known for its superelasticity or the ability to return

to original shape after severe deformation. NiTi can be stretched over 10% and still return to its original
length [172].

Figure 6-1a shows the loading and unloading cycle of Nitinol relative to other living

tissues that is characterized by a pronounced hysteresis. Compare to stainless steel, NiTi is much weaker
and exhibits a lower ultimate tensile strength. However, the loading and unloading curves exhibit plateau
regions, which a large strain can be gained on loading and the same strain can be relieved upon unloading,
without significant increase or decrease in loads or stress. Macroscopically, when stress is applied to
NiTi, the superelastic NiTi changes its crystal structure from austenite to martensite. The Austensite (A)
structure is cubic in nature, while the martensite (M) structure is complex monoclinic structure. When
stress is removed, the material returns to the original structure and recovers its original shape.

While superelasticity is the result of a stress induced phase transformation, shape memory is the
result of a thermal phase transformation [173]. The transformation temperature of NiTi is characterized
by four transformation temperatures: the martensite start temperature (Ms) which is the temperature at
which the material starts transforming from austenite to martensite, martensite finish temperature (Mf), at
which the transformation is complete and the material is fully in the martensite phase; austenite start
temperature (As) at which the reverse transformation from austenite to martensite starts; and austenite
finish temperature (Af) at which the reverse phase transformation is completed and the material is fully in
the austenite phase. When cooling and in absence of applied load, the material transforms from austenite
into twinned martensite with no shape change (Fig. 5-1c-phase A). At this stage, NiTi loses its stiffness.
By applying a pure mechanical load, a full phase transformation from twinned martensite to fully
detwinned martensite can be observed (Fig. 5-1c-phase B). Upon the presence of temperature Af, a
complete shape recovery is observed upon unloading, resembling elastic material behavior (Fig. 5-1c77

phase C). The effect of shape change and temperature dependency of NiTi is known as Pseudoelastic
Effect, which described in a stress-strain relationship as shown in Fig. 5-1d.
Nitinol is one of very few alloys that is both pseudo-elastic, thermal shape memory and
biocompatible. Thus, NiTi has become suitable material for a variety of self-expanding (SE) stents. These
SE stents are manufactured with a targeted diameter larger than the vessel diameter, so that they can be
crimped and restrained in a delivery system, then elastically released into the vessel. Early design of NiTi
stent was used in non-vascular applications, in a form of round or flat wire. For instance, Endocare s
Horizon Stent was used for the relief of bladder outlet obstruction and IntraCoil Stent for treatment of
patients with superficial femoral artery and popliteal artery lesions [173]. One advantage of simple wire
coil is the capability to retrieve the stent. As mentioned earlier, NiTi stent loses its stiffness at cooler
temperature, thus, retrieving can be easily done by a cold saline.
In the mid-1990s, the laser cutting tubular NiTi stents become popular in many peripheral and
vascular treatments. Early examples of laser-cut tubular NiTi stents are Angiomed Memotherm and the
Scimed Radius stents. The Memotherm was a rigid, closed-cell design with a diamond shaped pattern,
and the Radius is a flexible open-cell design with sequential rings and periodic peak-to-peak non-flex
bridges. More recent designs employ variations and/or combinations of these basic design features, e.g.
SMART Stent (from Cordis), Jostent SelfX Stent (Jomed) and Dynalink Stent (Guidant).
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Figure 5-1: a) Biomechanical compatibility of Nitinol: deformation characteristics of Nitinol and living
tissues, adopted from; b) schematic stress-strain diagram for Nitinol and stainless steel; c) macrostructure
of NiTi showing the Austenite and Martensite phases; and d) stress-strain curve of NiTi material. Images
from (a) and (b) are adopted from [174].

A distinctive feature of NiTi tubular stents is its nonlinear response and hysteresis. These unique
features create such a great advantage for endovascular stenting applications. To illustrate this, the
schematic stress-strain curve for NiTi can be described in the cycle of crimping a stent into a delivery
system, deploying, releasing it into the vessel, as shown in Fig. 5-2 [173]. The stress axis is put as the
hoop force and the strain axis as stent diameter. Since the stent is always manufactured in a way such that
the final expanded diameter is larger than the vessel diameter, it needs to be crimped into the delivery
catheter, from point a to point b, then packaged, sterilized and shipped. During the implantation, stent will
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be released into the targeted vessel, expanding from point b until further expansion is prevented by
impingement with the vessel (point c). Since the stent did not expand to its pre-set shape, it continues to
exert a low outward force, called chronic outward force (COF). From point c to point d, stent will exhibit
a force that will resist recoil pressures or any other external compression forces. This force is much
stronger than the unloading force (point c to point e), which is called the radial resistive force (RRF). In
summary, the stress hysteresis of NiTi allows a very low radial force, or COF, even stent is oversizing.
The stent generates forces that resist compression, or RRF, until plateau stress is reached. It has been
shown that the low COF allows vessel to remodel with less intimal hyperplasia [175].

Figure 5-2: Schematic stress hysteresis and concept of biased stiffness as demonstrated with
the cycle insertion into delivery system/deployment/compression of a tubular stent. Adopted
from [173].

5.1.2

Tissue-stent interaction (TSI) studies using Finite Element Analysis (FEA)
Upon delivered, the stent comes into contact with the vessel wall, thus the COFs impose

mechanical stresses on the vessel wall. In return the hemodynamic conditions (e.g. blood pressure) in the
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vessel generate cyclic pulsating load that accounts for the fatigue life of the device and eventually result
in mechanical failures. The schematic of this cycle is illustrated in Fig. 5-3.

As self-expanding stents

have proven to reduce vessel recoil and restenosis as compared to balloon expandable stents and provide a
less invasive alternative for the treatment of endovascular disease [176], adverse events as the result of
stent mechanical fatigue could result in undesirable clinical events such as thrombosis and intimal
hyperplasia [175] and particularly reoccurrence of MR in PTMA intervention. In order to prevent these
adverse events, it is important to understand the tissue-stent interaction (TSI) and their mechanical factors
that contribute to adverse outcomes during stent deployment process and after stent implantation.

Figure 5-3: Biomechanical interaction between stent and tissue schematic
Studies on the mechanical behaviors of NiTi stents and their interaction with surrounding vessels
have been conducted by many researchers. Wu et al. [177] evaluated the biomechanical properties of NiTi
carotid stents and their interactions with carotid arteries using FEA. Their TSI results showed that stent
with shorter struts may have better clinical results and that stent geometries have an impact on vessel
geometrical changes. Kleinstreuer et al. [178 studied the mechanical behavior (e.g. vessel stresses, stent
strain and radial forces) and fatigue performance of different NiTi materials and grafts during crimping,
deployment and cyclic pressure loading within the abdominal aortic aneurysm (AAA). Using the fatiguelife diagram, they were able to predict the acceptable AAA stent-graft design during crimping and cyclic
pressure loading. Azaouzi et al. {Azaouzi, 2012 #209] used Finite Element analyses (FEAs) to simulate
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the deployment of self-expanding NiTi stent into the artery under pulsatile loading. The authors analyzed
the impact of stent geometries on the arterial and to assess the influence of artery on the deformation field
within the stent. They concluded that stent geometries (e.g. length, width and thickness of strut) have an
influence on stent strength and the amount of stent oversizing has an impact on stent fatigue life.
Auricchio et al. [179] expanded FEA studies of self-expanding stent by evaluating three different stent
designs (e.g. laser-cut open-cell, laser-cut closed-cell and braided closed-cell) in a patient-specific carotid
artery. The authors found that stent design with closed-cell provides higher lumen gain and stent
configuration and size have a limited impact on the vessel straightening.
Although extensive work has been done to evaluate the self-expanding NiTi stents, little or no
attention has been focused on characterizing the biomechanical interaction between the NiTi PTMA stent
and the CS vessel. In this chapter, we present FEA of stent deployment within the CS vessel, considering
the realistic material models of CS vessels. Our FEA provides quantitative measures of stress and strain
of both stent and vessel and estimates fatigue life of stent, a very important key issue for medical
implants.

5.1.3

Human versus animal models
Animal studies have demonstrated the effectiveness of PTMA devices to reduce MR in heart

failure induced by rapid pacing in the short- term [7-9]. However, initial human trials were suboptimal.
The adverse events included compression of the left circumflex artery, perforation of vessel branches,
device migration and device fracture [10-14]. Some of these issues may be improved by a detailed
anatomical assessment of the CS and its tributaries prior to the procedure using imaging modalities such
as multidetector computed tomography. Device dysfunctions involving device migration and fracture,
however, are mainly associated with the biomechanical interaction between CS tissues and the device that
is largely unexplored in the literature. In pre-clinical trials of cardiovascular interventional devices,
animal results are often used as a guide for device design and development. However, without a
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quantitative understanding of the difference between animal and human tissues and the associated deviceCS tissue interactions, the development of these devices based on ad hoc and trial-and-error approaches
can be time-consuming and costly. In the present study, we first established a finite element (FE) study to
evaluate the biomechanical responses of the proximal anchor of this PTMA device when interacted with
the human and porcine CS walls. In addition, we chose two Nitinol stent materials to investigate the
impact of stent material stiffness. The biomechanical interactive properties between the stents and the CS
vessels were quantified by measuring the contact forces, vessel wall stresses, strains and fatigue safety
factor of stents were analyzed.

5.2 Materials and Methods
5.2.1

Model Geometries
The complete FE model for the stent deployment simulation consists of the proximal stent, the CS

vessel, and the stent expanding and crimping sheaths. Geometrical and numerical details of the models
are listed in Table 5-1. The proximal anchor can be thought of as an elastic lattice, deriving its strength
from the joints and bending action of component struts. Because of the lack of symmetry in this part, the
entire anchor has been modeled. The stent geometry, after the laser cut from a cylindrical Nitinol tube and
electroplishing, was 21 mm in length with an inner diameter (ID) of 1.6 mm and a thickness of 0.3 mm,
as shown in Fig. 5-4a. This stent geometry was further deformed, through a series of expansion and
annealing process, to an expanded shape as shown in Fig. 5-4b. Typically, the stent anchor’s diameter is
oversized and larger than the CS’s diameter by 2 – 4 mm [180]. Therefore, it was expanded from an ID of
1.6 mm to a targeted ID of 14.90 mm, assuming the CS’s ID is 12 mm. The radial expansion was carried
out in the FE simulation by displacing the expanding sheath that placed inside the stent anchor in
increments of 3, 4, 6, 8, 12 and 15.50 mm in outer diameter (OD), each followed by an annealing step.
The annealing process was simulated using a built-in function in ABAQUS (*anneal) where stent stresses
and strains were set to zero. By dividing one large deformation step into several steps of small
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deformations with an annealing process, the potential damages to the stent that may be caused by large
deformations can be effectively reduced. The final deformed geometry of the stent anchor is shown in
Fig. 5-4b, in which it was composed of two strut cells in the axial and twelve in the circumferential
directions. The two pairs of stent struts were joined by a strut link (Fig. 5-4c). Crimping and release of the
stent anchor were achieved by displacing the cylindrical crimping sheath located externally of the stent
anchor inwardly and outwardly, respectively.

Figure 5-4: a) The 3D undeformed shape of the stent prior to expansion-annealing process,
showing the connector and the stent body that is composed of 12 struts in the circumferential
(z) and 2 in the axial (x) directions; b) the 3D deformed shape of the stent after expansionannealing process; and c) the two struts of the stent are united by a strut link. The strut is
twisted asymmetrically after the process.
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Table 5-1. Geometrical and Finite Element modeling measures of all models

Models

Dimension (mm)
Undeformed Element type

No. of elements

CS

ID
Thickness
Length

12
0.74
60

C3D8I *

43,199

Stent

ID
Thickness
Length

1.60
0.30
21

C3D8I *

114,219

ID
Sleeve_expand Thickness
Length

11
‐
41.5

M3D4R †

2,231

ID
Thickness
Length

15.52
‐
41.50

M3D4R †

2,231

Sleeve_crimp

A study by El-Maasarany et al. [85] on the anatomy of the CS vessel showed that 80% (32/40
patients) of human specimens had coronary sinus as a cylindrical shape near the opening into the right
atrium. Thus, we simplified our CS vessel model to a cylindrical tube, with an inner diameter of 12 mm
and a thickness of 0.74 mm [181], to facilitate the comparison between different CS tissues and stent
materials.
The 8-node hexahedral linear incompatible mode element (C3D8I) was chosen to mesh both the
CS vessel and the stent as C3D8I is preferred for stent analysis due to the nature of bending during
loading. The 4-node quadrilateral element (M3D4R) was modeled for the expansion and crimping
sheaths. A mesh sensitivity analysis was performed, see appendix A for more details.

5.2.2

Material properties and constitutive modeling
The two different Nitinol materials, Nitinol 1 (N1) and Nitinol 2 (N2), were utilized in the

simulations, adopted from Kleinstreuer et al. [182] with modifications. For an isothermal analysis as the
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one presented here, the stent material model can be defined by a stress-strain curve and “breakpoint”
stresses, as shown in Fig. 5-5a. The inputs to this model are the two moduli of Elasticity, the plateau
transformation strain and the five stress breakpoints. From Table 5-2, it can be seen that N1 material is
stiffer than N2 material with higher austenite (EA) and martensite (EM) moduli.
Table 5-2. The material parameters of CS vessels and stents

µ1 (MPa)

a1

µ2(MPa)

a2

Human 127.653 5.928 -63.082 11.851
Porcine 8.213

EA(MPa)

µ2(MPa)

a2

4.674

19.317

10.608 22.689 -5.748 -12.515 9.184

νA

EM

νM

εL

SL

EL

SU

EU

SCL

T

(MPa)

Nitin-1 70,000

0.3

47,800

0.3

0.063

600

670

288

254

900

37

Nitin-2 40,000

0.3

18,554

0.3

0.04

390

425

140

135

585

37

The mechanical properties of the coronary sinus of both human and porcine were obtained from
the pressure-inflation tests of porcine (n = 7, 6-9 months old) [183] and human (n = 4, 85.25 ± 7.41 years
old) CS vessels. Briefly, the human CS vessels were subjected to the mechanical test while they were
intact (i.e. the CS vessel was not dissected out of the heart). After 10 preconditioning cycles, the vessels
were incrementally dilated up to 80 mmHg of pressure. The dilated CS diameters were measured to
obtain the CS pressure-radius curve, from which the hoop/axial stress-stretch relation were calculated
[183]. We chose the Ogden isotropic nonlinear hyperelastic model [184] to characterize the experimental
data,
N

W
i1

2i ai
(1  a2i  3ai  3)
2
ai
,

(6.1)

where μi and ai are the material constants and λi are the principal stretches. The mean data from four
human and seven porcine specimens were fitted with the Eq.6.1 to obtain the material parameters. The
goodness of fit was determined using R-square value based on the Levenberg-Marquardt nonlinear

86

regression algorithm using SYSTAT 10 (Systat Software Inc., Chicago, IL). The Ogden model curve
fitting results for both human and porcine tissues are illustrated in Fig. 5-5b & c.

Figure 5-5: a) A typical stress-strain curve for Nitinol material, mean b) human and c) porcine
CS stress-stretch curves fitted with the Ogden model.

5.2.3

Boundary and loading conditions
The expanded geometry of the stent was crimped in a catheter prior to the PTMA deployment. In

the simulation, the stent was crimped to an OD of 11.98 mm using a displacement-controlled deformation
of the crimping sheath, see Fig. 5-6. After the stent release and deployment in the CS vessel, the
biomechanical interaction between the device and the CS wall is rather complex. Here, we briefly
described the procedure and interactive forces involved: The proximal stent anchor is released from the
delivery catheter and deployed into the CS ostium. The expansion of the stent generates contact forces
between the CS tissue and the stent, which enable anchoring of the stent to the CS wall. A biodegradable
suture keeps the bridge links "open" and elongated; upon dissolution, the links close, the bridge length is
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reduced and the proximal and distal stent anchors are brought closer together, reshaping and reducing the
mitral annulus in the septal-lateral distance. Therefore, the bridge segment will impose an axial force on
the proximal stent. In addition, an internal venous pressure of 10 mmHg will also deform the CS wall and
affect the stent-tissue interaction. The major biomechanical loading steps in this process are illustrated in
Fig. 5-6. In the simulation, we developed three corresponding steps as follows:
Step 1 – Contact between CS wall and stent anchor during the stent deployment. The contact was
established by removing the crimping sheath to release the proximal anchor to contact with the CS inner
wall.
Step 2 – Effect of axial contraction force due to the bridge contraction. An axial load with a
magnitude of 2.45 N in the axial direction was applied to the connector elements to approximate the
pulling force generated by the contraction of the bridge section that occurs upon dissolving of the
biodegradable suture [185].
Step 3 – Deformation due to the pulsatile blood pressure in the CS vessel. An incremental
pressure, from 0 to 10 mmHg, was imposed on the luminal surface of the CS wall to mimic the
physiological condition.
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Figure 5-6: (Top) The crimping process was carried out by applying displacement control on
the crimping sheath to decrease the diameter of the stent to less than 12 mm. (Bottom) The 3step TSI simulation: step-1: release the crimping sheath, step-2: apply an axial load of 2.45 N,
and step-3: apply a pressure of 10 mmHg to the inner wall of CS.

The coefficient of friction between the stent and CS inner wall contact surfaces was set to 0.1 in
steps 1 and 2. For step 3, the contact definition was set as a non-slipping condition (an ABAQUS option:
ROUGH) to imitate the effect of long-term tissue in-growth in-between the stent struts. The FE analysis
was performed with the ABAQUS/Explicit release 6.11 on a high performance computing (HPC) Linux
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cluster with Intel Xeon X5650 Westmere cores. The following output variables were analyzed in each of
the three steps.

5.2.4

Finite Element output variables
1) Stress and strain. The von Mises stress was used to report the magnitude of peak stresses

induced by stents on the vessel wall. To facilitate comparison between different models and avoid the bias
caused by local high stress concentration, the 99-percentile values of the peak stresses of the CS vessel
wall were evaluated [186, 187]. The 99-percentile values were computed by excluding 1% of all nodes
containing the highest values (See Appendix A Table A2 for comparison between maximum (MAX) peak
and 99-percentile stresses). Stent strains were analyzed with the maximum tensile strain variable
(SDV24).
2) Contact forces. Contact forces between the outer stent surface and the inner surface of the CS
vessel were extracted from the model. Elevated contact forces in the vicinity of stent struts may lead to
injury of the CS inner wall, or ultimately causes tears of the posterior CS wall. Conversely, insufficient
radial contact forces will prevent proper device anchoring. The contact forces have normal and shear
components, denoted by CNF and CSF, respectively, and are expressed as:

CNF 
CSF 

nc

NF

n, post ,

n1
nc

SF

n, post

n1

.,

(6.2)

where nc is the total number of nodes of the stent cell that are in contact with the CS inner wall, and
NFi,post and SFi,post are the normal contact force and shear contact forces, respectively, at each node after
deployment.
3) Stent fatigue analysis and safety factor [182]. Quantitative studies of metal fatigue often utilize
the well-established Goodman-Haigh diagram [188], which is recommended by the FDA for stent fatigue
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analysis [188, 189]. In Goodman diagrams, a pair of the mean stress or strain and its amplitude (or halfamplitude) at a particular point is plotted and compared with constant life curves [189] for that particular
material. The mean tensile strain, ɛ, and the half-amplitude oscillating strain, Δε, at a given node are
calculated by:

 mean  ( max   min ) / 2
  ( max   min ) / 2

,

(6.3)

where εmax and εmin are the maximal and minimal strains, upon the application of 10 mmHg at a node on
the PTMA stent after deployment. For a Nitinol material, the constant life curves from Pelton et al. [190]
were used. Using the 0.4% strain amplitude delineated by the constant life line [190], the stent fatigue
safety factor can be predicted using the equation: safety factor = 0.4%/half-amplitude strain. Four cases
were analyzed: human-N1 (human CS vessel interacts with N1 stent), human-N2 (human with N2),
porcine-N1, and porcine-N2.

5.2.5

Impact of stent strut thickness
The evaluation of PTMA device performance was performed based on two criteria: 1) inducing a

minimal vessel injury and 2) enabling stent mechanical function (i.e., anchoring and fatigue life). The
mechanical stress on the vessel wall induced by the stent strut cells often provokes vascular wall injury
that stimulates the intimal hyperplasia [191]. Therefore, to minimize the vessel wall stress, the structural
compliance of the stent needs to be low to meet the compliance of the vessel wall. In the meantime, the
stent itself also needs to have enough structural strength to withstand the cyclic mechanical changes
induced by cardiac pulsatile pressures, and have enough radial force for its anchoring mechanism.
The purpose of this study is to alter the stent design to reduce radial interactive forces. The
approach includes maintain the same material properties of the stent and varying the strut thickness. Two
stents models with different strut thickness values were developed. The results from these models include
peak stresses and strains, interaction forces (shear and normal) of the CS wall and the stent, as well as the
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device fatigue life and safety factor were compared to the original design, and differences between these
design can provide insights into the stent designs that may help to reduce future device failure in the
PTMA intervention.
Table 5-3. Values of undeformed design parameters of different stents
No. of strut
Original
Mod1
Mod2

Length

Thickness

Circ.

Axial

No. of elements

26
26
26

0.30
0.23
0.18

12
12
12

2
2
2

114,000
91,370
68,532

5.3 Results
5.3.1

Vessel wall stress
The von Mises stress distributions on the CS vessel wall in Step 1 are illustrated in Fig. 5-7. It can

be seen that peak stresses were located on the regions of the CS wall that were in contact with the strut
links of the stent. The N1 stent induced the highest peak stresses on the human model, whereas N2 stent
had the lowest peak stresses on the porcine model. The 99-percentile peak stress in the human CS induced
by N1 stent was about two-fold higher than that in the porcine tissue, i.e., 31.40 kPa in human vs. 13.36
kPa in porcine. The stresses induced by N2 stent were slightly lower than those of N1 stent for both
human (30.97 kPa) and porcine (12.57 kPa) tissues. In steps 2 and 3, as shown in Fig. 5-8a, there was a
slight increase of the stresses in both human and porcine CS walls. The application of the axial force at
the connector end and the internal pressure could result in the loss of wall apposition at the proximal end
of the stent. As illustrated in the Fig. 5-8c, the porcine model had a gap between the vessel wall and the
stent, whereas a better stent apposition was achieved in the human vessel, as shown in Fig. 5-8b.
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Figure 5-7: Contour plots of von Mises stress distribution on the human and porcine coronary
sinus walls after initial contact with Nitinol stents (N1 and N2).
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Figure 5-8: a) The 99-percentile peak von Mises stresses on human and porcine vessel walls
imposed by N1 and N2 stents in the 3-step TSI simulation, b) the human-N1 interaction with a
good stent apposition, and c) the porcine-N1 interaction where stent is separated from the
vessel wall.
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Figure 5-9: a) The relation between stents’ inner diameter and radial force during crimping.
Lines across the graph represented the maximum normal forces generated from stent N1 in
human and porcine and dotted lines presented the N2 after step 1; the normal and shear forces
in the 3-step TSI simulation for b) human and c) porcine in the 3-step TSI simulations.

5.3.2

Contact forces
Maximum interactive radial forces of 16 N and 9.5 N were needed to crimp N1 and N2 stents

from the ID of 14.90 mm to 11.98 mm, respectively, as shown in Fig. 5-9a. In Step 1, the maximum radial
forces imposed by the stents on the human CS wall were about three times larger than those in the porcine
model, i.e., 5.99 N versus 1.86 N. It can be seen that in Fig. 5-9b & c, the stent N1 generated slightly
higher normal and shear forces than the stent N2 at the initial contact in step 1, i.e., 5.99 N and 0.50 N vs.
5.78 N and 0.44 N for human and 1.86 N and 0.17 N vs. 1.83 N and 0.15 N for porcine, respectively.
Both normal and shear forces slightly increased when applied an axial force of 2.45 N. In step 3, when a
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pressure was exerted to the inner vessel wall, shear forces increased while normal forces dropped due to
the tissue in-growth contact condition.

Figure 5-10: a) Visualization of the stent N1’s undeformed geometry prior to crimping (left)
and of the shape and strain contour of the stent after crimping overlapping with the shape after
the step-3 (right); b) the maximum tensile strains in each step of both stents in the human and
porcine TSI simulations.

5.3.3

Stent strain and fatigue analysis
Stent strain. Fig. 5-10a illustrates the un-deformed and crimped stent shapes, as well as the shape

after step 3 for the N1 stent. The stent deformed nearly back to its original configurations at the end of the
step 3. As shown in Fig. 5-10b, the peak strains of stent N1 stent did not fluctuate much throughout the 3step simulation in both human and porcine models whereas they increased significantly in the N2 stent
after step 1. The maximum strain on the stent in Fig. 5-11a was found to be at twisted struts near strut
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links in all simulations. During steps 2 and 3, high strain regions were observed mostly at the strut link
locations near the connector region (Fig. 5-11b).

Figure 5-11: a) Common maximum local strain observed on the stent strut in all steps (N1
stent is shown), and b) regions that are under high strain after applied a pressure to the inner
vessel wall for stent N1.

Fatigue analysis of stents. The Goodman diagrams in Fig. 5-12 plotted the fatigue-life responses
of the two stents under a cyclic loading pressure of 0-10 mmHg. Although all strain values of the N2 stent
in human and porcine tissues were below the constant life line curve of 0.4%, they were more scattered
and wide-spread compared to the N1 stent. The maximum oscillating strain of the N1 stent in the human
model was 0.23%, and its safety factor was 1.72. The safety factor of the N2 stent was higher, 2.98, with
the oscillating strain of 0.13%. When deployed in porcine tissue, the N1 stent had a safety factor of 4.07.
In contrast, a very high cyclic strain of 0.34% observed in the N2 stent resulted in a relatively low safety
factor of 1.17.

5.3.4

Impact of stent strut thickness
Stress and strain analysis. It can be seen in Fig. 5-4 that the stent strut was twisted after

expansion and annealing. The stent outer surface is not smooth. Thus, it is necessary to perform the
expansion and annealing procedure to obtain accurate per-deployment stent geometries. Table 6.4 lists all
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the maximum Von mises stresses and strains of the vessel wall, as well as three stent models. Both Mod1
and Mod2 stents are softer than the original stent model, resulted in higher maximum strains on the stent
after releasing the stents. Stresses on the stent increased as strains increased.

STEN
T

CS
WAL
L

Table 5-4 Maximum von Mises stresses and strains of CS wall and stent models

Steps
1
2
3
1
2
3

STRESS (MPa)
Original
Mod1
Mod2
3.47E-02 3.44E-02 3.30E-02
3.66E-02 3.55E-02 3.52E-02
3.58E-02 3.55E-02 3.46E-02
1001.00
955.00
947.40
358.60
380.00
371.60
444.70
480.30
525.90

Original
0.23
0.26
0.27
2.49E-02
4.96E-03
6.37E-03

STRAIN
Mod1
0.23
0.23
0.25
2.40E-02
5.40E-03
6.88E-03

Mod2
0.23
0.28
0.25
2.38E-02
5.32E-03
7.54E-03

Normal and shear forces. Because stiffer stent generated a higher normal force, Mod1 and
Mod2 stents exerted less forces compared to the original stent, as shown in Fig. 5-9a. There is a slight
difference in forces between the stent models in steps 1 and 2 but no difference was observed in step 3.
No device slippage was observed in step 2. Shear forces, illustrated in Fig. 5-9b, increased in step
3demonstrating the tissue in-growth over time.

5.3.5

Stent fatigue analysis
The strain amplitude of the original model is 8.43E-2% and the safety factor is 4.75. Decreasing

in strain amplitudes of Mod1 and Mod2 (6.61E-2% and 6.68E-2%) resulted in higher safety factors of
6.05 and 5.98, respectively. Changing stent thickness does not reduce the fatigue life of the stent in the
PTMA intervention. As shown in Fig. 5-12, strain points on the Goodman diagram of Mod1 and Mod2
are similar to the strain points of the original design, and all are condensed and below 0.1% strain
amplitude and 1% mean strain.
This computational study indicated that PTMA device performance can be improved by altering
the stent thickness. By reducing the stent thickness at a particular value, stress on the vessel wall can be
reduced without compromising the stent anchoring forces and fatigue life.
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Figure 5-12: Goodman diagrams presenting the fatigue life of stents N1 and N2 after applied a
10 mmHg of pressure in the vessel walls, the black line represents the predicted fracture above
0.4 % strain amplitude for a range of mean strains.

5.4 Discussion
5.4.1

Interaction forces and stent migration implication
In this study, we simulated and compared the biomechanical interactions between two anchoring

stents and two CS vessels – the human and porcine CS vessels. Under the same loading and boundary
conditions, the stents deployed into the stiffer human vessel underwent much higher interactive normal
contact forces than when deployed into the porcine vessel. In addition, a larger gap between the porcine
wall and the stents was observed, suggesting that the potential for stent migration is much higher in the
porcine model than in the human model. This result underscored the importance of the CS tissue
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mechanical properties, and also brought up questions on the validity of using animal models to evaluate
the device performance. We recently performed biaxial mechanical testing of CS tissues from three
species: aged human (86.5 ± 9.7 years old), porcine (6 - 9 months old) and ovine (1 year old) tissues. It
was also found that there were substantial mechanical property differences among these three species
[192], with the aged human tissue being much stiffer than animal tissues. Older animals may provide
stiffer tissue properties that are similar to aged humans, although this hypothesis has not been assessed.
In step 3, the contact definition between the CS wall and the stent was set as a non-slipping
condition to imitate the effect of long-term tissue in-growth in-between the stent struts. This contact
condition was designed mainly to study the long-term stent fatigue damage, during which tissue ingrowth would occur. It should be also noted that the axial pull mechanism from the bridge elements of the
PTMA device occurred gradually and would not be fully active until the imbedded suture dissolved
completely over approximately 1 month. During this period of time, stent anchoring inside the vessel may
be enhanced because of the tissue in-growth. In the immediate post-deployment period, the normal
contact force would be the dominant force. Without the axial pull the chance of stent migration is low.
Moreover, the PTMA procedure is a beating heart operation, any immediate migration of the device may
be corrected immediately in the operation.
Additionally, to investigate the no tissue in-growth condition, we further investigated the normal
and shear forces in step 3 by setting the coefficient of friction between the stent N1 and the human CS
inner wall as 0.1. From the simulation results, no stent migration was observed in step 3. The normal
force of 3.55 N was similar to the original (rough, non-slipping) model of 3.52 N. The shear force,
though, was reduced to 0.34 N while the shear on the original model is 3.34 N, as one would expect.
Another factor that could impact the stent migration is the CS geometry. We assumed the CS
vessel was a cylindrical tube at the anchoring location. The actual anatomic geometry of the CS vessel has
a larger diameter at the ostium and becomes narrower towards the GCV vessel, which may help prevent
the stent from migrating towards the GCV vessel. However, this effect was not investigated in this study.
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5.4.2

Vessel and stent fatigue damage implication
Vessel wall stress. Stent migration and perforation of CS vessel wall are the two competing

factors that require a delicate balance of the expansion force of the deployed stent. A higher interactive
force will facilitate the stent anchoring but may also cause damage to the CS vessel wall. The maximum
peak stresses on the CS wall were about 0.5 – 1 MPa for the human model and about 20 – 200 kPa in the
porcine model. Currently, the published data on the ultimate tensile strengths (UTS) of human CS wall
tissues are limited. One study reported the UTS of porcine CS vessel, which are in the range of 1.66 –
2.57 MPa [193].Thus, based on the simulated peak stresses and the reported UTS of porcine CS tissue,
the perforation of porcine CS wall would not occur. Moreover, we noticed that the peak stresses were
concentrated on a very small number of nodal points, which represented less than 0.06% of total nodal
points of the CS wall and were mainly located at the regions of the proximal and distal ends of the stent.
The high stress concentration might be due to the excessive bending of the elements as a result of
geometrical changes from expanded tissue-stent contact region to the non-tissue-stent contact region.
Thus, to avoid local stress concentrations, the 99-percentile peak stress was adopted for the comparison
among the four models [187, 194].
Stent fatigue analysis. In this study, we investigated the stents made of two different Nitinol
materials. We found that the interactive forces induced by the two stents were similar; however, the
fatigue safety factors of the four models were quite different. The stent N1 had a lower safety factor when
deployed in human than porcine, while stent N2 had a better safety factor in human than porcine model.
This result suggested that the stent material properties could have an impact on stent durability, but not
significantly on its interactive responses with the CS tissues. Thus, a greater impact on the biomechanical
interactions may be achieved by changing the structural design of the stent. Computational and clinical
studies [195, 196 , 197] have shown that decreasing the stent strut thickness has favorable outcomes in
terms of lower chronic vessel stresses and lower clinical restenosis rate, which may be a direction for
further improving the stent design.
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5.4.3

Clinical relevance
Currently, there are several percutaneous devices utilizing a similar trans-coronary sinus concept

to reduce the dilated mitral annulus. For instance, the CARILLON device (Cardiac Dimensions, Kirkland,
Washington), which consists of distal and proximal anchors (Nitinol and titanium) and joined by a Nitinol
ribbon connector, could reduce the dilated annulus by manually pulling the proximal anchor toward the
CS ostium. Due to the difficulty in anchoring to the CS wall, a second generation device was developed
with a twist at the distal anchor. The device was implanted in humans for up 6 months of follow-up [77].
A total of 30 out of 40 patients successfully received the device with an average of 23% MR reduction.
However, three patients suffered from CS perforation and dissection. Another device, Viacor (Viacor,
Wilmington, Massachusetts), consists of up to three rigid Nitinol rods. Various rod sizes and stiffness are
used to achieve the desired MR reduction. The issues with this device were associated with fracture,
migration and delivery failures due to the vast difference in CS structures and geometries [27, 78].
Patients not only have high variability in CS anatomical structures, the mechanical properties of CS also
varied greatly, as shown previously by Pham and Sun [192].
The current adverse events are associated with vessel injury (e.g. perforation and dissection) and
device malfunctions (e.g. migration and fractures), which possibly are the results of mechanical mismatch
between the implanted devices and the CS tissues. For instance, the CARILLON anchors were formed by
two wires twisted together. Hence, lack of a sufficient stent-tissue contact surface might result in high
stress concentration leading to perforation of the CS wall, as well as high possibility of device slippage.
Fractures of the VIACOR device might be due to its lack of flexibility and stress reduction (due to its rod
structure) to accommodate the dynamic motion of the CS vessel wall. Clearly, rigorous engineering
analysis is warranted for the investigation of these device malfunctions.
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6 Simulation of Complete PTMA Device Deployment into
Patient-specific CS*
In the previous chapter, we have introduced a FE method to analyze the biomechanical
interaction between the proximal stent and the ostial region of the CS vessel. In this chapter, we added
several key components of the delivery systems which are essential to the final deployed configuration as
seen clinically. It is well known that human anatomy is highly variable and the procedural outcomes of
any medical devices are essentially related to anatomic considerations. In this study, for the first time, we
will introduce FEA of a complete PTMA device being deployed within a selected patient-specific CS
model. Several techniques used to reconstruct 3D patient-specific model will be first reviewed in Sections
6.1.1-2 and a technique of reconstructing the CS will be introduced in Section 6.2.1. Next, the analysis of
tissue-stent interaction (TSI) will be divided into two phases. In phase 1 in Section 6.2, three patientspecific CS models were selected and PTMA stents were modeled with a simplified bridge section. A
complete PTMA stent with bridge section and the entire deployment process will be introduced in Section
6.3. Evaluation of the stent and its interaction with the CS vessel as well as the predicted clinical
outcomes were analyzed for each phase.

*

Some of the contents of this chapter are taken from:

W. Sun, C, Martin and T Pham, "Computational Modeling of Heart Valve Function and Intervention ", Annual Review of Biomedical

Engineering, accepted.
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6.1 Introduction
6.1.1

Patient-specific noninvasive imaging modalities
Much of the recent advancement in valvular heart disease evaluation and treatment can be

attributed to the advent of noninvasive cardiac imaging modalities, such as echocardiography (Echo),
magnetic resonance imaging (MRI), and computed tomographic imaging (CT), which are now being used
extensively for diagnostics and risk evaluation. Clinicians rely heavily on Echo for evaluating aortic and
mitral valve morphology. In particular, transesophageal echocardiography (TEE) is used extensively for
the evaluation and diagnosis of MV pathology as well as the feasibility of repair. The 2D TEE provides
high quality images of the MV, yet sometimes the site and degree of prolapse can be incorrectly identified
from 2D images [198-200]. Consequently, 3D TEE is being increasingly adopted. However, as TEE has
a relatively poor spatial resolution compared to MRI and CT, MRI is preferred for analyzing valvular
flow characteristics. Because CT has been shown to facilitate accurate and reproducible AV annular
measurements compared to Echo [201], it is more relevant in geometric measurement applications,
particularly in transcatheter aortic valve (TAV) intervention where AV geometries are of importance.

6.1.2

Valvular imaging process and segmentation
The precise patient-specific geometry and location of valvular features is of critical importance

for the proper diagnosis and treatment of valvular diseases. Recently, several research groups have
obtained in vivo AV and MV geometries using Echo [57, 202-204], MRI [33, 46, 58] and multi-slice CT
scans [44, 45, 205-207] to reconstruct patient-specific aortic and mitral valve models. From these
images, it is often difficult to identify the more delicate valvular substructures such as the leaflet free edge
and chordae tendineae. A more accurate description of the valve structures is achievable, but these
methods often employ manual tracing or manual geometrical reconstruction by point selection and
interpolation [57]. Now, many groups are using semi-automatic methods to segment the valve structures
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from clinical images through standard image processing techniques such as intensity-based thresholding
to distinguish the valve structures from the surrounding blood pool [32, 44, 58, 207].
Many of the segmentation methods discussed previously are static or at one time snap-shot. The
segmentation process would have to be repeated for additional time points in order to analyze the
dynamic valve geometries through the cardiac cycle. Real-time visualization of the 3D valve geometries
throughout the cardiac cycle could also greatly benefit clinicians. There are now a couple dynamic valve
models in the literature to address this need. Veronesi et al. [208] were among the first group to quantify
the 3D AV and AV dynamics from matrix array transesophageal images. The AV and MV features were
semi-automatically detected and then automatically tracked through the cardiac cycle. Ionasec et al.
[209] have also developed a dynamic model of the aortic and mitral valves with the ability to capture
morphologic and pathologic differences over an entire cardiac cycle based on the trajectories of landmark
points. The robustness and accuracy of the method was demonstrated by extensive experiments on 1516
TEE and 690 cardiac CT volumes with an average processing time of 4.8 seconds and an average
accuracy within 1.45 mm of the expert defined ground-truth. The use of subject-specific dynamic valve
models for pre-operative planning holds great promise; however, an automated, fast, and user-friendly
method to load 3D imaging data, refine them into nonlinear FE models, and from there to further
visualization and simulation processing has not yet been accomplished.

In this Chapter, we adopted the semi-automation method to reconstruct the geometry of the CS
vessel for the purpose of analyzing the tissue response after PTMA stent deployment. Full phase cardiac
MSCT scans were collected from patients at Hartford Hospital (Hartford, CT). Institutional Review Broad
approval to review de-identified images was obtained for this study. Selected patients with very good
visualization of the CS geometry were selected and digitized at our laboratory.

6.2 Modeling the biomechanical interaction of a whole PTMA deployment
into the CS
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6.2.1

Patient-specific model of the CS vessel
Del Valle-Fernandez et al. [84] studied the dynamic anatomy and the relationships of the

CS/GCV and its spatial relation with the MA using multi-detector computed tomography angiography
(MDCTA). Through the injection of nonionic contrast media through a peripheral vein, CS vasculature
could be visualized and at various phases of a cardiac cycle (40%, 75% and 0% of the RR interval
presenting the end-systole, mid-diastole and end-diastole, respectively) were analyzed using the EKG
signal. They found that the geometries of the CS/GCV were statistically significant different among the 3
phases of the cardiac cycle, with the largest diameter and area observed at phase 40% (end-systole) and
the smallest dimensions observed at phase 0% (end-diastole). Therefore, the reference (initial) geometry
of the CS/GCV was reconstructed at the end-diastole phase.

The MSCT examination was performed on a GE LightSpeed 64-channel volume computed
tomography scanner. In general, a total of 2000 slices of images with thickness of 0.625 mm were
collected for the whole cardiac cycle [205]. A collimation of 25-30 × 0.625 mm and a rotation time of 375
ms were used resulting in a temporal resolution of less than 200 ms depending on the heart rate and pitch.
Typically, 10 phases can be obtained for each cardiac cycle. MSCT images of the CS at end-systole and
end-diastole were imported into Avizo 6.7 software (VSG, Burlington, MA) for 3D reconstruction and
evaluated using a selected range of Hounsfield units. The end-systole was identified on a frame after
mitral valve closing and before mitral valve opening, while the end-diastole was identified prior to mitral
valve closing and after mitral valve opening. For each phase, the CS ostium was first identified at the
right atrium in view 3 in Figure 6-1, which shows the curved planar geometry of the vessel. Upon
manually tracing the CS in several frames, the cross section of the CS were automatically marked in
views 1 and 2, which show the CS relative position to the mitral valve. The 3D presentation of the vessel
was formed after generating a surface and formulating tetrahedral mesh in Avizo.
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Figure 6-1: The 3D reconstruct of the coronary sinus (CS) using three views, xy (view 1), YZ (view 2)
and XZ (View 3) using Avizo image-processing software and meshed using Hypermesh software.

6.2.2

Patient selection
From the 14 CS vessel reconstructed models, three CS models were selected for the analysis of

PTMA stent deployment. The geometrical measurements of the CS vessel includes the CS and GCV
diameters, the length of septal-lateral and anterioposteior mitral annulus, the distances between the CS
ostium and middle cardiac vein, between the middle cardiac vein and left marginal vein, between the
great cardiac vein and the left marginal vein, see Figure 6-2. Table 6-1 summarizes the CS and GCV’s
diameters and their respective proximal and distal anchor’s diameters.

Table 6-1. Patient CS geometries and their respective stent geometrical measurements.

P1
P2
P3

Length (mm)
CS
Stent
103.67 82.45
108.20 76.00
118.70 89.20

CS
0.61
0.74
0.74

Thickness (mm)
GCV
Prox
0.51
0.30
0.37
0.30
0.37
0.30
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Dist
0.30
0.25
0.30

CS
10.53
6.76
10.04

Inner Diameter (mm)
Prox
GCV
Dist
14.88 (+4)
4.71 8.47 (+4)
12.00 (+5)
5.21 6.83 (+2)
14.88 (+4)
4.24 8.47 (+4)

Figure 6-2: Representative CS vessel identified from a patient CT images in a) short-axis and b) longaxis views, and c) the CS vessel geometrical measurements. L sl – length of septo-laterol mitral
annulus, L ap – anteroposterior length, D gcv – Great Cardiac Vein dia., D ost – CS ostium dia.,
MCV – Middle Cardiac Vein, LMV – Left Marginal Vein

6.2.3

Tissue properties and modeling techniques
The CS material parameters were obtained from fitting the experimental pressure-inflation data

collected from four cadaver CS vessels to the nonlinear hyperelastic Ogden model as specified in Chapter
5. Please refer to Table 5-2 and Fig. 5-5 for the mean values of material parameters and mechanical
behaviors of human CS vessels and of a Nitinol stent material, respectively.
The simulation process was divided into three steps: Step 1: Releasing both anchors into
contacts with the CS wall. Step 2: Connecting the bridge element to the distal anchor connector. Step 3:
Applying the CS pressure in the vessel wall. The analysis was run with ABAQUS/Explicit v6.9 on a
Linux cluster using 12 2.8GHz CPUs. The tissue-stent interaction (TSI) was evaluated based on the
following parameters: 1) the normal and shear contact forces between both of the stents and the
corresponding vessel wall, 2) the maximum tensile strain of the stents and maximum principal strain
imposed on the CS vessel wall, and 3) Von Mises stresses of CS wall.

108

6.2.4

Finite element simulation results
Figure 6-3 a&b show the CS and GCV strain and stress distributions in the three-step simulation.

Due the smaller size of the GCV, all GCVs were overstretched more than the CS ostium. As the result,
the GCVs exhibited significantly higher stresses and strains compared to the CS ostial regions. It could
be that the tortuosity of the CS vessel plays a role in the overall wall stress. For instance, for the less
tortuous vessel, stent can conform well to the vessel curvature and no local high strain to be observed.
Patient 3 has a very tortuous CS geometry where the GCV section was constricted, as shown in Figure
6-4. As the result, highest wall stress was observed, see Figure 6-3b. The radial forces generated by the
distal anchors were greater than by the proximal anchors after stent release and come in contact with the
vessel wall in step 1, Figure 6-3c. The normal forces were greater than the shear forces in all simulation,
which indicated a less likely of stent migration. From Figure 6-3c, it can be seen that patient 2 exhibited
lower distal normal force than proximal normal force. It could be that the GCV was only 11% over
dilated while patients 1 and 3 were 32.22% and 38.29% over dilated, respectively.
We approximated the mitral annulus area by measuring the change in the region encircled by the
CS vessel from the undeformed to the final step. The results show that on average, 15% of the area was
reduced in three patients.
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Figure 6-3: a) CS vessel stress and strain results and the normal in the three simulation steps; and b)
normal and shear forces of the proximal and distal anchors after stent release and come in contact with the
CS vessel wall in Step 1.

Figure 6-4: Strain distribution on the cs ostial and Great Cardiac Vein sections after step 3.
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A consistent increase and decrease pattern of normal contact forces was observed in all patient
results, see Figure 6-5. Shear forces were very low in step-1 due to the stent expansion. The shear forces
increased dramatically in step 2 as the bridge section connected to the distal stent. Shear forces become
greater in step 3 in patients 2 and 3 after applied a CS pressure of 20 mmHg. However, because it was not
significantly greater than the normal force, no stent migration was observed. In patient 3, the shear force
was smaller than the normal force. This could be that the bridge section is slightly longer.

Figure 6-5: The reactive forces in each of the three deployment steps for three patients, and the CS/stent
deformed shapes of the three patients.
A longer bridge section in patient 3 could affect the functionality of PTMA stent. It can be seen in
Table 6-2 that the stent length for patient 3 is 89.20 mm or bridge length of 48.96 mm, which is longer
than patients 1 and 2. As the result, patient 3 has a lower reduction in mitral annular area compared to
patient 1, 13.88% versus 16.75%. For patient 2, although the bridge length is shorter than patient 1, it’s
CS length is 5 mm greater, which resulted in smaller mitral annular area reduction. To summarize the
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results, the shorter the stent is relative to the CS length, the more reduction is in mitral annular area,
although too short stent might increase the chance of stent slippage. Table 6-2 also shows the change in
the left ventricle end-systolic (LVES) from patients undergo PTMA intervention in Harnek et al. study. It
has been shown that the mitral annular size linearly correlates with the changes in left ventricle endsystolic (LVES)/end-diastolic (LVED) volume. Therefore, this study showed that a reduction in mitral
annular area is within the range reported in clinical study.
Table 6-2. The reduction in mitral area and the left ventricle end-systolic (LVES) and the corresponding
stent length.

P1
P2
P3

CS_L

Stent_L

Bridge_L

(mm)

(mm)

(mm)

103.67
108.22
118.80

82.45
80.63
89.20

41.50
43.13
48.96

ΔA (%)
‐16.75
‐7.91
‐13.88

Δ‐LVESV (%) Follow‐ups
Harnek et al.
‐6
3 mo
‐4
6 mo
‐17
12 mo

6.3 Modeling of a complete PTMA device deployment with a delivery
catheter system
In this section, we selected a patient from our database to study the TSI incorporating two
additional features: (1) a complete PTMA stent model with ‘spring-like’ bridge section incorporating the
effect of bio-degradable material and (2) a complete stent deployment process including the stent delivery
catheter components. By adding these two features, PTMA stent deployment and its interaction with the
CS vessel wall will be more accurately simulated and analyzed.

6.3.1

Patient selection
The patients chosen for this study was a 49 years old female. She was selected for CT scans for

suspicion of coronary artery disease. However, from her full-heart CT scans, there was no sign of
calcification in her coronary arteries, as well as no indication of calcification elsewhere. Her left ventricle
size was normal and the mitral leaflets coapt properly at mid-systole phase. Therefore, this patient is
considered healthy.
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6.3.2

Modeling of complete PTMA device with pre-stretch biodegradable materials
The PTMA device consists of three components: the proximal, distal and bridge. Details on the

modeling method of the proximal anchor were previously mentioned in Chapter 5. The structure of the
distal anchor is similar to the proximal anchor but smaller in size and the number of strut cells. There are
9 and 2 cells in the circumferential and axial directions, respectively. The bridge section is a ‘spring-like’
section that can be elongated and retracted. A biodegradable material (BMD) is incorporated within the
bridge section and maintains the device in an elongated form before and during implantation. The 8-node
hexahedral linear incompatible mode element (C3D8I) was chosen to mesh the stent as C3D8I is
preferred for stent analysis due to the nature of bending during loading without experiencing hourglass
effect for relatively coarse mesh. The proximal and distal anchors were modeled with 2,251 and 1,371
elements and 8,432 and 5,048 nodes, respectively. The 8-node hexahedral linear reduce-integration mode
element (C3D8R) was chosen to mesh the bridge with 1,723 elements and 6,264 nodes. The
biodegradable component was modeled using 468 C3D8R elements with 1664 nodes. The CS vessel was
also modeled using 18,630 C3D8R elements and 25,020 nodes with four layers through the thickness. For
the C3D8R element, hourglass control stiffness was utilized to mitigate the strain-free hourglass modes
when loaded in bending. In order to ensure proper hourglass control was used, the kinetic energy was
carefully monitored and kept below internal energy.
The tension of the bridge is determined by prestretching the entire bridge. To prestretch the
bridge, displacement control was used to extend the bridge about 20 mm. According to the manufacture
standard, PTMA device length is 20 mm shorter than the CS implantation length. In order to retain the
tension of the bridge after the bridge was prestretched and throughout the simulation, BDM, which is
modeled as brick element, was incorporated within the bridge cells, as shown in Figure 6-6. Contacts
between the BDM and the bridge elements were enabled after the first prestretch step with a rough
surface interaction (*friction, rough).
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Figure 6-6: Proximal and Distal Anchors and the bridge section with biodegradable material (BDM). The
popup window shows a realistic and simulation demonstration of three bridge cells with three BDM’s
sandwiched in-between.

6.3.3
6.3.3.1

Delivery catheter system and process
Components of the delivery catheter system

The delivery catheter system consists of several components. In this study, we did not include a
complete delivery system. We mainly focused on the biomechanical interaction between the device and
the CS vessel, therefore, we simplified the system to include: the crimper, guide wire and catheter. Other
anchoring components were also used during stent crimping and releasing within the catheter: inner tube
and plate components are to stabilize the bridge section and the distal stent during crimping, respectively.
Figure 6-7 shows the delivery components as well as their respective locations.

6.3.3.2

Stent crimping process
Both the proximal and distal anchors were crimped to a 3 mm ID catheter. The crimper was

modeled as a cylindrical tube with shell elements. Displacement-controlled deformation of the crimper
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was utilized to crimp the stent to the diameter smaller than 3 mm. The inner-tube component, modeled as
cylindrical tube with shell elements, was also radially displaced during this step to stabilize the bridge
element during crimping. The 4-node quadrilateral element (M3D4R) was used to mesh the crimper,
catheter and inner tube with 966, 12426 and 2173 elements and 987, 9752 and 2214 nodes, respectively.

Figure 6-7: Prior and after crimping process showing the geometries of the PTMA stent, crimper,
catheter and inner tube.
6.3.3.3

Deployment of PTMA stent and boundary conditions
Deployment of the PTMA stent was first achieved by delivering a catheter into the CS vessel.

The delivering route of the catheter was specified by a motion path along the CS vessel. Clinically, the
geometry of the CS vessel can be visualized by injecting a contrast agent and imaging with
echocardiography. A practitioner then can have a visualization of a CS geometry and then maneuver the
catheter through the vessel. The motion path is formulated and carried out by a set of unit vectors, their
angles of rotation and velocities.
The unit vectors were selected at various locations within the CS vessel. The angles of rotation
between two unit vectors were calculated from their rotational matrix. According to Euler’s rotation
theorem, any rotation of a rigid body may be described using three angles: , , ϕ. A rotation of an angle
of

about x-axis is defined as:
1
0
0

0
cos
sin
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0
sin
cos

(6.1)

A rotation of an angle of

about the y-axis is defined as:
cos
0
sin

0
1
0

sin
0
cos

(6.2)

A rotation of an angle of ϕ about the z-axis is defined as:
cos ϕ
sin ϕ
0

ϕ

s in ϕ
cos ϕ
0

0
0
1

(6.3)

A generalized rotation matrix can be described as:

ϕ

R
R
R

R
R
R

R
R
R

(6.4)

To solve for , we know that
tan

(6.5)

Then
atan2 R , R
Where atan2(y,x) is the arc tangent of the two variables x and y. When cos(
atan2

R , R

(6.6)
< 0, then

. To prevent this, the equation 6.6 can be modified as
atan2

,

(6.7)

A similar calculation holds for finding ϕ. We know that
tan ϕ

(6.8)

To solve for ϕ
ϕ

atan2

,
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(6.9)

To solve for , we know that
R

sin

(6.9)

Then,
arcsin R

(6.10)

The motion path was controlled by applying the kinematic coupling constraint between a node
and the tip of the catheter. Basically, a kinematic coupling constraints the tip of the catheter (i.e. a set of
slave nodes) to the translation and rotation of a master node in a specified manner. It is useful in this case
since a larger number of slave nodes are constrained to the rigid body motion of a single master node.
Each slave node of the tip of the catheter has a unique relationship with the master node, therefore, the
kinematic coupling constraint can be considered as a combination of general master-slave constraints
{ABAQUS}. The motion of the catheter can be described as turning, twisting and rotating. Therefore, a
kinematic coupling constraint can be used to prescribe a twisting and turning motion without constraining
radial motion. Due to the tortuosity of the CS, a total of 12 locations were selected from the ostium to the
entrance of GCV, as shown in different views of CS vessel Figure 6-8. The translational and rotational
boundary conditions were imposed on the master node, preferred as refnode, in each step to perform the
concerted maneuver through the CS vessel.
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Figure 6-8: A representative CS vessel shows different views of the virtual deployment of the PTMA
device performed by generating a delivery pathway along the guidewire positioning within CS vessel, and
the graph shows the vectors in 3D space.
The CS pressure waveform is assumed to be mimicking the atrial pressure prior to mitral valve
closure. Since the simulation process was treated as quasi-static and only analyze at the end-diastole, a
range of pressure was chosen to simulate the CS pressure, as demarcated in red box in Figure 6-9a. This
pressure wave was applied to each step during the deployment process to simulate the pulsatile blood
flow inside the CS. As shown in the pressure waveform of the entire cardiac cycle in Figure 6-9a,
pressure within the CS does not exceed 20 mmHg. Therefore, we generalized the CS pressure as shown in
the Figure 6-9b.
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Figure 6-9: The CS pressure waveform obtained from a) standard physiological pressure waveform and
b) extracted CS pressure.
The guide wire was modeled as a hollow cylindrical tube that has a curvature similar to the CS
geometry. To simplify the process, deployment of the guide wire will not be simulated; instead, it was
created and meshed according to the CS curvature. Contact between the outer surface of guide wire and
the inner surface of the catheter was enabled in order to prevent catheter from penetrating the CS vessel
wall.
Next, the deployment of the PTMA stent was carried out by retracting the delivery catheter.
Basically, additional 12 steps were performed in which the magnitude of displacement were equal and
opposite direction of the forward delivery route. The distal anchor was first deployed into the CS vessel
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by retracting the catheter at position 11 and the proximal anchor at position 4 (Figure 6-8). According to
the procedure in the instructor manual of PTMA device, the stent needs to be pulled back until the
proximal anchor is at the desired target site. This strategy is numerically implemented as follows. At
position 5, the contact between the proximal anchor and the catheter was set to ‘rough’ so that as the
proximal anchor is pulled back to the direct of the CS ostium, the entire device was also dragged towards
the same direction. Because the distal anchor was already expanded at the GCV end, the friction helps to
resist the anchor slippage. However, if the distal anchor’s diameter is undersized, stent migration is
inevitable. After this step, the rough contact between the proximal anchor and the catheter was released
and proximal anchor release continued at the position 4.
The final step was of the simulation is the contraction of the bridge to cinch the CS vessel. This
step involved removing the contacts between BDM and bridge elements. This step might result in high
inaccuracy due to the high kinetic energy as the stent bounced back to its contracted and non-stretched
geometry. To minimize this affect, viscous damping was added to the bridge section.
Most contact algorithms were performed using either ‘general contact’ or ‘contact pair’
algorithms. The ‘general contact’ was set for stent only due to unspecified surface interactions, which
automatically detects and computes all interactions within the domain. The ‘contact pair’ algorithm was
modeled as master-slave surfaces which were specified by users. Table 6-3 list all the contact surfaces
and their algorithm and friction coefficients.
Table 6-3. Contact surfaces and their contact algorithms and friction coefficients
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Contact bodies

ABAQUS contact
algorithm

Friction coefficient
Or rough (no slippage)

Bridge/Biodegradable

Contact pair

Rough

Crimper/Stent

Contact pair

0.1

Stent/Catheter

Contact pair

0.9, 1.0

Catheter/Guidewire

Contact pair

0.01

CS/Guidewire

Contact pair

0.01

CS/Catheter

Contact pair

0.05

Stent/CS

Contact pair

0.1, 0.9

General contact

0.1

Stent

6.3.4

Post-processing
The simulation was similar to the data analysis methods performed in Chapter 5, in this simulation

process, CS stress, stent strain, interactive forces and stent fatigue were analyzed throughout the process.
Figure 6-10 shows which components of the model were analyzed during particular steps. Particularly,
only the bridge section was analyzed during the stent pre-stretch step. In this step, the distal anchor was
fixed and displacement controlled was applied to stretch the bridge and its cell with a total of 20 mm. The
tension of the bridge was measured at the proximal stent connector as total reaction forces. Peak stress
and strain of the bridge was analyzed for potential failure. In the stent crimping step, both proximal,
anchor and bridge sections were analyzed for peak stress/strain, though bridge section was expected to
exhibit minimum stress since only displacement was imposed with no deformation. For the catheter
deliver steps, peak stress/strain of the stent was checked only in the initial deliver step to ensure no high
localized stress. It is assumed that stress will not significantly highly than the peak stress in the previous
crimping step since only displacement control was imposed on the catheter to move the stent into the CS
vessel. However, kinematic energy with respect to strain energy of the stent was monitored throughout
the entire deliver process. The interaction between the CS and the catheter was carefully monitored in the
catheter delivery steps to ensure no CS peak stress or damage. In the stent release in the CS vessel step
and the last step of the stent contraction, all components were analyzed in details. Additionally, the mitral
annular area was measured to determine the functionality of the PTMA device.
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Figure 6-10: Schematic of stent deployment process and selected (checked) components to be analyzed.

122

6.3.5

6.3.5.1

Results

Stent prestretch, crimping, release in catheter and delivery process

As shown in Figure 6-11, an uniform expansion of the bridge section of the PTMA stent can be
observed. With the imbedded bio-degradable material, the PTMA stent bridge has a peak strain of 10.2%.
The reaction force has a steep increase at the displacement of less than 9 mm and then levels from 9 – 16
mm of the displacement.

Figure 6-11: a) The stent pre-stretch step where the bridge is prestretched to obtain the bridge tension,
maximum strain on the stent at the end of the step is 10.2%; b) the measurement of reaction forces (RF)
or bridge tension force after prestretched, showing the RF and displacement relationship, which
correspond to the stress-strain Nitinol characteristics.

With the crimping catheter reducing its diameter, the anchoring stents (both proximal and distal
anchoring stents) were crimped into a small diameter, as shown in Figure 6-12. Note that upon the release
of the stent into the delivery catheter, the bridge stent is not straight, but wavy due to the force balance of
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between anchoring stents and the bridge. The proximal anchor has a peak strain of 14.9%, whereas the
distal anchor has a peak strain of 17%. It is clear that the distal anchor has a relatively larger oversize than
the proximal stent. Note the maximum strains did not increase after release into the catheter.

Figure 6-12: The geometry of the stent prior and post crimping process and release into the catheter. The
strain distribution (SDV24) of proximal and distal anchors. Maximum strains did not increase after
release into the catheter.
During the stent delivery process, it can be seen from Figure 6-13 that the delivery catheter would
not induce additional stress and strain on the CS and anchoring stents. At the start of the catheter delivery,
the CS wall stress is about 0.029MPa. When it is delivered about half way into the CS, the CS wall stress
is about 0.031, and the end of the delivery, it is about 0.032
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Figure 6-13: Peak stress and strain of CS, catheter, proximal and distal anchors and bridge section during
the catheter deployment steps.

Due to the shape-memory characteristics of Nitinol material, both anchors spring open during the
release steps. Figure 6-14 and Table 6-4 show the maximum stent strains of selected increments during
the simulated release steps. The spring-open shape of the stent is similar to the realistic shape of Nitinol
stent during release step that observed clinically. Maximum strains of both proximal and distal anchors
are similar, between 0.138 – 0.161. Strain reduced significantly from 0.153 to 0.048 and from 0.138 to
0.024 for distal and proximal anchors after completely removed from the catheter, respectively. The
bridge section strain remained between 0.10 – 0.14 during the entire release step. This demonstrates that
during release step, stent will not experience any critical peak stress that could eventually result in fatigue
damage.
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Figure 6-14: Distal and proximal anchor releasing steps: strain distribution of the entire stent during the
selected ten releasing increments.

Figure 6-15 shows the peak von Mises stresses of both CS ostial region and GCV during the
proximal and distal anchor release steps. The peak stress on GCV was 1.41 MPa after complete distal
anchor release and decreased below 0.8 MPa following proximal anchor release. The proximal anchor
release did not cause high stress at the CS ostium, peak stresses were below GCV stresses. The highest
stress was during half-way release at a value of 0.73 MPa. It could be that GCV was over dilated, at
69.1% while CS ostium was only dilated by 24%. It is interesting that although both anchors were
selected so that they are 2 mm oversize, the GCV showed much over-dilation compared to the CS ostium.
One reason could be the thickness—GCV thickness is half of CS ostium thickness (0.37 versus 0.74 mm,
measured in Chapter 1).
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Table 6-4. The maximum strains during release steps for distal and proximal anchors.

Maximum Stent Strain (SDV24)
Steps
1 (Start)

Proximal anchor
‐‐

Distal Anchor
0.161

Bridge
0.14

‐‐

0.14
0.10

2
3

‐‐

0.159
0.153

4

‐‐

0.048

0.10

6 (Bridge pulling)
7

‐‐
0.149

‐‐
‐‐

0.10
0.10

8
9

0.160
0.138

‐‐
‐‐

0.10
0.10

10 (End)

0.024

‐‐

0.10

Figure 6-15: Peak von Mises stresses on CS ostium and GCV regions due to stent release.

127

The final form of the PTMA stent after deployed within the CS vessel is shown in Figure 6-16a.
It can be seen that the distal anchor is not circular, while the proximal anchor is more uniformly expanded
and conformed to the CS ostium. This could be due to the aggressive oversize of the stent anchor to the
GCV section. At about 6.9 mm extension from the proximal anchor connector, maximum strain of 0.31
was observed. Although the magnitude is relative low compare to maximum 8-10% strain value for
Nitinol to reach to plastic deformation range, this peak could be higher due to stent fatigue overtime. It
has been reported in the first clinical study by Webb et al. that bridge separation is observed at 9-mm gap
between the proximal anchor and the shortened bridge at 22 days in one patient, 30 mm gap at 28 days
and 41-mm gap at day 81 with the return of grade 3 MR. This could be due to the bridge length which
could be too short for this particular patient. However, note that shorter bridge length might produce a
better MR reduction. One possibility that could relieve high strain is increase the strut width of the bridge.
In addition, strains on the stent strut along the connector direction were higher, similar to the observation
in Stent strain and fatigue analysis.
Figure 6-16b shows the reduction in mitral annular area after stent deployment. In Section 6.2.4,
from the same patient, using the simplified bridge model, the MA area was reduced by 16.75%. In this
section, the MA area reduced from 15.21 to 13.45 cm2, by 13.09%. The difference in MA reduction could
be due to the simplified bridge model and delivery process. The results from this section show a more
accurate CS curvature and stent conformity compared to Section 6.2.4. The addition of bridge section
incorporating the biodegradable material and the delivery process could also produce more accurate
responses.
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Figure 6-16: A) A final deformed shape of the PTMA stent in two views and b) reduction in mitral area
after stent deployment.
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6.4 Discussion
6.4.1

Tissue-stent interaction in PTMA intervention
PTMA stent was selected based on patient geometries. Currently, both anchors were 2 – 4 mm

larger in diameter than the CS and GCV diameters, and the bridge’s effective length is 20 mm shorter
than the CS length. Our simulation result from this particular patient showed that the current criteria for
PTMA stent selection might not be appropriate, such that the GCV section might need to be less
oversized compared to the CS ostial section. From the preliminary study of the CS ultimate tensile
strength (UTS), it shows that the human GCV samples were weaker than human CS samples, 1.0 versus
1.5 MPa. By comparing the UTS with the peak stresses observed in this chapter, it can be seen that the
GCV section is most likely ruptured due to its maximum stress (1.41 MPa) exceeding the UTS of 1.0
MPa. However, the CS region’s maximum stress (< 0.8 MPa) was well below the UTS of 1.5 MPa. This
demonstrates that sizing using diameter alone might not provide confidence on tissue damage, as the
tissue properties are of important factor that could greatly affect the outcome of the procedure.

Our study shows the regions of high strain distribution on PTMA stent that are similar to clinical
observation. To prevent stent fracture at the bridge section, the second generation of PTMA device
incorporated suture reinforcement. However, in the second clinical study by Harnek et al., they observed
several stent fractures along the stent anchors, which were observed in our simulations. This information
could shed some lights into the current PTMA stent problems of high strain and fatigue.

6.4.2

Clinical significance of the study
The TSI during catheter delivery and stent release cannot be visualized and analyze by

practitioners during PTMA procedure. Thus, adverse events such as endothelial cell damage, vessel
perforation and stent fatigue could eventually result in device failure and mortality. Quantitative
understanding of the biomechanics is clearly an enabling step for science-based design of the devices.
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This approach will avoid the currently observed disasterous fatigue failure and move towards patientspecific sizing of the implants.

6.4.3

Limitations
There are several limitations of this study. First, the CS vessel was assumed to be fixed at both

ends. The CS vessel starts at the right atrium and ends at the GCV which continues to descend into the
left ventricle wall. Thus, it is appropriate that both ends of the CS will be fixed. Second, there is no
surrounding tissues (i.e., connective tissues, myocardial tissues and mitral annulus) surround the CS
vessel. The cinching force, due to lack of surrounding tissues, could be under estimated. Therefore, in this
study, cinching force was not measured. The mitral annular area could also be overestimated due to the
same assumption. However, this study focused mainly on the interaction between the device and CS
tissues, the measurement of MA area was for the purpose of evaluating the simulation of the bridge after
contraction and comparison between the two bridge models. Third, the material properties of human CS
were not patient-specific and CS model was not obtained from MR patients. A database of human CS
tissues was obtained in Chapter 2, which will be utilized in future studies in combination with a more
robust material model. Currently, CT scan is not standard of care for patients with MR condition.
However, such protocol can be developed and CT scan information will be valuable for MR geometries.
Lastly, the simulation model was not validated with experimental data due to lack of imaging data from
post-procedural patients. In Chapter 4, a method was developed to cinch the ovine MV ex vivo to obtain
the cinching force and MA area. Thus, the computational model in this chapter can be validated by
replicating this experiment using ovine heart model in place of human heart and PTMA stent in place of
the suture. Future validation work will be further discussed in the next section.

6.4.4

Future works
In the future validation study, we will be developing a Nitinol material PTMA stent and the

delivery process. There are several steps to achieve this: 1) obtain the laser cut stent geometry of the
PTMA stent. The laser cut sent geometry is needed for stent manufacturers/vendors such as NDC, or
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Memory, to laser cut the stent from a standard 10 mm or 6 mm Nitinol tube. We will first generate
SolidWork geometry files for various final PTMA stent designs. Afterwards, the FE models of the stents
will be generated from the SolidWork files using the software HyperMesh (Altair Engineering, MI).
Computational simulations will be performed to study the stent forming process from the laser cut
geometry to the fully expanded final shape. The laser cut geometry of the stent will be sent out to either
NDC or Memory for fabrication. Once physical laser cut stents are obtained from vendors, we will
prepare the necessary tools for the heat treatment and forming process to expand the laser cut tube to the
fully expanded shape. 2) Deploy of the PTMA stents into an ovine heart via the coronary sinus (CS)
vessel and measure deformation at passive state (i.e. vessel diameter and mitral annulus reduction) using
ultrasound and 3D digital image correlation system. We will set up an ex vivo ovine heart model to
perform the delivery of the stent into the CS vessel. Mitral valve annulus deformation, mitral valve orifice
area and stent deformation will be obtained and correlated with the FE simulation results of the whole
system stent. In vivo implantation of the PTMA stents is also an option.
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7 Summary and Future Studies*
In this chapter, I will summarize main findings of the previous Chapters (1 to 7). Major
contributions from this dissertation will be highlighted. Then, I will discuss the areas for future studies.

7.1

Summary
In Chapter 1, a brief review of the heart and heart valves, and normal mitral valve structure and

function was provided. Main clinical issues and current clinical treatment techniques for mitral valve
disease were also summarized. Following it, I gave a brief overview of current mitral valve
biomechanical studies on experimentally characterizing mitral valve tissue properties, constitutive
modeling of valve elastic tissue, and computational studies of mitral valve function and intervention.
Finally, I reviewed the recent mitral valve treatment techniques, in particularly the minimally invasive,
percutaneous, transcatheter mitral valve repair, which leaded to the motivation of my research on the
modeling of minimally invasive PTMA intervention for mitral valve repair.
Since coronary sinus (CS) vessel serves as a conduit for the deployment of the PTMA device for
the treatment of functional mitral regurgitation. Characterization of CS mechanical response is an
important step toward an understanding of tissue-device interaction in the PTMA intervention. The
purpose of the study in Chapter 2 is to investigate mechanical properties of the porcine CS vessel using
pressure-inflation test and constitutively model the wall behavior using a four-fiber family strain energy
function (SEF). My results showed that CS vessel exhibited a S-shape pressure-radius response and
could be dilated up to 88% at a pressure of 80 mmHg. Excellent results from model fitting indicated that
the four-fiber family SEF could capture the experimental data well and could be used in future numerical
simulations of tissue-device interaction. In addition, histology study was performed to identify the

*

Some of the contents of this chapter are taken from:

W. Sun, C, Martin and T Pham, "Computational Modeling of Heart Valve Function and Intervention ", Annual Review of Biomedical

Engineering, accepted.
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microstructure of the CS vessel wall. I found a high content of striated myocardial fibers (SMFs)
surrounded the CS vessel wall, which was also mainly composed of SMFs, while the smooth muscle cells
are very low in content. The elastin and collagen fibers are highly concentrated in the luminal and outer
layers and sparsely distributed in the medial layer of the CS wall. These structural and mechanical
properties of the CS should be taken into consideration for future PTMA device designs.
There are two limitations in the study of Chapter 2: 1) the experiment was conducted under
relatively simple pressure inflation loading conditions, and 2) only the porcine CS was examined. Due to
complex tissue-device interactions, quantification of tissue behaviors under multi-axial loading conditions
may be needed. Moreover, a study of CS tissue properties from different species (i.e., porcine, ovine and
human) may be helpful in understanding the outcomes among animal trials and human studies, and
establishing a proper animal model to evaluate the device efficacy. Thus, in Chapter 3, I studied the
mechanical properties of the CS wall from porcine, ovine and human models. The human cadaver CS
tissues were selected from an age group of 86.5 ± 9.7 years old. The CS tissues were subjected to multiprotocol biaxial tests and characterized by the Fung-type elastic model. Histological analysis was also
performed to compare the difference in tissue microstructure among porcine, ovine and aged human CS
tissues. My results showed that the aged human CS tissues exhibited much stiffer and highly anisotropic
behaviors compared to the porcine and ovine. Both of the porcine and ovine CS vessel walls were thicker
and mainly composed of striated muscle fibers (SMF), whereas the thinner aged human CS had higher
collagen, lesser SMF, and more fragmented elastin fibers, which are possibly due to the aging effects. I
also observed that the anatomical features of porcine CS vessel might be not suitable for the PTMA
deployment. These differences between animal and human models raise questions for the validity of using
animal models to investigate the biomechanics involved in the PTMA intervention. Therefore, caution
must be taken in future studies of PTMA stents using animal models.
Since the PTMA technique uses a stent to cinch a segment of the mitral annulus (MA) and
reduces mitral regurgitation. The cinching mechanism results in septal-lateral annular shrinkage.
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However, the mechanism has not been characterized completely. In Chapter 4, a method was developed
to quantify the relation between cinching tension and MA area in an ex vivo ovine model. The cinching
tension was measured from a suture inserted within the coronary sinus (CS) vessel with one end tied to
the distal end of the vessel and the other end exited to the CS ostium where it was attached to a force
transducer on a linear stage. The cinching tension, MA area, septal-lateral (S-L) and commissurecommissure (C-C) diameters and the leakage were simultaneously measured in normal and dilated
condition, under a hydrostatic left ventricular pressure of 90 mmHg. From the experimental results, it can
be seen that the mitral annulus area was increased up to 22.83% after MA dilation. A mean tension of 2.1
± 0.47 N reduced the MA area by 21.30 ± 5.6% and S-L diameter by 24.18 ± 5.28%. Thus, leakage was
improved by 51.72 ± 16.19% following by restoration of normal MA geometry. In conclusion: The
cinching tension generated by the suture acts as a compensation force in MA reduction, implying the
maximum tension needed to be generated by annuloplasty device to restore normal annular size. The
relationship between cinching tension and the corresponding MA geometry will contribute to the
development of future PTMA devices and understanding of myocardial contraction function.
With the quantification and modeling of CS material properties, in Chapter 5, a finite element
analysis was performed to investigate the biomechanical interaction between the proximal anchor stent of
a PTMA device and the coronary sinus (CS) vessel in three steps including i) the stent release and contact
with the CS wall, ii) the axial pull at the stent connector and iii) the pressure inflation of the vessel wall.
To investigate the impact of the material properties of the CS tissues and of the stent on the interactive
responses, the CS vessel was modeled with human and porcine CS material properties, and the proximal
stent was modeled with two different Nitinol material properties with one being stiffer than the other. The
simulation results indicated that the vessel wall stresses and contact forces imposed by the stents were
much higher in human than porcine models. However, the mechanical differences induced by the two
stent types were relatively small. The softer stent exhibited a better fatigue safety factor when deployed in
the human model than in the porcine model. These results underscored the importance of the CS tissue
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mechanical properties. Higher vessel wall stress and stent radial force were obtained in human model than
those in porcine model, which also brought up questions as to the validity of using porcine model to
assess device mechanical function. The quantification of these biomechanical interactions can offer
scientific insight into the development and optimization of PTMA device design.
In Chapter 6, I added several key components of the delivery catheter systems which are
essential to the final deployed configuration clinically. Furthermore, the outcome of the procedure
depends on a proper selection of device that is specific to a patient and his/her anatomical structure. It is
well known that human anatomy is highly variable and the procedural outcomes of any medical devices
are essentially related to anatomic considerations. In this chapter, for the first time, we introduced FEA of
a complete PTMA device being deployed within a selected patient-specific CS model. Three patientspecific CS models were selected and PTMA stents were first modeled with a simplified bridge section.
Evaluation of the stent and its interaction with the CS vessel as well as the predicted clinical outcomes
were analyzed for each phase. To accurately study the functionality of the device and its interaction with
the CS vessel, the bridge section of the PTMA stent was modeled with a spring-like structure, similar to
the realistic one, and with a built-in biodegradable material to allow the bridge to remain extended prior to
its contraction. The entire stent crimping and deployment process was simulated that allowed detailed
analysis of tissue-stent interaction: high stress concentration in the stent and on vessel wall, oversizing of
the CS vessel and possible fracture locations of the stent based on peak strain value.
Major contributions of this dissertation are:
1. Reported, to our knowledge, the first study of the structural compliance of the porcine coronary
sinus using pressure-inflation tests
2. Reported, to our knowledge, the first study of the biaxial mechanical properties of the porcine,
ovine and aged human coronary sinus using planar biaxial mechanical tests
3. Reported, to our knowledge, the first study of aged human mitral leaflet mechanical properties.
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4. Quantified the relation between cinching tension and mitral annulus area in an ex vivo ovine
model
5. Simulated the deployment of PTMA proximal stents into the CS using porcine and human models
and with two different nitinol materials.
6. Simulated the deployment of a complete PTMA device into a patient-specific CS.

7.2 Future Studies
7.2.1

Quantification of in vivo human tissue properties
Although the use of aged-matched human tissue properties in valve simulations is a substantial

improvement over animal tissue properties, there are also limitations to using ex vivo tissue properties
from human cadaveric hearts. First of all, ex vivo tissue properties are not patient specific. Rather the
tissue properties are selected from a cadaveric heart with similar characteristics (age, sex, etc.) to the
patient of interest. This requires a thorough testing database of human tissue properties from an array of
patients with differing ages [210], genders, and degrees of disease because all these factors can
significantly impact the cardiovascular tissue properties. Furthermore, tissue property homogeneity is
generally assumed over a particular region. Ex vivo testing data generally only represents the average
response from the center region of a specimen.

In reality, the tissue structure and the associated

mechanical properties are heterogeneous. The ultimate goal would be to obtain the patient-specific tissue
properties from non-invasive imaging modalities using either the inverse FE method or new techniques. It
is possible to measure aortic tissue expansion over the cardiac cycle by utilizing time-elapsed noninvasive imaging modalities [210]. The difficulty is that the physiological stress/strain range is rather
narrow. The challenge remains to be how to quantify the arterial material responses at low (0-80 mmHg)
and high (>120mmHg) stress levels to obtain the complete material response from the un-stressed and unloaded state to the state of tissue dissection, tear and rupture. Several groups have adopted an inverse FE
procedure to perform stress analysis from in vivo imaging [211-213]; however, such approaches have not
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been applied to valve tissues. A future effort could be to develop an inverse FE method which would
utilize existing databases of human tissue properties to guide the inverse FE solution progress.

7.2.2

Incorporation of the mitral apparatus and left ventricle model
As mentioned in Chapter 1, the MV is a complex yet elegantly structured cardiac valve that

consists of four anatomic components working congruently during a cardiac cycle: an annulus, two
leaflets, approximately 25 chordae tendineae, two papillary muscles, and the underlying left ventricular
myocardium. To complete understand the biomechanics involved in the PTMA treatment of MR, one
needs to incorporate the complete MV apparatus into the computational model.

Currently, the tissue model is greatly simplified to only CS vessel without surrounding structure.
In order to fully analyze the functionality of the PTMA device, it is important to incorporate the
surrounding structure, which consists of the mitral valve, part of the left atrium, left ventricle and the
surrounding connective tissues of the CS vessel. I am in the process of constructing such a computational
model, as shown in Figure 7-1. However, there are still many fundamental studies that remain to be done,
including the characterization of material properties of each of those anatomic components. I have
completed, to my knowledge, the first study on the characterization of 21 aged human mitral leaflets. The
results have been published and incorporated into this dissertation in the Appendix B.
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Figure 7-1: A FEM model of a whole MV apparatus together with the CS, left atrium and left ventricle.

7.2.3

Image-based fluid dynamic and fluid structural interaction simulation
Structural FEA, as conducted in this dissertation, can provide a full and detailed quantitative

stress and strain analysis of regions of interest, while computational fluid dynamics (CFD) can provide a
quantitative description of the flow characteristics, which was not performed here. Fully-coupled fluidstructure interaction (FSI) methods are also emerging to more comprehensively model valvular
biomechanics.

However, the accuracy of computational simulations depends heavily on the valve

geometry, material properties, and the loading and boundary conditions used. Due to the complexity of
the mitral valve, most of the early valve models utilized idealized, symmetric geometries of the valve
structures and adopted linear elastic material properties. Only in the past several years have clinical
images been utilized to develop patient-specific valve models with improved accuracy. Most of the
imaging modalities offer 3D volumetric, time-resolved data that encompass comprehensive structural and
fluid flow information. Such 3D data, although largely unexploited in clinical settings, offers researchers
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the possibility to reconstruct the 3D geometry of heart valves and study MV function and intervention at a
patient-specific level, and pre-operative planning tools can be developed for a specific patient.
Nonetheless, much more remains to be done in the areas of CFD and FSI studies of mitral valve
intervention.

7.2.4

Multi-scale modeling
A normal heart valve functions at multiple length-scales, including organ, tissue, cell and

molecular scales [214]. Since the overall behavior of the heart valve is linked to every length scale,
alteration of one scale would trigger and activate changes in another. Thereby, one cannot fully describe
the heart valve biomechanics from a single length-scale. Mechanical stimuli, such as transvalvular
pressures, impose stretches on the organ-scale that translate to the tissue-scale [215]. It has been shown
that such dynamic deformation in-vitro can mediate the responses of valvular interstitial cells (VICs),
which serve to maintain tissue structural integrity via protein synthesis and enzymatic degradation. The
aortic VIC deformation under a quasi-static physiological pressure was quantified by Huang et al. [216].
They found that the nuclear aspect ratios, measured as an index of overall cellular strain, increased
substantially from 4 to 90 mmHg, with the fibrosa layer exhibiting a greater rate of change compared to
the ventricular layer. Owing to the heterogeneity of the leaflet structure, Vesely and Noseworthy [217]
studied the layer-specific mechanical properties of the porcine AV leaflet, by separating the fibrosa and
the ventricularis from fresh and glutaraldehyde-fixed porcine aortic leaflets, they found that although the
two layers differ structurally, mechanically, they complement each other during AV function, e.g. more
radial extensibility to facilitate valve closure. Later, Stella and Sacks [218] characterized the material
properties of the layers using strip biaxial tests. Their mechanical data were later implemented in a series
of computational studies by Weinberg et al. [219], who developed a computational model to simulate the
mechanical behaviors of valves across the range of length scales. In their most recent study [220], a multiscale simulation in both solid and fluid domains was performed to analyze whether the geometric
difference or the mechanical deformation difference causes the major differences in function and
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pathology (e.g. calcification) between normal tricuspid and BAV valves. Interestingly, the model predicts
that cell-scale deformations were similar in both valves regardless of organ-scale differences, suggesting
calcification may instead be due to a genetic difference which gives rise to a difference in matrix
constituents. Limitations of the study that may have affected their results include modeling both tissueand cell-scales using isotropic constitutive relations, the use of homogenized BAV tissue structures, and
the lack of BAV tissue properties. Although their cell-scale model was greatly simplified, their simulation
was the first to link across the length scales to create a multi-scale model. Clearly, much more
computational work remains to be done at cellular and molecular levels, and innovative methods linking
both the spatial and temporal scales to simulate the development of pathological events remains to be
developed.
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7.3 Conclusion
Minimally invasive percutaneous transvenous mitral annuloplasty (PTMA) devices have been
shown to be promising in correcting MR in several animal studies, however, device dysfunction and
fatigue fracture have been reported in the human clinical trials. These adverse events reflect a pressing
need for a better understanding of the biomechanical interaction between a device and mitral valve
apparatus. In this work, integrated experimental and computational studies were performed to apply
engineering analysis of a minimally invasive mitral valve repair to study the biomechanical interaction
between a PTMA device and surrounding tissues (i.e., CS vessel). A series of experimental methods were
performed to characterize the biomechanics of the CS vessel, which have not been published in the
current literature. Constitutive formulations were introduced to accurately model the tissue properties and
apply to the finite element (FE) simulations. Realistic patient-specific geometries of the CS vessel were
obtained from clinical imaging data and reconstructed into three-dimensional (3D) FE model. By
incorporating patient material properties and 3D patient-specific geometries, FE simulation of the device
deployment into the vessel could be achieved to investigate the tissue-stent interaction (TSI) and the
associated biomechanics involved in the system. The results from experimental and computational data
showed that the mechanical properties of human CS and valvular tissues were significantly stiffer than
ones from animal models and also varied largely among the aging population. These results underscored
the need for carefully evaluating the biomechanics involved in the PTMA intervention and the importance
of having an appropriate animal model for evaluating device function for its ultimate use in human. From
the TSI simulation, detailed analysis include proper sizing of the device, high stress concentration in the
stent and on the vessel wall during delivery and upon deployment, contact forces between the stent and
tissues for tissue damage analysis and possible stent fracture based on fatigue analysis. It is hoped that the
approaches developed in this work will provide a valuable tool that will allow one to virtually assess and
predict the clinical outcomes of PTMA intervention and to facilitate optimal device design and
development.
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8 APPENDIX A: PTMA Element Selection and Mesh
Sensitivity Analysis
Element Selection. In this study, we used the C3D8I element that has 8-integration points with a
5x5 layers of elements cross the stent and CS walls. For most of the stent analyses, due to the bendingdominated loading nature of the stent, the maximum stresses/strains are usually detected at the stent
surface. The incompatible mode eight-node brick element (C3D8I) is preferred for stent analysis because
it provides a good estimation on peak stress and strain and does not suffer from the hourglassing
phenomenon if the integration points are closer to the surface. Although the quality of the C3D8I element
is far from the fully integrated brick element, of which the best results are usually obtained with quadratic
elements, they are relatively low in computation cost. For the current analysis, the computation time takes
about 14 hours with 50 CPUs running on Intel Xeon X5650 Westmere cores.
Mesh Sensitivity Analysis. A selection of different mesh sizes was used to perform a mesh
sensitivity analysis on the interaction of the CS vessel and PTMA proximal stent. Both of the
CS wall and stent meshes were refined, and the results are shown in Table 9-1. The small
differences (results from the end of step-1) between the three meshes suggest that mesh density
has low impact on the simulation results. For the CS model, the mesh 3 achieved the smallest
high stress compare with meshes 1 and 2. Therefore, the finest mesh 3 was chosen for both CS
and stent models in this study. Table 9-2 shows all the maximum (MAX) and 99% stress values
in each TSI step for all four models.
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Table 8-1: Mesh sensitivity analysis

y

y

Variables (Step‐1)

No. of element – CS vessel
von Mises Stress at 99% (Mpa)
von Mises Stress at 1% (Mpa)
No. of element – Stent
Strain (SDV24)
Normal forces (N)
Shear forces (N)

Mesh 1

Mesh 2

Mesh 3

25,920
0.044
1.109
68,532
5.39E‐03
6.514
0.551

34,561
0.035
1.097
91,375
5.82E‐03
6.071
0.523

43,199
0.031
0.884
114,219
5.99E‐03
5.993
0.498

Table 8-2 : Maximu (Max) and 99% peak stress of CS vessel wall

(

)

p

STEP 1
N1‐human
N2‐human
N1‐porcine
N2‐porcine

STEP 2

STEP 3

99 %(MPa)

MAX (MPa)

99 %(MPa)

MAX(MPa)

99 %(MPa)

MAX(MPa)

0.031
0.031
0.013
0.013

0.884
0.507
0.056
0.039

0.034
0.032
0.017
0.017

1.345
0.951
0.175
0.076

0.035
0.033
0.024
0.024

1.268
1.074
0.239
0.118
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9 APPENDIX B: Material Characterization of Mitral Valve
Leaflets*
A complete study of the material properties of human mitral leaflets is reported in this section. The
study characterized human mitral valve leaflets using biaxial testing method and fitted with Fung’s elastic
model. Information obtained in this chapter will be useful for future incorporation of mitral valve into the
left heart model, to study the patient-specific material properties of mitral valve with more accurate
prediction of valvular mechanical responses.

9.1 Introduction
The prevalence of MV disease has been shown to be strongly associated with age of the patients,
particularly in mitral regurgitation patients, increasing from 0.5% in patients aged 18 to 44 years to 9.3%
in patients aged ≥75 years [15, 221]. Clearly, MV disease mainly affects the aged population. It is well
known that aging has a substantial impact on soft tissue mechanical properties. Studies have shown that
the stiffness of aortic vessels is much higher in aged patients compared with that of young patients [222226]. However, our knowledge on the mechanical properties of mitral valve tissues in aged patients has
been very limited. Quantification of native tissue properties has many implications in the development of
medical treatment and prosthetic device, and the understanding of physiological function and disease
progression. For example, mitral valve repair, benefited from the improved understanding of mitral valve
biomechanics, has now been acknowledged as desirable and superior to mitral valve replacement in
virtually all pathologies of mitral disease [227].

The contents of this chapter were partially published in
T Pham, W Sun, Material properties of aged human mitral valve leaflets , Journal of Biomedical Material
Research Part A, 2013, DOI: 10.1002/jbm.a.34939
.
*
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Our current knowledge of mitral valve mechanical properties is mainly derived from that of
porcine mitral valves [7, 228-235]. The assumption that porcine MV is similar to that of human ones is
frequently adopted, even though it has not been rigorously validated. Indeed, there are numerous
computational models of human mitral valve that had utilized porcine MV tissue properties [31, 46, 164167, 236]. Moreover, for prosthetic valve device approval, the Food and Drug Administration (FDA)
mandates pre-clinical animal trials, using either porcine or ovine models, to demonstrate sufficient safety
including performance and handling, as well as to study the efficacy of new valve devices [237]. While
many disparate results between human and animal trials have been observed, the current assumption
taken for heart valve device trials (such as for transcatheter valve intervention [137, 138, 238-241]) porcine and ovine animal models are similar to those of aged humans – is still prevailing.
In this chapter, the mechanical properties of aged human MV tissues, both mitral anterior (AML)
and posterior (PML) leaflets, were characterized using the planar biaxial testing method. The MV tissues
were obtained from individuals above 65 years old with no prior history of valvular disease. The material
stiffness, extensibility and degree of anisotropy of the leaflet samples were quantified. Histological
analysis was performed to examine tissue microstructural properties. The presence of abnormal valvular
structures such as calcific deposits and disrupted fiber structure was assessed. Finally, the material
properties of aged human mitral leaflets were compared with those of animal mitral leaflets published in
the literature.

9.2 Materials and Methods
9.2.1

Materials and sample preparation
A total of 21 hearts from 82.62 ± 8.77 years old human cadavers were obtained from the National

Disease Research Interchange (NDRI, Philadelphia, PA). An approval was obtained from the Institutional
Review Board at the University of Connecticut for human tissue research in this study. The selection
criteria for the hearts were no history of valvular disease or any valvular repair or replacement. See Table
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9-1 for characteristics and medical history of all patients. All hearts were fresh frozen within a postmortem recovery of less than 24 hours and kept frozen during delivery. Upon arrival, the hearts were
defrosted in a hot water bath, and the MV leaflets were dissected out. A total of 20 AML and 18 PML
specimens were removed from the hearts and used in this study. All chordae tendineae were carefully cut
off from the leaflets. The MV leaflets that could not be tested immediately were cryopreserved in 10%
DMSO [110] and stored in the -80˚C freezer until testing. It has been showed that connective tissues can
preserve their structural architecture [242] and mechanical properties [110, 243, 244] when store in a
cryoprotectant agent at low temperature (-80°C). The cryopreserved specimens were thawed using a fourstep process [110] to remove cryoprotectant agent prior to testing. Specimen thickness was measured and
averaged at three locations in the belly region and two in the free-edge region (Fig. 9-1) using a thickness
gauge (Mitutoyo, Model 7301).
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Table 9-1. Patients’ medical history
Specimen

Age

Gender

Smoking

Diabetes

Heart Weight (g)

Cause of death

1

69

M

Unknown

Unknown

733

CPA secondary to HA

HTN

2

88

F

n

Unknown

342

Alzheimer

CAD

2

no data

3

78

M

Unknown

Unknown

396

CPA secondary to HA

HBP, HA

1

0

4

79

F

y*

Unknown

545

Respiratory failure

CHF

2

1

5

81

F

n

y

330

Unkonwn

Stroke

2

1

6
7

96
95

F
F

y
y*

n
n

545
330

CPA
Respiratory arrest

None
None

2
2

1
1

8

79

F

n

Unknown

404

CPA

HTN

1

1

9

98

F

n

y

303

Respiratory arrest

None

1

1

10

82

M

y*

y

714

COPD

HTN, CHF, CAD

2

1

11

75

M

y*

n

425

HA

None

1

1

12

63

M

y*

n

369

Unknown

HTN

2

0

13

75

F

y*

n

575

CPA

HTN

2

1

14

82

M

y*

n

510

CPA

HTN

2

1

15

83

M

y

n

412

Vascular Dementia

HTN, CHF

2

no data

16

87

F

y*

n

295

Unknown

None

2

no data

17

80

F

y*

n

397

Unknown

None

1

1

18

82

M

y

n

544

Aspiration Pneumonia

None

3

3

19

95

M

y

n

425

Natural Causes (Age)

None

2

1

20

87

F

n

n

490

Unknown

None

1

1

21
Mean
SD

81

F
F:10
M:7

y*
---

n
---

621

Alzheimer's related
---

None
---

1
---

0
---

82.00
8.51

464.00
130.86

Heart related disease(s)

Calcification grade
AML
PML
1
1

COPD - Chronic obstructive pulmonary disorder, HTN - Hypertension, HBP – High blood pressure,
CAD - coronary artery disease, CHF - Congestive heart failure, CPA - chronic pulmonary aspergillosis,
HA - heart attack.
*Smoking = quit more than 5 years prior to death.
Calcification 1 = focal, calcification 2 = densely distribution over the belly region, calcification 3 =
complete calcification
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Figure 9-1. a) An image of one excised mitral valve from a cadaver heart. The testing regions are located
in the dash square boxes and above and below regions of the dashed curved lines on each leaflet are belly
and edge, respectively; b) five regions of thickness measurements; and c) mounting position and
alignment of the leaflet specimen.

9.2.2

Biaxial mechanical test
Details on planar biaxial mechanical testing techniques and methods of analysis can be found in

Sacks and Sun 2003 [38]. Briefly, all specimens were mounted in a trampoline fashion by continuous
strands of silk suture looped along each of the four specimen sides, with the circumferential (CIRC) and
radial (RAD) directions aligned to the loading axes of the biaxial test fixtures. In each specimen side, four
barbless fish hooks (size 22) were punctured through the tissue thickness and spaced out evenly near the
leaflet edge (Fig. 9-1-c). All specimens were tested in a phosphate buffered saline solution bath at 37°C.
The four markers were affixed to the lower-belly region of the tissue above the line demarcating the edge
and the belly regions (Fig. 9-1-b). This region was chosen due to its relatively homogenous fiber structure
where collagen fibers are aligned to the circumferential direction. A stress-controlled test protocol was
utilized [117], wherein the ratio of the normal Lagrangian stress components T11 : T22 was kept constant
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with T12 = T21 = 0. Preconditioning was performed to minimize tissue hysteresis. Each tissue specimen
was preconditioned for at least 40 continuous cycles with T11 : T22 = 1 : 1. The seven successive protocols
were performed using the ratios T11 : T22 = 1 : 0.3, 1 : 0.5, 1 : 0.75, 1 : 1, 0.75 : 1, 0.5 : 1, and 0.3 : 1. The
unloaded reference markers were obtained after preconditioning cycles and used to analyze all the
consecutive protocols.

9.2.3

Biomechanical analysis
The mechanical properties of valve leaflets were compared by means of secant modulus at three

equibiaxial membrane tension levels: 1) at 10 N/m for tissue responses under small load, 2) at 60 N/m to
produce responses at physiological level [245], and 3) at high load of 120 N/m for high stress state. From
the equibiaxial protocols, the areal strain, e, was also obtained , e = λθθ* λzz – 1, where λθθ and λzz are
the CIRC and RAD stretch values at the three equibiaxial membrane tension levels, respectively. In
addition, the degree of anisotropy (DA) was calculated as the ratio of CIRC strain to RAD strain under
equibiaxial stretching. With the value of DA approaching 1, the tissue response is considered isotropic,
while others represent various degrees of anisotropy. The correlations between the mechanical property
data and clinical variables were also examined.
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9.2.4

Microstructural analysis
The microscopic anatomy of representative AML and PML tissues used in mechanical testing

were examined. Specimens were fixed in 10% formalin for 24 hours prior to histological process and
analysis. After dehydrated and embedded in paraffin, the specimens were sectioned into 5 μm thick
sections. Tissues were stained with Verhoeff Van-Gieson (VVG) for elastic fiber (as black), collagen
fiber (as pink) and muscle cell (as dark brown/gray) visualization. Crimping of collagen fibers were also
assessed using Picro-sirius red stain. The calcified deposits on the leaflets were identified with von-Kossa
stain. Histological images were obtained from an Olympus U-TVO.5xC digital camera coupled to an
Olympus BX40 light microscope.

9.2.5

Constitutive Modeling
The valve leaflet materials are assumed to be homogeneous and incompressible, and exhibited

nonlinear, hyperelastic and anisotropic responses. The Fung-type model was utilized to model the biaxial
mechanical responses of these valve samples. The in-plane 2nd Piola-Kirchhoff stresses, Sij, were derived
from a strain energy function (SEF), W,

S

(9.1)

where Eij is the Green-Lagrange strain tensor and W is expressed as:
e

W
Q

A E

A E

2A E E

1
A E

(9.2)
2A E E

2A E E

(9.3)

with c and A1-6 are material parameters. The constitutive model was fit to the seven stress controlled
protocols for each individual specimen to obtain the material parameters. The goodness of the fit was
determined by a correlation coefficient, R-square value, based on the nonlinear regression LevenbergMarquardt algorithm in SYSTAT 10 (Systat Software Inc., Chicago, IL).
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9.2.6

Statistical analysis
Data were tested for normality prior to statistical tests. Statistical differences between the AML

and PML variables were determined using the Student’s t-test. A paired-sample t-test was performed to
compare the directional responses. Non-parametric tests, including the Wilcoxon signed-rank test (for
paired data) and Mann-Whitney rank sum test, were used for non-normal distributed sample groups.
Correlations between the parameters and clinical variables were determined using the Pearson’s (for
normal) and Spearman (for non-parametric data) correlation coefficient (r), and p-values were calculated
based on the aforementioned statistical tests. A p-value less than 0.05 was considered statistical
significant, with high significance indicated by p < 0.001. Statistical analyses were performed using
SigmaPlot (V11.0, Systat Software Inc., San Jose, CA) and SYSTAT 10 (Systat Software Inc., Chicago,
IL). All measurements were presented as mean ± standard deviation (SD).
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9.3 Results
9.3.1

Valve leaflet thickness and degree of calcification
The general observations of the leaflet samples were: thickening of leaflets, calcification and

chordae tendineae fusion. As showed in Fig. 9-2, calcified regions on the leaflets were classified into four
groups: 1) no calcification, defined as CALC 0, 2) focal or spotted dense mass of calcium deposition,
defined as CALC 1, 2) dense and uniform calcium deposition over a large continuous region, defined as
CALC 2, and 3) completely calcified and thickened leaflet, defined as CALC 3. From the 20 AML
samples, 35% (n = 7) had CALC 1, 60% (n = 12) had CALC 2, and 0.05% (n = 1) had a complete
calcification or CALC 3. Therefore, all AML samples had some degree of calcification. The CALC 2 or a
uniform and continuous distribution of calcification in the AML samples were observed mainly at the
aortomitral curtain or the anterior annular region that is anatomically coupled to the aortic annulus [246],
and focal calcified spots were observed at the regions of chordal insertions. There was no uniform
calcification in 18 PML samples, 78% (n = 14) exhibited CAL 1, 0.06% (n = 1) with CAL 2 and 17% (n
= 3) with no calcification. Similar to the AML samples, the focal calcification in PML samples were
mostly found at the annular and chordal insertion regions.

One valve had AML and PML thickness of 4.28 mm and 4.0 mm, respectively, due to severe
calcification, which was identified as outliers and removed from the subsequent data analysis. The mean
thickness of AML and PML samples were then 1.74 ± 0.37 (n = 19) and 1.83 ± 0.34 (n = 17) mm, p =
0.51, respectively. Both the interquartile and overall ranges of both leaflet data sets are similar, see Fig. 93. The mean belly and free-edge thickness values are also examined. It can be seen in Fig. 9-3 that the
belly (denoted as AB) regions were significantly thinner than the free-edge (denoted as AE) regions of
AML samples, 1.62 ± 0.34 mm versus 2.00 ± 0.54 mm, p < 0.05. Fusion of the chords and calcification
most likely contributed to a higher value in thickness in the free-edge regions of all AML samples. No
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difference between the free-edge (PE) and belly (PB) regions of the PML leaflets, 1.90 ± 0.44 mm versus
1.70 ± 0.39 mm, p = 0.09. No correlation between age and thickness was observed in both leaflet groups.

Figure 9-2: a) The anterior and b) posterior mitral valve leaflets showing calcification (CALC) degrees:
(1) - focal or spotted dense mass of calcium deposit, (2) - dense and uniform calcium deposition over
large continuous regions, and (3) completely calcified and thickened leaflet.
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Thickness (mm)

4

*

3

2

1

2.00

1.74
1.83

1.62

PML

AB

1.90
1.70

0

AML

AE

PB

PE

Figure 9-3: Boxplots of the thickness of AML (n = 19) and PML (n = 17) samples (left side) and of
thicknesses of belly and edge regions of AML and PML samples (right side). The black lines inside the
boxes represent the median. The red dashes and the numbers represent the mean values. (*) indicates a
statistical significant difference between two groups. AB – Anterior Belly, AE – Anterior Edge, PB –
Posterior Belly, PE – Posterior Edge.

9.3.2

Biomechanical responses
In general, the stress-strain response curve of leaflet tissues exhibits an anisotropic behavior, with

the CIRC direction being the stiffer one. This MV leaflet characteristic has been observed and reported in
studies of porcine [228] and human [43, 247] mitral leaflets. However, in our sample set, several AML (n
= 6) samples had the RAD direction being stiffer than the CIRC direction, see Fig. 9-4b. This reverse
directional response could be possibly due to the calcium deposits within the leaflet, which might
dominate these leaflet responses. In our data analysis, we considered the samples with reverse directional
response atypical for normal aged mitral leaflet tissues, and thus, they was excluded the subsequent data
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analysis. The mean equibiaxial membrane tension-strain curves for the AML (n = 13) and PML (n = 14)
samples in the CIRC and RAD directions after removal of reverse response data at 60 N/m are illustrated
in Fig. 9-4a.

The

mean

secant

moduli

of

mitral

leaflet

samples

were

calculated

(Fig.

9-5).

The AML samples were significantly stiffer than the PML samples at the three membrane tension levels
(10 and 60 N/m, p = 0.002, and 120 N/m, p = 0.006), see Fig. 9-6a. Similarity in the mean areal strains at
60 and 120 N/m membrane tensions indicated that both AML and PML samples reached to a high
stiffening region on a stress-strain curve at 60 N/m, where the collagen fibers may have already been
straightened. Both leaflet groups were anisotropic with mean DA values of 0.46 ± 0.25 and 0.47 ± 0.26 at
10 N/m, respectively, and the values did not change significantly at higher membrane tension levels, 0.48
± 0.18 and 0.48 ± 0.27 at 60 N/m and 0.53 ± 0.13 and 0.46 ± 0.20 at 120 N/m, respectively, as shown in
Fig. 9-6b.

Membrane Tension (kPa)

70

a)

60
50

b)

40

50
40
30
20
10
0
0.00

70

30
20

AML - CIRC
AML - RAD
PML - CIRC
PML - RAD

10
0
0.00

60

0.02

0.04

0.06

0.08

0.12

0.16

Strain

0.05

0.10

0.15

0.20

Membrane Tension (kPa)

Membrane Tension (kPa)

70

AML - CIRC (n = 6)
AML - RAD (n = 6)

c)

PML - CIRC (n = 2)
PML - RAD (n = 2)

60
50
40
30
20
10
0
0.00

0.04

0.08
Strain

Strain
Figure 9-4: a) Mean equibiaxial protocols of the anterior (AML) and posterior (PML) mitral leaflet
samples in circumferential (CIRC) and radial (RAD) directions prior to data removal, b) the AML (n = 6)
and c) PML (n = 2, one sample had stiffness lower than 10 N/m) samples with reverse directions.
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Figure 9-5: Comparing stiffness between the circumferential and radial directions (short bar) and
between the AML and PML samples (long bar) (*) p < 0.05 and (**) p < 0.001.
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Figure 9-6: Comparison of a) the extensibility and b) the degree of anisotropy at 10, 60 and 120 N/m for
the AML and PML samples, no significant variation in degree of anisotropy was found. (*) indicates
statistical significant difference with p < 0.05.
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9.3.3

Correlation with patients’ medical history
No correlation was observed between the mechanical properties and patients’ characteristic data

(Table 9-1) of age, smoking, and diabetes. The leaflet samples were further divided into subgroups of
hypertension (HTN) versus normotensive (NTN), and calcification levels, and compared between the
groups. Of note, for calcification levels, we compared CALC 1 versus CALC 2 for the AML samples, and
CALC 0 versus CALC 1 for the PML samples. Table 9-3 listed the stiffness, the areal strain and the DA
values of each subgroup at 60 N/m membrane tension. An increase in tissue stiffness was observed when
CALC 1 was increased to CALC 2 and when NTN was increased to HTN. All samples remained
anisotropic in all disease states.

9.3.4

Constitutive modeling
A representative seven-protocol stress-strain curves with the Fung-elastic model fits in each

direction of a set of leaflet samples are illustrated in Fig. 9-7-a&b. The patient-specific material
parameters obtained from fitting the multi-protocol experiment data to the seven-parameter Fung-elastic
model of Eq. 9.2 for both leaflet groups are shown in Table 9-2. The model demonstrated an excellent fit
with the mean R2 values of about 0.93 for AML and 0.92 for PML.
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Table 9-2. Material parameters of mitral valve leaflets.
Specs

c

1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
20
21
Mean
SD

0.87
0.85
1.55
0.37
0.26
0.61
2.22
0.98
1.10
0.30
0.13
3.01
0.71
1.00
0.83

A2

A3

A4

A5

A6

R2

c

A1

A2

A3

A4

A5

A6

R2

328.54 220.00
354.72 294.61
371.86 328.02
672.03
94.99
292.65 250.12
188.25
74.98
168.85
72.49
974.11 221.35
351.79 1017.67
368.61 329.88
56.48
11.50
484.73 452.11
460.83 159.80
390.26 271.35
233.15 256.84

58.72
115.29
37.72
80.02
112.10
1.68
42.84
-23.19
344.84
12.17
3.77
251.34
1.11
79.88
107.55

270.79
13.94
339.71
42.72
66.92
1.21
13.90
449.04
178.34
34.12
8.61
60.38
183.35
127.92
145.67

-26.74
0.59
-33.78
-7.12
7.42
0.01
-8.62
17.23
75.48
8.36
-8.30
-41.49
60.34
3.34
33.40

15.92
4.96
65.17
-4.07
28.11
0.71
1.89
32.84
-9.12
-3.04
-1.57
32.19
51.44
16.57
23.49

0.98
0.98
0.95
0.93
0.88
0.96
0.98
0.86
0.85
0.93
0.98
0.86
0.96
0.93
0.05

0.71
5.30
0.33
0.58
0.76
0.73
0.65
1.21
0.28
0.46
0.71
0.84
0.34
0.22
0.94
1.28

145.59
389.56
99.93
30.75
227.88
147.93
26.67
391.98
326.87
83.72
327.54
7.80
228.46
223.13
189.84
133.21

65.70
66.31
85.12
37.56
57.53
54.29
23.90
34.42
62.51
19.45
163.94
246.06
201.21
57.99
84.00
69.15

42.81
92.15
0.03
8.26
7.95
-20.76
8.94
37.73
50.23
11.85
35.08
24.88
0.65
27.18
23.36
27.74

104.35
13.65
13.85
-28.74
13.80
10.39
5.47
84.78
94.13
1.39
34.74
15.57
11.11
39.44
29.57
38.59

-8.67
-1.57
4.33
5.34
-31.37
-2.65
1.26
48.47
0.61
-2.59
5.47
-1.89
3.87
-5.10
1.11
16.48

-10.32
-4.02
1.81
-11.22
17.13
-3.97
1.71
-5.05
2.53
0.23
7.39
-7.91
-17.88
1.58
-2.00
8.68

0.96
0.82
0.97
0.88
0.88
0.98
0.89
0.79
0.95
0.95
0.95
0.87
0.97
0.96
0.92
0.06

A1

Table 9-3. Differences in stiffness, areal strain and degree of anisotropy (DA) between tissue valve
leaflets.
AML

PML

NTN
HTN
CALC 1
CALC 2
NTN
HTN
CALC 0
CALC 1

n
6
7
7
6
8
6
2
12

SM‐CIRC (MPa)
2.03 ± 1.51
2.48 ± 1.28
1.96 ± 1.27
2.64 ± 1.46
1.22 ± 0.99
1.39 ± 0.81
0.94 ± 0.35
1.35 ± 0.95

p
0.30
0.45
0.57
/

SM‐RAD (MPa)
0.77 ± 0.57
1.28 ± 0.64
0.88 ± 0.55
1.23 ± 0.73
0.42 ± 0.20
0.56 ± 0.29
0.28 ± 0.09
0.51 ± 0.24

p
0.10
0.35
0.30
/

Areal strain
0.19 ± 0.19
0.08 ± 0.03
0.17 ± 0.18
0.09 ± 0.03
0.25 ± 0.09
0.19 ± 0.10
0.29 ± 0.09
0.21 ± 0.09

p
0.07
0.45
0.29
/

DA
0.42 ± 0.20
0.54 ± 0.15
0.46 ± 0.18
0.51 ± 0.19
0.52 ± 0.32
0.44 ± 0.21
0.30 ± 0.01
0.52 ± 0.28

p
0.24
0.65
0.63
/

NTN – normotensive, HTN – hypertensive, CALC – calcification, SM – Secant Modulus, CIRC –
circumferential, RAD – radial, DA – Degree of Anisotrophy, AML – Anterior Mitral Leaflet, PML –
Posterior Mitral Leaflet.
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Figure 9-7: Representative experimental data and Fung’s model fit of multiple biaxial in the
circumferential (CIRC) and radial (RAD) of the AML (top) and PML (bottom) samples.
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9.3.5

Microstructural analysis
Figure 4-8 illustrates the Movat stain sections of the belly and free-edge regions of the

representative AML and PML samples in both CIRC and RAD directions. Both AML and PML samples
appeared to undergo the pathological changes: accumulation of fibrous components (arrows in Fig. 9-8),
multiple replicated elastic lamellae in the atrialis layer and disorganized and fragmented elastin fibers
(Fig. 9-8b). In the belly region, infiltration of the massive amount of proteoglycan (PG) and
glycosaminoglycan (GAG) (Fig. 9-8a) together with disorientation of the collagen networks, appeared as
marble-like structure as reported by Stephens et al. [248] in aged porcine mitral valve leaflets, were
observed in both leaflet groups. In the free-edge region, collagen content was abundant in the fibrosa
layer and also evident in spongiosa layer of the AML sample while the amount of PG/GAG was merely
visible in the same region. Fibrin was also evident within the fibrosa layer and highly expressed in the
belly regions in both AML and PML samples. In addition, the von Kossa stains showed the calcified
deposits in the belly regions with a high distribution in the fibrosa layer of the AML sample, see Fig. 9-9.
The calcification content decreased toward the free-edge region and disappeared near the belly and freeedge junction. For the PML samples, only small calcified spots were observed, which scattered in the
spongiosa layer along the radial direction of the valve leaflet.
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Figure 9-8: Representative histological results of the AML and PML samples from one patient. The
images on the top row show the cross sections through thickness in the circumferential (CIRC) direction,
the one on the left is at the belly and the right is at the free-edge region. The bottom row displays images
of sections cut in the radial direction. The pop-up image A on the bottom left shows the proteoglycan
(PG) and glycosaminoglycan (GAG) infiltration in the belly region, and the pop-up image B on the right
shows fragmented elastin fibers in the radial direction within the atrialis layer. The pop-up image C shows
the reduction in undulation of collagen fibers stained with Picrosirius red stain 100x. Red arrows indicate
the accumulation of fibrous layers in the atrialis layers. Asterisk (*) indicate the presence of fibrin
(intense red color) in the fibrosa layers. Movat-pentachrome stains: collagen – yellow, elastin – black,
PG/GAG – blue/greenish, red – muscle fibers, intense red – fibrinoid, fibrin. All histology slides were
captured with 10x magnification under the light microscope. Bar = 400 um.
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Figure 9-9: Representative histological results for calcification (dark brown color indicated by the
arrows) in the belly and belly/free-edge regions in the radial direction. Dense and thick calcified deposits
were seen on the AML belly region covered the spongiosa and fibrosa layers and spots on belly/free-edge
region in the fibrosa. Calcification were scattered throughout the thickness and along the radial direction
of PML sample. Von Kossa stains. Bar is 400 µm.
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9.4 Discussion
9.4.1

Tissue properties related to aging
Heart valve disease mainly affects senior patients. Therefore, a study of normal and diseased

valve tissue properties in advance aged patients is more relevant than a study of younger age groups, and
it could enhance our understanding of the heart valve disease progression and the development of clinical
treatment techniques. In this study, we presented, to our knowledge, the first comprehensive biaxial
characterization of aged (82.62 ± 8.77 years old) human MV leaflets using a relatively large sample size
(n = 21). A comparative study of age-dependent valve property changes was conducted by Stephens et
al. [248] using a porcine model. They compared the three age groups, i.e., 6 weeks, 6 months and 6 years
old of porcine mitral and aortic valves and observed an elevated stiffness and a higher collagen fiber
distribution with increasing age. Another animal study by Stephen et al. [249] showed that changes in
valve PGs and GAGs with age are complex and distinct within valve type. In human mitral valve leaflets,
the GAG content and many different PG subclasses were found to be significantly decreased with
advancing age [250]. Other studies have also shown that age has a significant impact on the composition
of soft tissues [251, 252], resulting in significant differences in both material and microstructural
properties of human aortic tissues [253]. Interestingly, our results suggest that the mechanical properties
of leaflet tissues remain unchanged for persons older than 65 years of age. A broad age range of 30 – 90
years could possibly reveal significant differences as previously reported by others [253].
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9.4.2

Comparison with human MV tissue properties reported in the literature
An early study of human mitral leaflet mechanics performed in 1970s by Clark [254] showed the

unidirectional non-linear stress-strain behavior of generalized leaflets, though with unknown leaflet types,
patient background and medical history. Recently, the uniaxial data of mitral valve tissues from a 88 yearold patient in the study by Prot et al. [43] showed the CIRC and RAD maximum stretches were
approximately 4% and 12% for the AML sample and 23% and 69% for the PML sample, respectively.
Our mean maximum strains were similar to their data for the AML samples, 4% and 10% for CIRC and
RAD directions, respectively, but our PML samples were much stiffer, with 6% and 17% for CIRC and
RAD directions, respectively. Barber and coworkers [247] showed that normal posterior mitral valve
leaflets could stretch up to 15.5 ± 6.2% and 24.1 ± 4.0% strain in the CIRC and RAD directions,
respectively. They cut the tissues into strips, stretched until failure (with higher load range 200-400g) and
reported the maximum tangent modulus as stiffness, which were 6.1 ± 1.6 kN/m (CIRC) and 6.4 ± 0.3
kN/m (RAD). Because of different testing methods (i.e., uniaxial versus biaxial tests), a direction
comparison cannot be made across studies. However, in general, the mechanical behaviors of our samples
seem to be stiffer than others. In our biaxial testing protocols, we performed rigorous pre-conditioning of
at least 40 cycles and analyzed the experimental data using the post-preconditioning reference state. As
shown in the studies by Martin and Sun [255] and Carew et al. [256], valve tissues exhibited significant
residual strains upon unloading, even after 20 cycles of preconditioning. Therefore, in this study, the
tissue response was evaluated after 40 cycles of preconditioning to obtain reproducible mechanical testing
data. By applying rigorous preconditioning, the residual strain was removed when analyzed using the
post-preconditioning state. Thus, the tissue responses obtained in this study were stiffer than ones
analyzed using a less number of pre-conditioning cycles, as shown in the Figure 8 in Martin and Sun
[255].
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9.4.3

Valve microstructure
Even though the hearts collected from patients who were not diagnosed with valvular diseases,

we observed that all AML samples and 88% of the PML samples exhibited a certain degree of
calcification, some with severe calcification. Several retrospective studies of mitral valve calcification
found that it is a degenerative process that commonly occurring in elderly [257, 258]. Woodring and West
[259] found a prevalence of valvular calcification increased with increasing age, 36% of patients over 70
years and 75% over 80. Hence, the mean age of our samples was 83 which could explain the present of
calcification in all of our valves. Mechanically, the samples with more calcified deposits had higher
stiffness and lower areal strain comparing to ones with less calcification. Furthermore, calcification was
mostly found on the annulus and chordae insertion points. Recently, a computational study of mitral
leaflet dynamics has shown that the annulus and chordae insertion locations are associated with high
stress concentration [35]. Thus, the high stress could be one of the factors contributing to tissue
calcification.

Our histological data shows that the microstructure of our human MV leaflets was altered with
evidences of massive calcified deposition, marbling of PG/GAGs, straightened collagen fibers, high
collagen contents and fragmented elastin fibers. Similar observations were reported by Martin et al. [260]
who compared porcine and human aortic valve leaflets and also found straighter collagen fibers that
corresponding to higher stiffness in human tissues compared to porcine ones. The study by Pham and Sun
[261] also found significantly stiffer mechanical properties of their human coronary sinus vessels, which
exhibited a high collagen content in the intima layer, compared to those of porcine and ovine models.

We also examined the difference in mechanical properties of MV tissues between individuals
with and without hypertension. Hypertension has been shown to alter the structure and function of valve
leaflets to accommodate an increase in blood pressure and consequently correlates with valvular disease
such as degenerative and calcification [262-265]. We found that MV leaflets from hypertensive hearts
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exhibited a higher stiffness and lower extensibility values compared to that of normotensive hearts. Yap et
al. [266] studied the dynamic deformation of aortic valve during hypertensive loading conditions and
showed that valves experienced an increased diastolic stretch with high pressure conditions. A long-term
exposure to an increased tensile strain may lead to structural damages resulting in high stiffness and low
extensibility.

9.4.4

Modeling of MV leaflets
Although the overall thickness of the AML samples was similar to that of PML samples, AML

free-edge regions were thicker compared to the belly regions, whereas PML tissues had a relatively
uniform thickness. Mechanically, both of the AML and PML exhibited a nonlinear and anisotropic
behavior. However, the AML leaflets were stiffer than the PML leaflets in both circumferential and radial
directions. Differences between the anterior and posterior leaflets found in this study may indicate that
AML and PML might need to be modeled with separate sets of material properties in computational
studies. Finite element modeling (FEM) has been proven useful in predicting the biomechanics of mitral
valve at pathological [43, 168-170] conditions as well as the mechanical behaviors in the edge-to-edge
surgical repair [64 , 267, 268] and chordal replacement [53] techniques. Up to now, the patient-specific
material properties of heart valve have yet to be assessed in vivo. Thus, our ex vivo human biaxial material
properties data and the constitutive models will be useful in computational studies of aged human mitral
valve and provide more accurate prediction of valvular mechanical responses.

9.4.5

Difference in the mechanical properties between animal and human MV leaflet
tissues.
It is well known that some of bioprosthetic aortic valves are made from chemically-treated

porcine aortic valve and the pre-clinical animal studies are required by the FDA. In addition, there are
numerous studies in the literature that use either porcine or ovine valve tissue as a surrogate for human
one to study MV tissue structure and mechanical properties. For example, planar biaxial mechanical data
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of porcine mitral valve leaflets by May-Newman and Yin [228] and Kunzelman and Cochran [229] were
widely used in constitutive material modeling [31, 164] and simulation of human mitral valve dynamics
at physiological condition [46, 165-167, 236]. However, compared to our data, their tissue responses were
much compliant. For instance, May-Newman and Yin [228] reported stretches of 17% and 20% for AML
and 23% and 24% for PML at 20 N/m in the CIRC and RAD directions, respectively. This suggests that
human MV leaflets were much stiffer than porcine ones and that porcine valve models might not reflect
the functionality of aged human mitral valves.
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9.4.6

Limitations
Studies in the literature have shown the differences between fresh and preserved tissues [269-

277]. Particularly, Clark [254] showed that freezing at -70 °C without any medium markedly altered the
mechanical behavior of mitral valve tissues such that an increase in pre-transition modulus and a
markedly increase in post-transition modulus in frozen samples compared with fresh ones. Due to the
limited access to fresh human tissues, the obtained data from frozen tissue samples could be different
from those of fresh tissues. The additional freezing method using cryoprotectant at a very cold
temperature at our laboratory, however, has been shown to provide a minimal effect in the mechanical
properties [110]. The structures of both anterior and posterior valve leaflets were not homogeneous,
particularly at the free-edge region where the tissue was thicker and exhibited disorganized fiber
microstructures throughout the layers. An assumption of tissue homogeneity in the central region of the
leaflet samples might not represent the material properties of the entire leaflet area. Thus, regional
heterogeneity in mechanical properties of leaflet needs to be further studied. In addition, the degree of
calcification was classified based on structural observation, thus no quantitative correlation with the
mechanical data was assessed. A more detailed quantitative study of valvular pathogenesis including
changes in the ECM components as well as immunohistochemical analysis is needed to further
characterize and correlate with the mechanical data. Another limitation is our small range of ages. A
larger sample size including younger human mitral valves would facilitate comparison and correlation
data with age and further study the mechanics of pathologic valves. For instance, the myxomatous
degenerative disease of the mitral valve leaflet is a common cause of mitral regurgitation [278, 279].
Myxomatous disease occurs more frequently in younger age group [280], and mitral valve repair is a
common treatment technique [281]. Thus, material property data obtained for a younger patient
population with myxomatous disease would be more valuable in FE simulations for evaluating diseased
valvular structure and the efficacy of various surgical procedures.
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9.5 Summary
In this chapter, the mechanical properties of the human mitral valve leaflet tissues aged older than
65 years of age were characterized using a multiple planar biaxial testing method. The overall nonlinear
anisotropic valve leaflet tissue properties were quantified. We found that for mitral leaflets, the radial
direction was significantly more compliant than the circumferential direction. The anterior leaflets were
significantly stiffer and less compliant than the posterior leaflets in both directions. From the histological
results, the changes in the elastic components including the fragmented and disorganized elastin network,
high collagen content and the presence of fibrosis and PGs/GAGs infiltration were observed, suggesting
possible valvular degenerative characteristics in the valve samples. Additionally, calcification was
observed in most of the leaflet samples. Overall, stiffness increased and areal strain decreased with
calcification severity. Leaflet tissues from hypertensive hearts also exhibited a higher stiffness and low
areal strain than normotensive hearts. This study showed that the mechanical properties of aged human
mitral tissues might not be equivalent to that of animal tissues. The anterior and posterior leaflet
mechanical data herein could be implemented into finite element models to study the structure and
function of aged human mitral valve tissues.
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